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Elucidating and Pharmacologically Targeting Secondary Injury Cascades following 
Neural Injury 
Brandon P. Lucke-Wold 
 
 3.4 million concussions occur each year in the United States. Recent evidence 
suggests that some of these individuals are susceptible to neurodegenerative disease 
development following traumatic brain injury. The unknown factor is how acute injury 
contributes to this degenerative process. A prominent neurotrauma related 
neurodegenerative disease is chronic traumatic encephalopathy (CTE). CTE is defined by 
neurofibrillary tau tangles with a perivascular distribution and mood disturbances. In 
order to elucidate the pathologic changes associated with CTE, it is imperative to utilize 
adequate preclinical models. We have strategically developed and tested a clinically 
relevant rodent blast model. The model reliably produces a CTE phenotype including 
tauopathy, cell death, impulsivity, and cognitive decline. Using this validated model, we 
investigated several important secondary injury cascades that link acute brain injury to 
chronic neurodegenerative changes. More importantly, we pharmacologically targeted 
these pathways and found improved pathologic and behavioral outcomes. In chapter 1, 
we discuss the potential mechanisms linking acute injury to CTE in athletes and soldiers. 
In chapter 2, we highlight the physics behind the compression wave produced by our 
model and how this wave produces injury. In chapter 3, data is presented regarding the 
CTE phenotype generated by our model following repetitive blast exposure in rodents. 
Chapter 4 focuses on the role of blood brain barrier disruption and how targeting protein 
kinase C activity with bryostatin reduces this disruption. In chapter 5, we look at the role 
endoplasmic reticulum stress plays in human pathologic specimens from patients 
diagnosed with CTE and in rodents following repeat blast. We found that 
docosahexaenoic acid successfully targeted endoplasmic reticulum stress, reduced 
tauopathy, and improved cognitive performance. In chapter 6, we looked at lipoic acid 
and its role in reducing NADPH oxidative stress following repetitive neurotrauma. We 
found that lipoic acid reduces impulsive-like behavior and decreased cell death. Finally, 
in chapter 7 we discuss important strategies for improving preclinical models going 
forward and what needs to be investigated to improve our understanding of CTE. In this 
dissertation, we highlight important secondary injury cascades including blood brain 
barrier disruption, protein kinase C activity, endoplasmic reticulum stress, and oxidative 
stress that warrant further investigation for the development of novel treatment 
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Significant attention has recently been drawn to the potential link between head 
trauma and the development of neurodegenerative disease, namely chronic traumatic 
encephalopathy (CTE).  The acute neurotrauma associated with sports related 
concussions in athletes and blast induced traumatic brain injury in soldiers elevates the 
risk for future development of chronic neurodegenerative diseases such as CTE. CTE is a 
progressive disease distinguished by characteristic tau neurofibrillary tangles (NFTs) and 
occasionally transactive response DNA binding protein 43 (TDP43) oligomers; both of 
which have a predilection for perivascular and subcortical areas near reactive astrocytes 
and microglia.  The disease is currently only diagnosed post-mortem by neuropathologic 
identification of NFTs. A recent workshop sponsored by National Institute of 
Neurological Disorders and Stroke emphasized the need for pre-mortem diagnosis to 
better understand disease pathophysiology and to develop targeted treatments.  In order to 
accomplish this objective, it is necessary to discover the mechanistic link between acute 
neurotrauma and the development of chronic neurodegenerative and neuropsychiatric 
disorders such as CTE.  In this review we briefly summarize what is currently known 
about CTE development and pathophysiology, and subsequently discuss injury-induced 
pathways that warrant further investigation.  Understanding the mechanistic link between 
acute brain injury and chronic neurodegeneration will facilitate the development of 
appropriate diagnostic and therapeutic options for CTE and other related disorders. 






Neurotrauma is one of the most common injuries in contact sports and military 
conflicts (Goldstein et al 2012). Each year in the United States alone, over 1.7 million 
traumatic brain injuries (TBIs) occur (Gavett et al 2011b). Many of these TBIs are related 
to participation in contact sports, such as football and hockey, but a high rate of 
neurotrauma has also been reported for civilian and military populations in war zones 
(Stern et al 2011). In fact, the US Department of Defense labeled blast induced TBI 
(bTBI) as the “signature injury” of the recent wars in Iraq and Afghanistan (Goldstein et 
al 2012). The estimated annual cost of treatment for bTBI in the United States is 2.5 
billion dollars (Shenton et al 2012). The enormous economic burden is due, in part, to the 
progressive development of cognitive, motor, and psychiatric problems in blast-exposed 
veterans and civilians (Peskind et al 2013). These clinical symptoms, emerging in former 
athletes and soldiers alike, are often the first measurable signs for the development of a 
chronic neurodegenerative disease such as chronic traumatic encephalopathy (CTE) 
(Stern et al 2011). Clinical presentation of CTE has recently been divided into two 
categories:  young age of onset with primarily psychiatric and behavioral problems, and 
old age of onset with primarily cognitive and motor deficits (Stern et al 2013). Increased 
awareness about CTE has prompted widespread investigation into the progression and 
pathophysiology of this disease (McKee et al 2009).  
 The two populations at greatest risk for development of CTE are professional 
athletes and soldiers (Peskind et al 2013). It appears that individuals with one or two 
copies of the apolipoprotein ε4 (APOε4) allele have poorer outcome following head 
trauma and are at increased risk for developing CTE following TBI (Spillantini et al 
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2011). Athletes exposed to subconcussive and concussive injury, as well as soldiers 
exposed to even a single blast, can develop behavioral and psychiatric problems within a 
single year following injury (Bailes et al 2013). An area in need of further investigation is 
how acute neurotrauma relates to and/or causes chronic neurodegenerative diseases in 
susceptible individuals. In this review, we examine tau-based CTE pathophysiology and 
disease progression while discussing potential mechanistic pathways that may link acute 
neurotrauma with chronic neurodegenerative disease development and NFT formation.  
NEUROPATHOLOGICAL FINDINGS IN CTE  
 Post-mortem examination is currently the only widely-utilized and accepted 
method by which CTE is diagnosed clinically, although in vivo approaches have been 
identified and are currently under development for diagnosis and tracking pre-mortem 
(Small et al 2013, Stern et al 2011). Common neuropathologic findings of CTE include 
NFTS and transactive response DNA binding protein 43 (TDP43), as well as microglial 
and astrocyte activation (Lakis et al 2013). Although the mechanistic link responsible for 
these pathological outcomes is not fully known, the current understanding of the 
pathologic progression will be discussed in the following paragraphs (Stern et al 2013).  
NFTs 
 Normal tau binds to tubulin and stabilizes microtubule fibrils in neurons, thereby 
facilitating neurite outgrowth.  When tau becomes hyperphosphorylated it binds to other 
normal tau proteins, which leads to aggregation (Iqbal et al 2013). Tau 
hyperphosphorylation in the central nervous system (CNS) is common after TBI and 
other brain injuries (Mannix et al 2013). TBI can cause normal tau to dissociate from 
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tubulin; thereby, exposing multiple phosphorylation sites (Walker & Tesco 2013). 
Hyperphosphorylated tau is no longer able to bind to tubulin and translocates from the 
axon to the neuron soma (Iqbal et al 2013). A primary reason for this translocation is that 
normal tau is soluble while hyperphosphorylated tau becomes insoluble thus favoring a 
paired helical filament arrangement that is too large to function in axons (Mannix et al 
2013). The paired helical arrangement also leads to poor clearance of 
hyperphosphorylated tau from the neuron (Walker & Tesco 2013). Accumulation of 
insoluble tau within neurons contributes to the development of tau oligomers (Cowan & 
Mudher 2013). Tau oligomers are granular intracellular buildups of mutated tau, which 
precede the development of NFTs (Walker & Tesco 2013). When tau phosphatases can 
no longer dephosphorylate oligomers efficiently, NFTs grow and eventually mature 
(Whittington et al 2013). NFT maturation involves the acetylation of the lysine residue 
280 (Cowan & Mudher 2013). Once NFTs fully mature, they affect large projecting 
neurons in a progressive hierarchical pattern (de Calignon et al 2012). NFTs can spread 
to surrounding at-risk neurons through trans-synaptic propagation or extracellular 
secretion as depicted in figure 1.1 (Le et al 2012). Propagation can occur by direct 
seeding of tau oligomers into the lipid rafts of cell membranes thus increasing cell 
permeability and allowing access for the spread of larger secreted NFTs (Whittington et 
al 2013). After NFTs propagate, the post-translational modifications become finalized 
and behavioral and motor symptoms begin to surface in patients (Walker & Tesco 2013). 
A likely reason for the symptomatic changes is that NFTs cause neurons to become de-
innervated, in part, due to decreased neurite outgrowth, which ultimately leads to 




 Wild-type TDP43 is a nuclear RNA/DNA binding protein that regulates the 
transcription of thousands of genes (Hebron et al 2013). TDP43 is predominantly found 
in large motor neurons throughout the CNS (Bandyopadhyay et al 2013). TBI causes an 
up-regulation of Ca2+-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid (AMPA) receptors, which in turn lead to carboxy-terminal-cleaved TDP43 
fragments (Yamashita et al 2012). These fragments translocate to the cytosol mediated in 
part by the process of ubiquitination (Hebron et al 2013). The fragments form 
intracellular aggregates that are representative of several neurodegenerative diseases 
including: Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and 
CTE (Bandyopadhyay et al 2013). Aggregates sequester RNA leading to pronounced 
neurotoxicity (Yamashita et al 2012). One mechanism by which neurotoxicity occurs is 
TDP43 aggregate induced misfolding of Cu/Zn superoxide dismutase (SOD1), which 
predisposes surrounding cells to free-radical damage (Bandyopadhyay et al 2013). 
Associated clinical symptoms of TDP43 pathology include cognitive and motor 
impairment (Yamashita et al 2012). Cognitive impairment may take the form of apathy, 
poor impulse control, and lack of overall executive judgment (McKee et al 2010). It has 
yet to be determined exactly how TDP43 aggregates coincide and interact with NFTs to 
produce the wide spectrum of clinical CTE presentation seen in patients (Le et al 2012).  
Astrocyte activation 
Astrocytes in a healthy brain provide a supporting role for neurons (Sirko et al 
2013). If brain injury occurs, astrocytes become responsive by increasing expression of a 
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microfilament known as glia fibrillary acidic protein (GFAP), while simultaneously 
releasing cytokines that activate nearby neurons to increase nociceptive receptivity 
(Wang et al 2009). Astrocytes also trigger self-renewing neurospheres that may help in 
brain recovery (Sirko et al 2013). bTBI, in particular, causes increased astrocyte 
activation and GFAP levels within 24 hours post-injury (Kochanek et al 2013). Peripheral 
GFAP is absorbed and sequestered from the plasma immediately following bTBI leading 
to an initial decrease in serum levels at 6 hours, but GFAP is subsequently increased by 
augmented gene expression and changes in membrane permeability at 24 hours (Arun et 
al 2013a). The process of astrocyte activation involves an increase in astrocyte size, 
number, and motility that primarily occurs in the white matter following brain or spinal 
injury (Wang et al 2009). The activation is most pronounced in the corpus callosum, 
motor, and somatosensory cortex leading to symptoms of increased impulsive behavior 
and cognitive dysfunction (Kochanek et al 2013). One mechanism by which astrocytes 
are activated following brain injury is microglia-mediated crosstalk via pro-inflammatory 
cytokines (Wang et al 2009). These immune cells release interleukin-1β and other 
cytokines that act on toll-like receptors (TLRs) in astrocytes; thereby, inducing astrocytes 
to release reactive oxygen species (ROS) (Ferreira et al 2013). ROS indirectly cause 
excitotoxicity by decreasing the ability of astrocytes to uptake glutamate (Qureshi et al 
2004). This excitotoxicity was shown to cause changes in exploratory behavior and 
distinct motor deficits in mice exposed to cortical impact TBI (Madathil et al 2013).  
Microglial activation 
 Microglia are ramified immune cells of the brain that are inactive in healthy 
brains (Lai et al 2013). Following repetitive TBI, localized cell death activates microglia 
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in the striatum and thalamus, which can be measured by the markers OX6 and CD68 
(Acosta et al 2013). Activated microglia have a bushy appearance with thickened 
processes and enlarged cell bodies (Lai et al 2013). Furthermore, the microglia foster the 
spread of neuroinflammation (Hernandez-Ontiveros et al 2013). Short-term activation of 
microglia is neuroprotective, while chronic activation is involved in neurodegeneration 
(Acosta et al 2013). Chronic activation becomes more common in an aged brain 
accounting in part for the progressive nature of neurodegenerative diseases (Kumar et al 
2013). Glial tangles (GT), for example, are prominent in the frontal and temporal lobes of 
CTE brains many years after initial injury (Stern et al 2011). A primary reason for the 
persistence of microglia activation is due to diffuse traumatic axonal injury (dTAI) 
(Smith 2013). dTAI can cause the up-regulation of surface antigens on microglia that 
ultimately triggers the release of inflammatory cytokines (Hernandez-Ontiveros et al 
2013). Sensorimotor behavioral deficits following dTAI have been reported, possibly as a 
result of microglia induced inflammatory tissue damage (Smith 2013).  
BACKGROUND ON TAU 
Tau isoforms and tau mutations  
 The gene responsible for encoding tau is microtubule-associated protein tau 
(mapt) on chromosome 17 (Rossi et al 2014). After tau is encoded, six isoforms can form 
by various splicing of exons 2, 3, or 10 on the microtubule binding domain of pre-mRNA 
(Avale et al 2013). The exon 10 splice-variant, hTau40, is the most important in 
neurodegenerative disease development and is found specifically in the central nervous 
system (Agarwal et al 2013). The isoforms consist of three (3R) or four (4R) tau repeats 
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inserted at the carboxyl terminus (Takuma et al 2003). Ideally, the ratio between 3R and 
4R isoforms in the brain is maintained at 1:1 (Sadik et al 2009b). When mutations occur 
in the exon 10 splice-variant, the ratio is shifted to favor an increase in the 3R isoforms 
(Agarwal et al 2013). Normally, apolipoprotein E in the brain helps catalyze the 
proteolytic breakdown of mutated tau and restore the ideal 3R to 4R ratio, but the APOε4 
allele produces an apolipoprotein that is ineffective in this reaction (Stern et al 2011). 
When mutations persist, they play an important role in NFT development and the 
activation of astrocytes (Spillantini et al 2011). The altered tau proteins have widespread 
pathologic consequences (Le et al 2012). 
Tau kinase overview  
 Tau has 79 potential binding sites, and phosphorylation of these sites plays an 
important role in embryonic CNS development (Kanemaru et al 1992). 30 functional sites 
on the normal tau protein can be phosphorylated in the adult brain as depicted in figure 
1.2, but the amount of phosphorylation is kept to a minimum by tau phosphatases 
(Billingsley & Kincaid 1997). In the adult brain, tau is regulated through multi-site 
phosphorylation at serine/threonine residues by proline-kinases such as extracellular 
signal-regulated kinases (ERK1/2), cycline-dependent kinase 5 (CDK5), and glycogen 
synthase kinase 3-β (GSK3-β) (Tsujio et al 2000). Other non proline-kinases such as 
protein kinase C (PKC), c-Jun kinase (JNK), Akt, and various tyrosine kinases play a 
secondary role in tau phosphorylation (Zeng et al 2010). Following TBI, tau 
hyperphosphorylation is increased due to an elevation in kinases compared to 
phosphatases as depicted in figure 1.3, marking an initial pathologic change that indicates 
future development of chronic neurodegeneration (Liu et al 2013). The key tau kinases 
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are described in Table 1.1 and discussed in further detail with relation to changes caused 
by TBI in the following paragraphs.  
ERK1/2 
 ERK1/2 is dephosphorylated following a single mild TBI (Kuo et al 2013). The 
dephosphorylated ERK1/2 triggers apoptosis via caspase3 activation (Zhao et al 2012). 
Administration of estrone after TBI triggers ERK1/2 phosphorylation and pro-survival 
(Gatson et al 2012). This hormone warrants further investigation in regards to its 
potential role in ameliorating tau hyperphosphorylation. Estrone may initiate a 
neuroprotective priming response that protects against subsequent injury (Gatson et al 
2012). Other kinases, such as p70S6K and mitogen and stress activated protein kinase 1, 
may also be involved in this neuroprotective process (Chen et al 2007, Li et al 2013b). 
Facilitation of ERK1/2 via the compound PD90859 can additionally foster cell survival 
after brain injury (Mori et al 2002). Besides mediating the complex balance between cell 
survival and apoptosis, ERK1/2 plays another unique role by regulating the cytoskeleton 
of activated astrocytes following TBI (Kramerov et al 2011). ERK1/2 is therefore 
important not only for tau hyperphosphorylation but also in the process of reactive 
astrogliosis. 
CDK5 
Following TBI, CDK5 acutely binds to its receptor and activates a pro-apoptotic 
cascade (Li et al 2013a). Furthermore, CDK5 triggers cell-cycle activation and microglia 
activation following controlled cortical impact TBI (Kabadi et al 2012a). The extent and 
duration of microglia activation mediated by CDK5 requires further investigation. It is 
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known that inhibition of CDK5 with the roscovitine derivative, CR8, promotes 
neuroprotection and decreased apoptosis after controlled cortical impact (Kabadi et al 
2012b). Additionally, roscovitine itself can improve cognitive and motor function in 
Sprague Dawley rats after TBI (Hilton et al 2008). CDK5 inhibitors even improve 
outcome when administered several hours to days after TBI (Johnson et al 2010a). How 
these inhibitors alter the progression of tauopathies has yet to be investigated.  
GSK3-β 
 Protein kinase B (PKB) and serum and glucocorticoid-regulated kinase (SGK) are 
activated following TBI, which both subsequently phosphorylate GSK3-β (Shapira et al 
2007, Wu et al 2013). GSK3-β activation via its phosphorylation has been linked to 
apoptosis and tau hyperphosphorylation (Wang et al 2013b). Furthermore, GSK3-β up-
regulates NMDA receptors following brain injury causing an exacerbation of glutamate 
excitotoxicity (Deng et al 2014). Inhibition of GSK3-β consequently reduces apoptosis 
and the extent of excitotoxicity (Dash et al 2011). Humanin is a potential inhibitor of 
GSK3-β that increases neuroprotection following brain injury, but further studies are still 
needed to elucidate the mechanism of action (Wang et al 2013c). GSK3-β is also 
functionally significant in microglial migration, translocation of monocytes across the 
BBB, and inflammatory cascades following TBI (Lyman et al 2014). GSK3-β may 
therefore be a key target in discovering the link between acute brain injury and chronic 





 The five most common isoforms of PKC (α, δ, ε, ζ, η) play various supporting 
roles as Ser/Thr kinases throughout multiple tissues in the body (Kim et al 2003). 
Activation of specific PKC isoforms (α, δ, and ζ) is associated with perturbations in tight 
junction proteins following brain injury, which ultimately leads to increased BBB 
permeability (Combs et al 1998). The disruption in the BBB further increases PKC 
activity thereby triggering the tau kinase, GSK3-β (Martin et al 2013). PKCη additionally 
activates the pro-survival tau kinase, Akt, at several days post-injury (Cho 2011). After 
hyperphosphorylation occurs, PKCα maintains the phosphorylation changes by inhibiting 
tau phosphatases (Combs et al 1998). PKC prompts signal cascades that work in 
conjunction with altered calcium homeostasis to propel the development of NFTs (Martin 
et al 2013). Since PKC involvement is intimately associated with tau 
hyperphosphorylation and NFT formation, it seems reasonable to investigate the role of 
selective PKC inhibitors/activators, such as bryostatin and balonol, in the prevention of 
chronic tauopathies like CTE (Zohar et al 2011).  
JNK 
 JNK is increased in damaged axons following TBI (Tran et al 2012). JNK activity 
is also markedly increased in neurons and astrocytes of the hippocampus following TBI 
(Otani et al 2002). JNK signaling can cause post-traumatic cellular damage within the 
brain following injury (Tran et al 2012). JNK additionally may phosphorylate p53, which 
enhances neuronal autophagy (Hong et al 2012). When JNK is inhibited, the extent of 
abnormal tau hyperphospharylation is lessened (Tran et al 2012). Furthermore, glucagon 
has been used to inhibit JNK signaling immediately after TBI causing a decrease in 
intracranial cerebrovasodilation (Armstead et al 2012). Maintaining JNK signaling within 
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a tightly controlled range is not only important for tau regulation but also for maintaining 
blood flow to the brain following TBI (Armstead et al 2011).  
Akt 
Akt produces an interesting effect following brain injury by phosphorylating tau 
at Ser212, but also inhibiting GSK3-β (Ksiezak-Reding et al 2003). GSK3-β activation 
may therefore be necessary for initial tau hyperphosphorylation, but Akt activity 
maintains hyperphosphorylation at later time points (Zeng et al 2010). By inhibiting 
GSK3-β, it is thought that Akt triggers an anti-apoptotic pathway allowing for damaged 
cells to survive and propogate NFTs (Ksiezak-Reding et al 2003). If Akt is inhibited, cell 
death will occur (Farook et al 2013). Histone deacetylase inhibitors, such as Scriptaid, 
prevent the dephosphorylation of Akt, and therefore increase the number of surviving 
neurons after TBI (Wang et al 2013a). Akt regulation warrants further investigation to 
tease out the level of activation that is necessary for maintaining neuroprotective 
properties while avoiding the spread of NFTs.  
Tau phosphatases 
Two phosphatases, protein phosphatase 1 and 2A, are responsible for maintaining 
tau in a non-hyperphosphorylated state (Billingsley & Kincaid 1997). If these two 
phosphatases become dysfunctional or decreased, the hyperphosphorylated tau is quickly 
ubiquitinated, which then predisposes the neuron to increased NFT formation (Lambrecht 
et al 2013). TBI can cause a decrease in tau phosphatases (Kane et al 2012). In particular, 
protein phosphatase 2A is decreased in the hippocampus for several weeks post-TBI, 
which results in dysfunctional hippocampus plasticity (Bales et al 2010). Tau 
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phosphatase activity must drop by half before NFTs will begin to develop (Lambrecht et 
al 2013). Compounds that increase tau phosphatases, such as sodium selenate, may prove 
promising in slowing the progression of tauopathies (Corcoran et al 2010). 
DISCUSSION  
 Although the post-mortem pathology of CTE has been well described, the 
mechanism by which acute TBI leads to initial tau hyperphosphorylation and the eventual 
development of neurofibrillary tangles remains poorly understood. Since the term CTE 
was only recently reintroduced into the medical literature in 2005, understanding disease 
pathophysiology is in its infancy (Omalu et al 2005). Despite the link between TBI and 
CTE being associational rather than mechanistic at this point, the growing prevalence of 
this disease amongst soldiers, football players, wrestlers, and other athletes exposed to 
head injuries increases the urgency for finding a causative mechanism, and furthermore 
locating pharmacologic targets for treating this devastating disease. In the following 
paragraphs, we discuss a few molecular pathways previously associated with other forms 
of brain injury that warrant further investigation following TBI.  
Endoplasmic reticulum stress 
 The endoplasmic reticulum (ER) is responsible for the correct folding and sorting 
of proteins (Rubovitch et al 2011). Following brain injury, the ER becomes 
dysfunctional, as evidenced by changes in bound intracellular calcium, leading to the 
accumulation of unfolded proteins within the cell (Osada et al 2009). The increase in 
unfolded proteins is known as the ER stress response (Cullinan & Diehl 2006). Ischemic 
stroke and TBI can both cause acute activation of the ER stress response (Srinivasan & 
!
15 
Sharma 2012). Three arms of the ER stress response (protein kinase-like ER kinase 
(PERK), inositol requiring enzyme 1α (IRE1α), and activating transcription factor 6 
(ATF6)) regulate the amount of pro-apoptotic activity following injury (Rubovitch et al 
2011). All three arms affect the protein expression of C/EBP-homologous protein 
(CHOP) (Osada et al 2009). CHOP is noteworthy for its ability to trigger apoptosis via 
the activation of caspase12 (Srinivasan & Sharma 2012). If CHOP is maintained below-
threshold by the PERK arm, neuronal apoptosis does not occur (Cullinan & Diehl 2006). 
When CHOP is pushed beyond threshold through activation of the IRE1α and ATF6 
arms, neuronal apoptosis does occur, and tau hyperphosphorylation results from GSK3-β 
(Hoozemans et al 2009). Furthermore, two downstream targets of the ATF6 arm of the 
ER stress pathway are MAPK and JNK, which may subsequently be involved in tau 
hyperphosphorylation as well (Krajewska et al 2011).  In light of these findings, it may 
prove beneficial to utilize a pharmacologic agent that attenuates the ER stress response in 
a model of TBI. Salubrinal can increase activity of the neuroprotective PERK arm of the 
ER stress response and inhibit the pro-apoptotic activity of the IRE1α arm of the ER 
stress response (Gong et al 2012). Since GSK3-β and caspase12 are increased following 
brain injury, it may also be worth investigating the GSK3-β peptide inhibitors, L803-mts 
and TDZD-8, and the role they may play in preventing the development of NFTs 
(Hoozemans et al 2009, King et al 2014). 
Glutamate excitotoxicity  
Glutamate excitotoxicity is triggered following brain injury and results in elevated 
intracellular calcium, formation of reactive oxygen species, and mitochondrial failure 
(Wagner & Zitelli 2013). Ischemia and other forms of brain injury can cause an increase 
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in calcium that activates α-calcium/calmodulin protein kinase II, leading to memory 
impairment via increased AMPA receptor activity in the hippocampus (Atkins et al 
2006). The increased calcium also leads to intracellular accumulation in neuronal 
mitochondria, making the organelle dysfunctional (Wagner & Zitelli 2013). Activated 
microglia and astrocytes concurrently release interleukin-6, which triggers a further 
increase in intracellular calcium within neurons and sensitizes N-Methyl D-aspartate 
(NMDA) receptors (Ma et al 2013). Sensitized NMDA receptors promote auxiliary 
excitotoxicity and foster the release of reactive oxygen species from the mitochondria, 
which can eventually cause neuronal destruction (Qureshi et al 2004). Caspase3, a pro-
apoptotic factor, is increased following glutamate induced mitochondria dysfunction 
(Srinivasan & Sharma 2012). Caspase3 can cause tau cleavage and predisposes the 
neuron to NFT development (Hoozemans et al 2009). To stem the tide of neuronal 
destruction and progressive tau changes, it seems befitting to investigate compounds that 
are known to decrease the amount of reactive oxygen species such as the NADPH-
oxidase inhibitor, apocynin (Ferreira et al 2013). Furthermore, targeting mitochondrial 
dysfunction through p38 inhibitors may also prove beneficial following head trauma 
(Huang et al 2013). By targeting key downstream pathways of glutamate excitotoxicity, it 
may be possible to alleviate the potential progression to neurodegeneration.  
Microglial and astrocyte regulators 
 Neurotrauma can result in a dynamic equilibrium between classically activated 
(M1) and alternatively activated (M2) microglia (Acosta et al 2013). M1 microglia are 
pro-inflammatory while M2 microglia are anti-inflammatory (Smith 2013). Targeting the 
activation of M2 microglia immediately following injury may prove beneficial in 
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preventing neurodegeneration (Kuo et al 2008). Alternatively, acutely inhibiting M1 
microglia with the noncompetitive cholinesterase inhibitor, donepezil, has also decreased 
neuroinflammation and apoptosis after TBI (Hwang et al 2010). Similarly, neurotrauma 
triggers two distinct responses, pro-survival or apoptosis, in activated astrocytes 
depending on the extent and duration of injury (Kochanek et al 2013). If astrocyte 
activation extends several days post-injury, it was found that nitration of tau occurs, 
which may lead to a more rapid development of NFTs (Reyes et al 2008). Furthermore, 
mutations in tau may be occurring in activated astrocytes, resulting in tau oligomers 
being subsequently secreted into the extracellular milieu (de Calignon et al 2012). Future 
studies are needed to characterize the time-course of astrocyte activation following TBI, 
and more importantly at what point it is ideal to inhibit astrocyte activation.  
CLINICAL RELEVANCE AND CONCLUSIONS 
The Veterans Affairs Healthcare System reported that patients exposed to 
repetitive blast waves have quantitative electroencephalogram changes that are 
comparable to concussive injury (Tompkins et al 2013). Similarly, the detection of 
repetitive concussions in athletes has increased significantly over the past 20 years (Small 
et al 2013). The duration between injuries may account for why certain individuals 
develop rapidly progressive neurodegeneration and increased phospho-tau expression 
(Mannix et al 2013). The Department of Defense has recently invested 700 million 
dollars into improving clinical diagnosis and care for the 266,810 bTBI patients who 
were injured from 2001 onwards (Tompkins et al 2013). Likewise, the National Football 
League has recently organized a new medical committee to investigate the issue of TBI, 
and started a multi-prong approach for making football safer for the players (Ellenbogen 
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et al 2010). Increased investigation into understanding the pathology of CTE will 
hopefully aid in pre-mortem diagnosis as well as finding viable treatment options. The 
pathways mentioned in this review (ER Stress, glutamate excitotoxicty, and microglia 
and astrocyte modulation) appear promising in understanding the link between acute 
bTBI and CTE development. Discovering the process of tau hypephosphorylation and 
NFT development following TBI will likely provide a key for unlocking the unknown 
mysteries of similar progressive neurodegenerative diseases.  
ACKNOWLEDGEMENTS 



















Figure 1.1: Traumatic Brain Injury can lead to diffuse traumatic axonal injury and blood 
brain barrier disruption. Shearing of axons results in the disruption of tau binding to 
tubulin. Subsequent hyperphosphorylation of tau leads to formation of tau oligomers in 
the neuronal soma. Eventually, neurofibrillary tangles form and are secreted into the 
extracellular milieu or spread to other neurons via trans-synaptic propagation. Concurrent 
with axonal shearing, traumatic brain injury can cause a rapid blood pressure spike 
resulting in blood brain barrier disruption. The disruption leads to an inflammatory 
cascade as well as microglia and astrocyte activation. Microglia and astrocyte activation 





Figure 1.2: Tau is regulated by multiple biochemical processes including: nitration, 
glycosylation, ubiquitination, acetylation, sumoylation, and phosphorylation. A. We 
highlight some of the key regulation sites potentially involved in the pathophysiology of 
chronic traumatic encephalopathy. B. Each site has a specific antibody of interest that can 
be used to detect changes in intracellular/extracellular tau. C. Deglycosylation allows for 
conversion of tau tangles into bundles of straight filaments, thus increasing the 
accessibility of remaining tau located at microtubule edges. Glycosylation however 
reduces phosphorylation of PKA, CDK5, and GSK3B decreasing formation of 
neurofibrillary tangles. This example shows how post-translational modification of tau 
can regulate tau phosphorylation and ultimately lead to the development of 




Figure 1.3: Neurofibrillary tangle formation involves an imbalance between tau kinase 
and tau phosphatase activity. If tau kinase activity is increased and the phosphatase 
activity is decreased, hyperphosphorylation persists and can result in the formation of 
neurofibrillary tangles. Neurofibrillary tangles contribute to poor outcome by disrupting 
axonal transport and eventually causing the hierarchical spread of neurodegeneration. 
Neurodegeneration ultimately causes the classic symptoms seen in patients suspected of 




Kinase Name: Site of Regulation: Physiological Role: Activated by TBI: 
ERK1/2 Phosphorylation of 
threonine-x-tyrosine 
motif 





Yes (Kuo et al 
2013) 
CDK5 Binding to CDK 
Receptor 1 or CDK 
Receptor 2 
Plays a role in 
neural development, 
pain signaling, and 
sensory processing 
Yes (Li et al 2013a) 
GSK3-β Requires priming 
kinase to 
phosphorylate a 













Yes (Shapira et al 
2007) 
PKC 3 categories based on 
binding at C-terminal: 
conventional requires 
diacyl-glycerol and 











glycerol, and atypical 
does not require 
calcium or 
diacylglycerol. Once 
active, the receptors 
for activated C-kinase 
bind PKC and help 







JNK Diphosphorylation of 
the threonine-proline-
tyrosine motif 







Yes (Tran et al 
2012) 
AKT Akt binds to 
phosphatidylinositol 
(3,4,5)-triphosphate 
on the cell membrane 
Akt plays a role in 
apoptosis, cellular 
metabolism, and cell 
migration  
Yes (Ksiezak-
Reding et al 2003) 
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and then is 
phosphorylated at 




Table 1.1 Legend: Table 1.1 provides a list of tau kinases and the physiologic roles in 
which they function. In addition, it highlights if the overall levels of these kinases are 




















Elucidating the role of compression waves and impact duration for generating mild 
traumatic brain injury in rats 
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1.7 million concussions occur each year in the United States. The mechanisms 
linking acute injury to chronic deficits are poorly understood. Mild traumatic brain injury 
has been described clinically in terms of acute functional deficits, but the underlying 
histopathologic changes that occur are relatively unknown due to limited high-function 
imaging modalities. In order to improve our understanding of acute injury mechanisms, 
appropriately designed preclinical models must be utilized. The clinical relevance of 
compression wave injury models revolves around the ability to produce consistent 
histopathologic deficits. Repetitive mild traumatic brain injuries activate similar 
neuroinflammatory cascades, cell death markers, and increases in amyloid precursor 
protein in both humans and rodents. Humans however infrequently succumb to mild 
traumatic brain injuries and therefore the intensity and magnitude of impacts must be 
inferred. As accelerometers become more widely used in athletics, it is imperative that 
the physical and mechanical properties of pre-clinical concussion models be determined. 
This increased understanding could link the histopathologic deficits seen in rodents to 
what might be happening in human brains following repetitive concussions. Advances in 
mathematical and computer modeling can help characterize the wave properties 
generated by the compression wave model. While this concept of linking duration and 
intensity of impact to subsequent histopathologic deficits makes sense, numerical 
modeling of compression waves has not been performed in this context. In this 
collaborative interdisciplinary work, numerical simulations were performed to study the 
creation of compression waves in our experimental model. This work was conducted in 
!
27 
conjunction with a repetitive compression wave injury paradigm in rats in order to better 
understand how the wave generation correlates with validated histopathologic deficits.  
KEY WORDS: Finite Volume Modeling, Compression Wave, Traumatic Brain Injury, 
Apoptosis, Pre-clinical Model 
INTRODUCTION 
It has been estimated that 1.7 to 3.4 million concussions occur each year in the 
United States (McClure et al 2014). How mechanical forces cause brain injury and 
initiate injury cascades is poorly elucidated. Therefore, a diagnosis of concussion is 
primarily based on observable symptomatic changes (McCrea et al 2003). It is currently 
unknown how many athletes and soldiers are at risk for developing chronic traumatic 
encephalopathy (Bailes et al 2015). Chronic traumatic encephalopathy is a degenerative 
tauopathy characterized by mood disorders and cognitive deficits (McKee et al 2009). 
The biochemical mechanisms linking acute injury to behavioral deficits and the 
development of neurodegeneration over time warrants further investigation (Lucke-Wold 
et al 2014c). Banks and colleagues are conducting the first prospective cohort study to 
determine the incidence of chronic traumatic encephalopathy in mixed martial arts 
fighters (Banks et al 2014). Laboratory research can also provide important discoveries 
for how acute injury contributes to tauopathy. Most importantly, laboratory studies allow 
for a comparison of force dynamics to observed physiologic changes post-injury(Hua et 
al 2015).  
In order to improve our understanding of mild traumatic brain injury, it is 
necessary to utilize pre-clinical models that produce relevant pathologic changes 
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consistent with human brain injury. In previous papers, we have described acute 
biochemical changes that occur within a rat’s brain following compression-wave injury. 
These changes include blood brain barrier disruption, endoplasmic reticulum stress, and 
oxidative stress (Logsdon et al 2014, Lucke-Wold et al 2014a, Lucke-Wold et al 2015a). 
Recently, we discovered that these acute pathways are implicated in the development of 
tauopathy, and contribute to long-term cognitive and behavioral deficits (Turner et al 
2015). These deficits in humans can manifest as post-traumatic epilepsy, sleep 
disturbances, and increased risk for suicide (Lucke-Wold et al 2015b, Lucke-Wold et al 
2015c, Wasserman et al 2008). In this multidisciplinary project, we sought to delineate 
the wave dynamics associated with our clinically relevant model and correlate the wave 
properties to observed histopathologic changes within the rat’s brain post-injury. 
Simulation and numerical modeling can be used to enhance our understanding of the 
wave properties and impact force experienced by the rat. These properties are critical for 
determining how mechanical injury causes lasting damage that ultimately leads to 
behavior changes.  
METHODS 
Tabletop model 
The model consists of steel driven and driver section with a mylar membrane 
sandwiched in-between. The driven and driver section are screwed tight prior to rupturing 
the membrane. The apparatus is securely attached to a table and the 0.005” membrane 
was scored with a hand press prior to use. The intensity of the compression wave was 
determined by a pressure gage attached to a regulator. Nitrogen gas was used to rupture 
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the membrane. The pressure was allowed to build via a needle nose attachment and 
regulator prior to rupture. The compression tube has a short driver section in order to 
generate a short-duration wave. Piezoelectric sensors (Model 102AO5; PCB 
Piezotronics) were placed in the reflected and two incident positions near the exit of the 
shock tube to produce a linear configuration as shown in figure 2.1. To test for planarity, 
the three sensors were placed at the edge of the tube. Data was recorded using a sensor 
signal conditioner (482C Series; PCB Piezotronics) and a data acquisition board (DAQ 
23GF; National Instruments).  A computer program written with LabView version 12.0 
(National Instruments) was used for analysis. The anesthetized rats head was placed at 
the same position as sensor two. A polyvinyl tube to protect the thoracic cavity from 
wave exposure protected the body.  
Numerical approach 
Numerical simulations are used to reconcile pressure profiles with the 
experimental setup in order to characterize wave formation. The tube and the surrounding 
air may generally be modeled by the compressible Navier-Stokes equations describing 
fluid flow. The flow produces a shock wave and an expansion wave propagating into 
stationary flow at atmospheric conditions.  The timescales of both phenomena are small 
relative to the timescale of the viscous/diffusive terms within the Navier-Stokes 
equations.  It follows that the boundary layers formed near the interior of the compression 
tube will have a minimal influence on the flow.  Thus, the non-viscous Euler equations 




The Euler equations listed in conservation form are: 
!!!"+!"#!!#+!"$!!$=0. 
where, 
!=%%&%'%(),  "#=%&%&2+*%&'%()+*&,   "$=%'%&'%'2+*%()+* '. 
The conservative variables inside the vector ! represent density, %, x-momentum, %&, y-
momentum, %', and total energy, %().  The total energy per unit mass may be defined as 
the summation of the internal and kinetic energy: 
()=*%+−1+12&2+'2. 
An ideal gas equation of state ,=%-./0) is used to close the system of equations. 
The compression tube is modeled using an axisymmetric geometry, which 
reduces computation time by solving for a three-dimensional flow field on a two-
dimensional domain. The computational domain illustrated in figure 2.2 shows the 
compression tube with a large domain at the compression tube exit to capture the 
propagation of the blast wave after it exits the tube. The surrounding fluid region is 
chosen to be large enough to capture the transient evolution of the compression wave past 
the sensor two location without experiencing any interactions with the domain boundaries 
until much later.  
The burst of the diaphragm is modeled by using a discontinuous initial condition 
where the pressure is higher in the driver section and lower outside. The initial velocity is 
zero and the initial temperature is 20°C everywhere. The initial conditions across the 
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diaphragm are 110 psi in the driver section at atmospheric conditions, with 14.7 psi in the 
driven section and the domain outside the tube.  
The governing equations are solved numerically using Star-CCM+. The Weiss-
Smith Precondition Roe’s Scheme (Weiss et al 1999) is used to discretize the physical 
domain into cells, and the governing equations are solved with a finite volume scheme.  
The scheme uses a multidimensional linear reconstruction to calculate the fluxes at each 
cell edge.  The reconstruction uses a Taylor series expansion at the cell face to retain 
higher order accuracy. A multiple stage Runge-Kutta second order explicit scheme is 
utilized for the time integration (Huang & Ayoub 2008). The time-step used in each 
simulation is determined using the Courant-Freidrich-Lewis (CFL) number. The CFL 
number is defined 
!"#=($+%)&'&(, 
where $ and % are local fluid velocity. The maximum CFL inside the domain was used to 
choose the time-step. The CFL number used for the simulations in this work is 0.5.  
A range of grid spacing is used in this work and range from 0.3175 cm to 0.0595 
cm. A grid sensitivity study is performed to ensure that the solution is not grid dependent. 
Computing the #2 norm assesses grid sensitivity. The #2 error is typically calculated by 
comparing the solution for the different mesh refinements to an exact solution. Since no 
exact solution is available, the solution with the finest mesh is used as an exact solution.   




The !2 error value represents the error over an entire domain with individual 
contributions from each cell.  
Animals 
The Institutional Animal Care and Use Committee at West Virginia University 
approved all experiments involving animals. The experiments were conducted in 
accordance with the Guide for the Care and Use of Laboratory Animals. Sixteen (16) 
young-adult male Sprague dawley rats (Hilltop Lab Animals, Inc.) were used for 
immunohistochemistry (IHC). The rats were divided into two groups: repeat injury (6 
compression waves every other day over 2 weeks) and anesthetized (4% isoflurane with 
2% maintenance) control. Repeat injury exposure was performed with the 0.005” 
membrane according to the methods previously described (Turner et al 2013). A power 
analysis was conducted (DSS Research) with the equation n=1+[2C(s/d)2], where C is a 
value dependent upon the a and b values chosen. For this study a=0.05 and b=0.2 for a 
power of 1-b=0.8. C(0.05, 0.8)=7.85 (obtained from table). The number needed is based on 
effect size and standard deviation, which was estimated from previous work. Rats were 
housed with a 12h:12h light to dark cycle and food and water available ad libitum. 
Immunohistochemistry 
Animals were anesthetized as described above followed by decapitation.  The 
brain was removed and immediately flash frozen in isopentane and stored at -80°C.  
Brains were sliced to a thickness of 20µm using a cryostat. Standard Hematoxylin and 
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Eosin, Fluorojade B, Thioflavin, and DAB (Sigma Aldrich) staining protocols were 
utilized to stain for cellular morphology and Amyloid precursor protein (APP) (Cell 
Signaling).  
Images were obtained from a blinded observer using a Zeiss Axio Imager 2 and 
an Olympus MVX10 for brightfield and fluorescent imaging.  For immunohistological 
DAB stains, 100 total cells were counted in the stereologic selected region of interest 
within the prefrontal cortex and determined to be either expressing or non-expressing.  
The ratios between groups were compared using chi-squared analysis. For fluoroscent 
stains, a blinded observer used image J quantification. The measurements were adjusted 
for background giving corrected total cell fluorescence. The total cell fluorescence was 
compared between groups.  
Statistical analysis 
Data were analyzed using GraphPad Prism version 4.0. An observer blinded to 
experimental group did imaging quantification. A student’s t-test was used to compare 
across control and repeat injury groups for fluorescent imaging.  A χ2 analysis was used 
for DAB staining.  A p-value of <0.05 was considered statistically significant for all 
studies.!
RESULTS 
Compression wave formation 
Figure 2.2 shows a sequence of pressure contours, which illustrate the formation 
and propagation of a traditional blast wave. At t=0, the diaphragm separates the fluid 
!
34 
inside the driver section from the fluid inside the driven section. The fluid inside the 
driver section is at higher pressure than the atmospheric pressure in the driven section. 
Once the diaphragm bursts, the t=0.1 ms frame shows that a shock wave moves to the left 
and an expansion wave moves to the right. At t=0.3 ms the shock wave has exited the 
tube and expands in all directions. The exit of the shock wave creates an expansion wave 
that moves inside the shock tube. The induced flow from the shock wave as it propagates 
to the left further away from the compression tube creates a low-pressure region behind 
the shock wave. This region is where the pressure drops below atmospheric pressure. 
A one-dimensional axis is selected down the center of the compression tube to 
evaluate the error.  The pressure values along the axis are compared between different 
mesh refinements at a physical time of 1 ms. Figure 2.3 shows the !2 error as a function 
of grid spacing on a log-log scale. The solution with the finest resolution is used as an 
exact solution. Figure 2.3 also shows that the slope is 1.841, which indicates that the 
solution is converging at a rate between first and second order accuracy. This 
convergence rate is consistent with the scheme’s accuracy since the reconstruction step 
makes the solution second order accurate everywhere except for discontinuities such as 
shocks and contact discontinuities. 
Figure 2.4 shows a contour plot of pressure on an x-t diagram using the solution 
data located along the axis in the center of the compression tube. The green dashed lines 
in figure 2.4 represent the analytical solution for an ideal one-dimensional compression 
tube.  Looking exclusively at the shock wave and the head of the expansion wave 
propagation, both phenomena are represented relatively accurately compared to a purely 
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1-D shock tube case.  It may also be seen that the expansion wave reflects off the driver 
wall at t=0.4 ms and begins propagating in the direction of the shock wave.  The solid 
blue lines represent the end of the compression tube and the initial diaphragm location.  
When the shock exits the compression tube at t=0.149 ms an expansion wave is created 
as the wave expands radially outward in all directions. The contour shows that the 
pressure behind the transmitted compression wave decays with distance from the tube 
exit.  The red dashed lines represent the locations of each of the pressure transducers in 
the experiment.   
Pressure sensors 
Pressure readings are obtained using pressure taps at specific locations within the 
compression tube and at the location where the rat will be placed.  Figure 2.1 provides the 
geometry and location of each of the sensors from the experiment.!The pressures versus 
time profiles were analyzed for each pressure sensor placed linearly. The waves were 
mapped and quantified with MATLAB as previously published (Turner et al 2013). 
Three transducers were then placed in the same plane at the edge of the tube. These three 
transducers showed variation in the pressure histories, which suggests that non-planar 
shock waves are produced. This non-planar wave behavior is likely caused by 
inconsistent burst patterns of the diaphragm.  The diaphragms are scored in similar 
patterns with a press to improve the planarity of the wave. Since there is some planar 
variability in pressure histories from case to case, an average pressure history is 
calculated using 7 membrane ruptures. The averaged pressure histories are then readily 




The pressure profiles for each sensor are shown in figure 2.5 for both the 
averaged experimental data and the numerical simulation.  The pressure histories of the 
experimental data were shifted to match time of peak pressure occurrence. The time shift 
allows an average between pressure profiles and direct comparison between the averaged 
experiment and the simulation.  
The third sensor shows the same general trend between the experiment and the 
simulation. The over-pressure does not reach the peak value observed in the simulation 
and the rise time is finite.  The lower peak pressure and more gradual pressure increase 
indicate a wave that more closely resembles a strong compression wave. This is likely 
due to incomplete or partial diaphragm rupture. However, since the pressure ratio across 
the diaphragm is sufficiently large to create a shock (approximately 7.5), the wave 
created inside of the tube from the diaphragm burst will still be regarded as a shock wave. 
It can also be seen that the time scale of the pressure recovery matches between the 
simulation and the experiment. This pressure recovery occurs from the shock exiting the 
tube and the expansion wave travels inside. 
The first sensor is near the exit of the tube and shows a similar behavior between 
the experiment and the simulation.  The peak of the simulation is almost twice the 
magnitude of the experiment. Similar to the third sensor, the first sensor pressure 
recovery timescale is consistent between the experiment and the simulation. 
The second pressure sensor is oriented for the experiment as a reflected sensor 
where the pressure transducer is pointed into the flow direction.  The pressure tap is held 
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within a large metal plate approximately 2 inches from the end of the shock tube. As can 
be expected, the pressure trace for sensor two shows that the experiment and numerical 
model are consistent on the arrival time of the blast wave at the transducer two location. 
Beyond this time the two pressure histories deviate because the numerical simulation 
does not model a reflecting plate. Instead, the numerical simulation measures what the 
pressure profile would be in the absence of an object that alters the wave profile. In the 
experiment, the pressure rises much higher and retains that high pressure for 
approximately 1.5 ms. This higher pressure rise occurs because of the wave reflection 
that occurs at sensor 2 from the wall plate. It should be noted that the reflection of the 
wave alters the wave profile to make the wave duration much longer than an unobstructed 
wave. This suggests that very different pressure histories may be recorded for the same 
compression wave depending upon the pressure transducer placement and geometry. 
Immunohistochemistry 
Compression wave TBI can lead to long-term changes in the brain. Neurons are 
acutely injured and can undergo apoptosis or survive with aggregated proteins. We show 
nuclear fragmentation, pyknotic nuclei, blebbing, and chromatolysis in the contralateral 
prefrontal cortex of repeat TBI animals compared to control animals (Figure 2.6 A-B).  A 
significant increase in amyloid precursor protein was also seen 72 hours post repeat TBI 
(41/100) compared to controls (2/100) in the contralateral prefrontal cortex χ2 = 81, 
p<0.001 (Figure 2.6 C-D). In addition to apoptosis, damaged tissue can degenerate over 
time. Fluorojade B was used to mark early signs of neurodegeneration. We found a 
significant increase in the contralateral prefrontal cortex at 72 hours post repeat TBI 
compared to controls t=8.96, p<0.001 (Figure 2.7 A-B). We also found a significant 
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increase in fluorojade B in the contralateral hippocampus 72 hours post repeat TBI 
compared to controls t=3.22, p<0.01 (Figure 2.7 C-D). The compression wave caused 
significant degeneration in the contralateral hemisphere due to rapid 
acceleration/deceleration forces. Finally, a significant increase in thioflavin staining was 
seen in the prefrontal cortex following repetitive TBI 72 hours post-injury compared to 
controls t=3.636, p<0.01 (Figure 2.7 E-F). Thioflavin marks increased tau 
hyperphosphorylation and protein aggregation.  
DISCUSSION 
Panzer and colleagues recently urged for better understanding of pre-clinical TBI 
models and how these models produce head injury (Panzer et al 2012). Gupta proposed 
that the most clinically relevant understanding of TBI is to determine how compression 
waves penetrate into tissue (Gupta & Przekwas 2013). The numerical simulations 
contained in this work show that the tabletop model produces a pressure wave consistent 
with a compression wave. The expansion wave is created after the shock wave exits the 
shock tube and combines with the shock wave to produce the compression wave. The 
simulation results correlated well with the model recordings for sensor one and sensor 
three. The wave duration for the numerical simulation at the sensor two location was five 
times shorter than that observed from the averaged pressure transducer history. This 
suggests that obstacles in the flow can significantly alter incident wave profiles. 
Compression waves such as these can cause rapid acceleration/deceleration contributing 
to damage at density gradients within the brain (Boulet et al 2011). This type of injury 
from compression waves is most frequently seen in clinics due to athletic concussions 
and motor vehicle collisions (DeKosky et al 2013). In this multidisciplinary paper, we 
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show that the tabletop model creates compression waves and that these waves cause 
significant acceleration/deceleration injury measured with immunohistochemistry. 
The acceleration/deceleration can cause shearing of vessels and axons (Su & Bell 
2016). We observed significant increases in amyloid precursor protein and thioflavin 
after repetitive TBI showing damage from axonal shearing and persistent neuronal injury. 
Likewise H&E and fluorojade B staining revealed increased cell death and nuclear 
damage consistent with compression wave penetration into tissue. The damage was 
particularly pronounced at the white/grey junction within the cortex and within the 
hippocampus. It is therefore representative of an impact producing substantial coup and 
contra-coup effects due to the acceleration/deceleration of the skull over time (Ommaya 
et al 1971). Readnower and colleagues observed substantial disruption of the blood brain 
barrier on the ipsilateral hemisphere following blast exposure likely due to a longer 
duration compression wave (Readnower et al 2010). Due to the rapid 
acceleration/deceleration seen with our model, we observe the disruption in the BBB on 
the contralateral hemisphere where the brain collides acutely with the skull (Lucke-Wold 
et al 2014a). The coup/contre-coup phenomenon is much more relevant to what is seen in 
the clinical setting instead of models using a fixed skull (Sato et al 2014). 
Going forward, the use of advanced animal imaging can help determine the extent 
and progression of injury over time following exposure to repetitive compression waves 
(Tompkins et al 2013). Functional magnetic resonance imaging would help detect some 
of the more subtle differences produced by the injury that is not as readily detected by 
traditional assays. These changes could then be mapped in conjunction with advanced 
simulation techniques. Finite element and finite volume modeling are needed to further 
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map the waves progression through the skull and into the brain (Jean et al 2014). 
Combining the computational modeling with in vivo injury data will continue to require 
interdisciplinary collaboration (Ganpule et al 2013). The development of these 
multidisciplinary teams is necessary to address the complexities of 
acceleration/deceleration neurotrauma. By developing better understanding of pre-clinical 
models, important injury factors relevant to the brain such as duration until degeneration, 
number of impacts needed for cognitive decline, and the time scale of acute injury 
cascades initiated post-injury can be determined. We provide evidence that compression 
waves cause acceleration/deceleration injuries consistent with those seen clinically. 
CONCLUSION 
The use of numerical modeling provides a unique understanding of the wave 
dynamics generated by our TBI model. The model reliably produces compression waves. 
The wave is of sufficient duration and force to cause both acceleration/deceleration and 
direct penetration. The injury profile outlined by immunohistochemistry confirms that 
cell death, axonal shearing, and tau hyperphosphorylation occurs following repetitive 
injury. These injury patterns may provide important clues for what is occurring in the 
brains of athletes following repetitive injuries. The use of advanced imaging will improve 
the ability to correlate between pre-clinical models and human pathology.  
ACKNOWLEDGMENTS 
A Neurosurgery Research and Education Foundation Medical Student Summer 
Fellowship, an American Medical Association Foundation Seed Grant, a Sigma Xi 
!
41 
Grants-in-Aid of Research, and an American Foundation of Pharmaceutical Education 




















Figure 2.1: Geometry of Sensor Layout. A two dimensional representation shows the 















Figure 2.2: Contour Plot 2D Pressure. Domain pressure profile shown at different times 
























Figure 2.4: x-t Diagram. An x-t pressure contour plot shows the evolution of the shock 









Figure 2.5: Pressure vs. Time by Sensor.  A line plot provides a comparison between 
experiment and simulation.  The experiment uses pressure taps to measure gage pressure 







Figure 2.6: Acute Pathophysiology. H&E staining reveals nuclear enlargement and 
fragmentation in the contralateral prefrontal cortex 72 hours post repetitive TBI. A 










Figure 2.7: Neuronal Degeneration. A significant increase in fluorojade B was seen in 
the contralateral prefrontal cortex and hippocampus 72 hours following repetitive TBI.  
Thioflavin shows tau hyperphosphorylation and protein aggregation 72 hours following 
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Chronic neurodegeneration following a history of neurotrauma is frequently 
associated with neuropsychiatric and cognitive symptoms.  In order to enhance 
understanding about the underlying pathophysiology linking neurotrauma to 
neurodegeneration, a multi-model pre-clinical approach must be established to account 
for the different injury paradigms and pathophysiologic mechanisms.  We investigated 
the development of tau pathology and behavioral changes using a multi-model and multi-
institutional approach, comparing the pre-clinical results to tauopathy patterns seen in 
post-mortem human samples from athletes diagnosed with chronic traumatic 
encephalopathy (CTE).  We utilized a scaled and validated blast-induced traumatic brain 
injury model in rats and a modified pneumatic closed-head impact model in mice.  Tau 
hyperphosphorylation was evaluated by western blot and immunohistochemistry.  
Elevated plus maze and Morris water maze were employed to measure impulsive-like 
behavior and cognitive deficits respectively.  Animals exposed to single blast (~50 PSI 
reflected peak overpressure) exhibited elevated AT8 immunoreactivity in the 
contralateral hippocampus at 1 month compared to controls (q = 3.96, p < 0.05).  Animals 
exposed to repeat blast (6 blasts over 2 weeks) had increased AT8 (q = 8.12, p < 0.001) 
and AT270 (q = 4.03, p < 0.05) in the contralateral hippocampus at 1 month post-injury 
compared to controls.  In the modified controlled closed-head impact mouse model, no 
significant difference in AT8 was seen at 7 days, however a significant elevation was 
detected at 1 month following injury in the ipsilateral hippocampus compared to control 
(q = 4.34, p < 0.05). Elevated plus maze data revealed that rats exposed to single blast (q 
= 3.53, p < 0.05) and repeat blast (q = 4.21, p < 0.05) spent more time in seconds 
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exploring the open arms compared to controls.  Morris water maze testing revealed a 
significant difference between groups in acquisition times on days 22-27.  During the 
probe trial, single blast (t = 6.44, p < 0.05) and repeat blast (t = 8.00, p < 0.05) rats spent 
less time in seconds exploring where the platform had been located compared to controls.  
This study provides a multi-model example of replicating tau and behavioral changes in 
animals and provides a foundation for future investigation of CTE disease 
pathophysiology and therapeutic development.  
KEY WORDS: Chronic Traumatic Encephalopathy, Tauopathy, Animal Models, 
Cognitive Performance, Perivascular Pathology 
INTRODUCTION 
Current limitations in understanding CTE pathophysiology are unlikely to be 
addressed in a clinical population in the near future due to the challenges associated with 
establishing long-term, prospective cohort studies in such a population.  Preclinical 
rodent models serve to fill this gap in knowledge for various disorders and could allow 
for further investigation of the molecular mechanisms responsible for CTE, as well as 
testing the potential of diagnostic and therapeutic approaches under development.  Few 
preclinical models of CTE have been proposed that sufficiently demonstrate both the 
requisite tauopathy and behavioral changes attributed to CTE (Aungst et al 2014b, Bailes 
et al 2014, Blaylock & Maroon 2011, Brody et al 2015, Creeley et al 2004, DeFord et al 
2002, DeRoss et al 2002, Donovan et al 2014, Friess et al 2009, Fujita et al 2012, 
Genovese et al 2013, Goldstein et al 2012, Hawkins et al 2013, Klemenhagen et al 2013, 
Longhi et al 2005, Lucke-Wold et al 2014b, Mannix et al 2014, Mannix et al 2013, 
!
52 
Mouzon et al 2012, Mouzon et al 2014, Petraglia et al 2014b, Petraglia et al 2014c, 
Shitaka et al 2011, Turner et al 2012a, Uryu et al 2002). 
The purpose of this paper is to present two preclinical models that successfully 
reproduce some neuropathological and behavioral changes consistent with CTE-like 
phenotypes, and discuss future directions for CTE animal modeling. Brody and 
colleagues (Brody et al 2015) present several unanswered questions that we expand upon 
in our accompanying review such as the role of 1) inter-injury interval, 2) number of 
impacts, 3) impact severity, 4) age at time of impacts, 5) mechanism of impact, 6) 
genetics, 7) gender, and 8) effect of environment on the likelihood and/or progression of 
CTE development.  We recently reported that endoplasmic reticulum stress might be a 
contributing factor linking acute neurotrauma to behavioral deficits (Logsdon et al 2014). 
The quest for elucidating CTE pathophysiology development is ongoing with the goal of 
targeting specific injurious cascades a key priority in order to prevent the emergence of 
clinical symptoms. 
In this work we present novel models of neurotrauma-induced neurodegeneration 
in both mice and rats following exposure to single or repetitive brain injury, respectively.  
These models replicate both the tauopathy and some of the behavioral changes implicated 
in CTE in the clinical population.  We believe the blast model is particularly relevant 
clinically due to utilization of a scaled, short-duration blast exposure. This is a striking 
contrast to long-duration blasts utilized in numerous studies that may more closely 
approximate an atomic blast than a blast from an improvised explosive device (Bass et al 
2012, Panzer et al 2012, Panzer et al 2014a, Turner et al 2013). Park and colleagues show 
that by having the animal outside of the tube, the wave is directed towards the skull 
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causing neurologic injury without extensive lung injury (Park et al 2011).  Extended 
duration waves are generated when the tube has disproportionate length and volume 
ratios for the driven and driver sections. When the animals are placed within a tube that 
has not been scaled, the impulse exposure to the skull might not be representative of 
human exposure (Cho et al 2013). The modified closed-head injury in unanesthetized 
animals described previously by Petraglia and colleagues offers the benefit of injuring 
awake animals, more closely replicating the clinical picture seen in athletes than most 
other TBI models (Petraglia et al 2014b, Petraglia et al 2014c).  Further studies are 
required to address injury paradigms that do or do not contribute to CTE development but 
utilization of these models appears promising in not only modeling CTE but also 
identifying therapeutic targets based upon other recently published work by our groups 
(Logsdon et al 2014, Lucke-Wold et al 2014a). 
METHODS 
Animals and human samples 
All experiments involving animals were approved by either the Institutional 
Animal Care and Use Committee of West Virginia University or that of the University of 
Rochester and were performed based upon principles of the Guide for the Care and Use 
of Laboratory Animals.  Fifty-six (56) young-adult male rats (300-350 grams) were 
acquired from Hilltop Laboratories (Scottdale, PA). All blast procedures were performed 
at West Virginia University. Twelve (12) young-adult male C57BL/6J mice were 
acquired from Jackson Laboratories (Bar Harbor, ME) and used for modified controlled 
cortical impact at the University of Rochester.  All animals were allowed to acclimate 
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upon arrival for 1 week prior to any experimentation.  At all times animals were provided 
food and water ad libitum and maintained on a 12 hour light-dark cycle. Human samples 
were from deceased professional athletes that were previously diagnosed with chronic 
traumatic encephalopathy (Omalu et al 2010a). The tissue was collected from the 
entorhinal cortices.  
Experimental groups 
Fifty-six (n = 56) rats were divided into three primary experimental groups for 
behavior – anesthetized controls (n = 24), a single blast injury (n = 16), and repeat blast 
injuries (n = 16).  Each of these groups was sacrifed at 1 month following the final blast 
or sham-injury and after undergoing functional assessment. Elevated-plus maze was done 
at 7 days post-blast (n = 24; 8 controls, 8 single blast, and 8 repeat blast) and the Morris 
water maze started at 21 days post-blast (n = 32; 16 controls, 8 single blast, and 8 repeat 
blast).  Following behavioral analysis, rats from the EPM group were divided into two 
separate groups with one utilized for immunohistochemistry (n = 10; 4 controls, 3 single 
blast, and 3 repeat blast) and the other for western blotting (n = 14; 4 controls, 5 single 
blast, and 5 repeat blast).  Twelve (12) mice were divided into three primary experimental 
groups – anesthetized controls  (n = 4), single injury with sacrifice at one week (n = 4), 
and single injury with sacrifice at one month (n = 4).  All mice were utilized for western 
blotting techniques at time of sacrifice. An experimental schematic can be seen in figure 
3.1. 
Traumatic brain injury 
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Briefly, all blast injuries administered to rats as part of this work were of 
moderate intensity (~50 PSI peak reflected overpressure) as determined previously and 
completed under isoflurane-based anesthesia (Logsdon et al 2014, Lucke-Wold et al 
2014a, Turner et al 2013).  Blast exposure occurred on the right side of the animal and 
was only administered to the head and neck region. The rat was outside of the blast tube 
and a rigid barrier protected the remainder of the animal.  Blast waves were of a short-
duration (~2 ms) to ensure clinical relevance based on elucidated scaling parameters 
(Figure 3.2 A). The scaling parameters are based on impulse dynamic measurements, 
which are more representative of human blast than closed models based on duration 
(Needham et al 2015). 
Mice were utilized in a manner previously described (Petraglia et al 2014b, 
Petraglia et al 2014c).  Briefly, mice were placed, unanesthetized, into a rodent restraint 
bag/cone and immobilized on top of a foam bed of known spring constant.  A helmet was 
secured to the head using an elastic band, allowing for administration of a diffuse impact 
through force distribution. The helmet is made of stainless steel and measures 3 mm in 
thickness and 6 mm in diameter. Impacts were delivered using a modified controlled 
cortical impact device that was adjusted to include an altered tip of vulcanized rubber 
(Figure 3.2 B). The impact was zeroed so that it was directly perpendicular to the helmet 





Animals were anesthetized and sacrificed by rapid decapitation.  Brains were 
extracted and immediately placed in a lysate buffer with protease and phosphatase 
inhibitors as described elsewhere (Logsdon et al 2014).  Brains were dissected and tissue 
flash frozen and stored at -80 °C prior to blotting.  Hippocampal protein samples were 
dissolved in 0.5 mL of 1% sodium dodecyl sulfate (SDS) prior to sonication and protein 
assay.  Pre-cast 10% 12-well gels (Life Technologies, Carlsbad, CA) were loaded with 30 
µg of protein per well and run with 2X Lammeli buffer.  Wet transfer was performed 
using nitrocellulose membranes (Bio-Rad, Contra Costa, CA) at 60 volts for 2.5 hours.  
Primary antibodies against AT8 (Pierce; Rockford, IL), AT270 (Pierce; Rockford, IL), 
CP13 (kindly supplied by Dr. Peter Davies), and PHF-1 (kindly supplied by Dr. Peter 
Davies) were utilized and detected utilizing the corresponding secondary.  Membranes 
were imaged using a LI-COR fluorescent scanner (LI-COR; Lincoln, NE) and images 
converted to gray scale.  Analysis was performed using background subtraction (Odyssey 
Processing Software, LI-COR) and values normalized to β–actin levels, resulting in a 
normalized intensity value. 
Immunohistochemistry 
For immunohistochemistry preparation, animals were anesthetized using 
isoflurane and transcardially perfused with ice-cold physiologic saline followed by 10% 
formalin for a total of 10 minutes.  Brains were extracted and placed in fresh 10% 
formalin for a minimum of 24 hours prior to blocking and subsequent paraffin 
embedding.  Sections were prepared in 6 µm thickness using a Leica RM2235 microtome 
(Leica Microsystems, Wetzlar, Germany).  Staining was performed using standard 
protocols used within the field and previously by our laboratory, using the antibodies 
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described above as well as thioflavin for detecting neurofibrillary tangles (Goldstein et al 
2012, McKee et al 2010, Stern et al 2013). 
Behavioral assessments 
Learning and memory was assessed using the Morris water maze.  Spatial 
acquisition trials began at Day 21 after the final blast exposure (in both single and repeat 
injury paradigms).  The pool utilized was ~180 cm in diameter and filled with water at 
ambient temperatures (18-21 °C).  A platform (10 cm x 10 cm) was submerged 2.5 cm 
below the surface of the water.  A series of objects was placed in the environment around 
the pool to provide visual cues for the animal during trials.  The training paradigm 
(spatial acquisition) consisted of 6 days with a total of 4 trials occurring each day per 
animal.  Animals were placed into the maze from four different locations each day (4 
trials) with a total of 2 minutes (maximum) allowed per trial.  Upon finding the platform, 
animals were allowed 15 seconds for acquisition to occur.  If unsuccessful in finding the 
platform, animals were placed on the platform at the conclusion of 2 minutes by the 
investigator.  On the probe trial day (platform removed), animals were placed in the maze 
at a novel location and allowed to explore the maze for 1 minute.  Data was acquired 
using AnyMaze™ video tracking software (Stoelting Co., Wood Dale, IL) throughout all 
studies and allows for acquisition of latency, distance, and speed data to be analyzed 
across maze regions/quadrants. 
Impulsivity was determined, at 7 days after the final blast, as previously described 
using an elevated-plus maze and measuring exploratory behavior (Johnson et al 2013, 
Logsdon et al 2014, Mosienko et al 2012).  The apparatus was placed at a height of 60 cm 
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from the floor and consisted of two open and two closed arms, with open arms opposing 
one another and intersecting perpendicularly with the opposed closed arms.  Each arm 
was 50 cm long by 10 cm wide.  Open arms were surrounded by clear plastic edging ~1.5 
cm high.  Closed arms were encased with black walls 30 cm tall, creating a 3-sided and 
comforting enclosure for the rodent.  At the start of each 5-minute trial, animals were 
placed in the middle of the intersecting arms facing an open arm prior to release.  
Animals were allowed to explore the apparatus for the duration of the trial.  AnyMaze™ 
software was utilized to record the animals’ position, distance traveled, and entry pattern 
into various arms throughout the trial.  An increased percentage of time spent in the open 
arms was considered a sign of impulsive behavior (Johnson et al 2013, Logsdon et al 
2014, Mosienko et al 2012).  
Statistical analysis 
An observer blinded to experimental condition performed all data acquisition.  
One-way Analysis of Variance (ANOVA) was used for statistical analysis of all tests 
except spatial acquisition trials of the Morris water maze and immunohistochemical 
comparisons in which a two-way, repeated measures ANOVA and students t-test were 
utilized, respectively.  Bonferroni post-hoc comparison was used to determine differences 
between experimental groups on two-way ANOVA with repeated measures for spatial 
acquisition.  For all other comparison’s, a Tukey’s post-hoc was utilized.  Analysis was 
completed using GraphPad Prism 5.0 (GraphPad Software, Inc.; La Jolla, CA).  A p 




Neurotrauma induces tau hyperphosphorylation in both blast and closed-head injury 
models 
To elucidate the effect of neurotrauma on the development of CTE-like 
neuropathology, animals were exposed to sham-injury, single-injury (either blast or 
modified closed-head), or repeat-injury (blast).  Animals were first assessed for tau 
phosphorylation, using AT8 and AT270 antibodies, believed to be the initial precursor of 
neurofibrillary tangle development. AT8 forms a single band in rats and a double band in 
mice (Hawkins et al 2013). Conversely, AT270 forms a double band in rats, but only a 
single band in mice (Green et al 2007). The number of bands is indicative of calpain 
dependent phosphorylation, which is regulated uniquely between rats and mice (Medeiros 
et al 2012). Increased phosphorylation of tau was observed after blast exposure and 
modified closed-head injury but the location of the increase was model-dependent.  
Specifically, tau phosphorylation was observed in the contralateral hemisphere in rats 
exposed to repeat blast injury but only in the ipsilateral hemisphere, and only with the 
AT8 antibody, in mice receiving a single modified closed-head injury.   
In rats exposed to blast, no significant difference in tau phosphorylation was 
observed in the ipsilateral hippocampus after blast injury for AT8 (Figure 3.3 A) or 
AT270 (Figure 3.3 E).  A significant difference was observed in AT8 (F2,11 = 16.64, p < 
0.001) and AT270 (F2,9 = 4.37, p < 0.05) levels in the contralateral hippocampus of rats 
exposed to blast injury.  At one month following a single blast, a significant increase in 
tau phosphorylation recognized by AT8 increase was measured compared to control (q = 
3.96, p < 0.05) (Figure 3.3 B).  A significant increase in phosphorylation detected by 
AT8 was also observed after repeat blast (q = 8.12, p < 0.001) (Figure 3.3 B). 
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In the modified closed-head injury model utilized on the mice, a significant 
difference was observed in tau phosphorylation AT8 (F2,9 = 4.93, p < 0.05) in the 
ipsilateral hippocampus.  At one-month following injury, AT8 expression was elevated in 
comparison to sham-injury (q = 4.34, p < 0.05) (Figure 3.3 C).  No significant difference 
was observed at 7-days post-injury on the ipsilateral side or between any groups or time 
points on the contralateral side (Figure 3.3 D). 
At one-month following repetitive blast exposure, a significant increase 
phosphorylation recognized by the AT270 antibody was measured in the contralateral 
hippocampus of rats compared to anesthetized control animals (q = 4.03, p < 0.05) 
(Figure 3.3 F).  No significant differences were observed in tau phosphorylation 
recognized by AT270 in either ipsilateral (Figure 3.3 G) or contralateral (Figure 3.3 H) 
hippocampus of mice receiving modified closed-head injury. 
Hyperphosphorylation of tau following neurotrauma occurs in perivascular brain 
regions 
Clinical case series documenting patients with CTE have demonstrated the 
deposition of neurofibrillary tangles (NFTs), an end product of tau hyperphosphorylation, 
in perivascular regions, which is a distinct difference from other tauopathies such as 
Alzheimer’s disease (AD).  Possible mechanisms leading to NFTs in perivascular regions 
include the disruption of the blood-brain barrier (BBB), leading to punctate 
microhemorrhages, red blood cell breakdown, oxidative stress, and finally, persistent 
neuroinflammation.  We observed a significant difference in tau hyperphosphorylation 
within perivascular regions of the contralateral hippocampus in rats exposed to repeat 
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blast in comparison to control when identified with both AT8 (t = 4.46,  p < 0.001) and 
AT270 (t = 11.47, p < 0.001) at 1-month post-injury (Figure 3.4).  These findings were 
consistent with prior reports of CTE in humans and from our collection of post-mortem 
human samples with documented CTE. 
Neurotrauma is associated with conformational changes in tau that are recognized 
precursors of neurofibrillary tangle formation 
Following hyperphosphorylation, tau is purported to undergo conformational 
changes associated with subsequent insolubility and deposition/precipitation in the form 
of neurofibrillary tangles.  Following neurotrauma in rats and mice, we found an 
elevation in markers of conformational change of the tau molecule based on 
immunoblotting with PHF-1 and CP13.  After blast exposure, markers of tau 
conformational change were observed in the contralateral hemisphere of rats, while after 
the impact procedure in mice, the markers were found ipsilaterally.  No significant 
differences in markers of tau conformation change were observed in the ipsilateral 
hippocampus after blast injury for neurofibrillary precursor PHF-1 (Figure 3.5 A) or 
CP13 (Figure 3.5 E). 
A significant difference was observed in PHF-1 (F(2,11) = 7.92, p < 0.01) and CP13 
(F(2,9) = 6.03, p < 0.05) levels in the contralateral hippocampus of rats exposed to blast 
injury.  At one month following a single blast, a significant increase in PHF expression 
was measured compared to control (q = 4.76, p < 0.05) (Figure 3.5 B). 
A significant difference was observed in PHF-1 (F(2,9) = 7.18, p < 0.05) levels in 
the ipsilateral hippocampus of mice exposed to injury.  At one month following modified 
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impact, a significant increase in PHF-1 expression was measured compared to control (q 
= 5.17, p < 0.05) (Figure 3.5 C).  No significant differences were observed in PHF-1 
expression in the contralateral hippocampus of mice exposed to cortical impact (Figure 
3.5 D). 
At one month after repetitive blast exposure, a significant increase in CP13 
expression was measured in the contralateral hippocampus of rats compared to control (q 
= 4.73, p < 0.05) (Figure 3.5 F).  A significant difference was observed in CP13 (F(2,9) = 
21.70, p < 0.001) levels in the ipsilateral hippocampus of mice exposed to  injury.  At one 
month following impact, a significant increase in CP13 expression was measured 
compared to control (q = 9.28, p < 0.001) (Figure 3.5 G).  No significant differences were 
observed in CP13 expression in the contralateral hippocampus of mice exposed to 
cortical impact (Figure 3.5 H). 
Similar findings were seen using immunohistochemistry when comparing repeat-
injured animals to sham-injured animals at 1 month post-injury. Specifically, a significant 
difference was seen on PHF-1 staining (t = 6.06, p < 0.001) and CP-13 staining (t = 3.88, 
p < 0.01) (Figure 3.6).  Again, the distribution of the staining was notable for being 
perivascular in nature, a finding shared across the clinical specimens diagnosed with CTE 
as seen in figure 3.7. We show that PHF, AT8, and a thioflavin stained neurofibrillary 
tangle are increased perivascular in human CTE specimens. CP-13 is increased in a 
perivascular distribution following repeat blast in a rat.  
Neurotrauma produces cognitive impairments 
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Cognitive deficits have long been associated with the neuropathological diagnosis 
of CTE in the clinical population, particularly amongst the population diagnosed with 
CTE at a later age in life.  Similarly, cognitive impairments in both learning and memory 
have been associated with neurotrauma but have not been presented in the context of a 
corresponding tauopathy in both a single and repeat blast injury paradigm.  In cohorts of 
animals subjected to either sham-, single-, or repetitive-injury, spatial acquisition 
(learning) was assessed 3 weeks after the injury in single-injury animals and the final 
injury in repeat-injury paradigms (Days 21-27 post-injury).  Blast injury exposure was 
associated with worsened performance in the Morris water maze as evident by latency to 
find the platform in seconds when analyzed using a two-way repeated measures 
ANOVA.  Post-hoc tests revealed significant differences between anesthetized controls 
and single-injury animals during spatial acquisition on Days 22-24, and Day 26 (Day 21: 
t = 1.38, p > 0.05; Day 22: t = 3.70, p < 0.01; Day 23: t = 4.12, p < 0.001; Day 24: t = 
4.38, p < 0.001; Day 25: t = 2.17, p > 0.05; Day 26: t = 3.20, p < 0.01).  Similarly, post-
hoc tests demonstrated a significant impairment in acquisition between anesthetized 
controls and repetitively injured animals on Days 22-26 (Day 21: t = 0.66, p > 0.05; Day 
22: t = 5.01, p < 0.001; Day 23: t = 4.16, p < 0.001; Day 24: t = 4.72, p < 0.001; Day 25: t 
= 3.69, p < 0.01; Day 26: t = 3.76, p < 0.01).  Notably, no differences were seen between 
single- and repeat-injured animals during the course of acquisition trials, despite the 
notable difference in tau pathology at this time presented earlier (Figure 3.8).  The 
differences in latency to platform between blast-injured animals and anesthetized control 
animals is apparent as well based on visualization of the track plots recorded during data 
acquisition (Figure 3.9).  Clearly different swimming patterns emerge with blast-injured 
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animals exhibiting what appears to be more thigmotaxis (circling around the outer edge 
of the pool) than anesthetized control animals that reached statistical significance 
between controls and repeat-injured animals on Day 23 (q = 3.58, p < 0.05), although this 
data point did not reach significance on Days 21 and 26 based on automated 
measurements generated using AnyMaze™ (Figure 3.8). 
Memory, as measured during the probe test (time spent in area surrounding the 
now-removed platform) conducted on Day 27, again demonstrated deficits in animals 
subjected to blast-induced neurotrauma when analyzed using a one-way ANOVA (F2,29 = 
20.01, p < 0.0001).  Post-hoc tests showed significant differences between sham and 
single injury animals (t = 6.44, p < 0.05) as well as between sham and repetitively injured 
animals (t = 8.00, p < 0.05) but no difference between single injury and repeat injury 
paradigms (Figure 3.8).  These findings were confirmed visually using track plots 
generated during data acquisition (Figure 3.9).  Anesthetized control animals exhibit a 
greater preponderance of pool crossings and swimming behavior within the region near 
the platform in contrast to blast-injured animals (Figure 3.9). 
Impulsivity is increased following neurotrauma 
Clinically, impulsive behavior has been described extensively in those with a 
history of repetitive neurotrauma and the context of CTE.  To make an analogous 
comparison between our animal model of blast-induced traumatic brain injury and 
clinically reported symptoms, the elevated-plus maze was utilized to measure impulsive-
like behaviors based upon the percentage of time spent in the open-arms of the maze.  
Significant differences between groups were observed when analyzed using a one-way 
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ANOVA (F2,32 = 5.03, p < 0.05).  Post-hoc tests revealed a significant difference between 
sham and single injury animals (q = 3.53, p < 0.05) as well as between sham and 
repetitively injured animals (q = 4.21, p < 0.05).  No difference was seen between single 
and repeat injury paradigms with regards to percentage of time spent in the open arms of 
the apparatus (Figure 3.10).  While not statistically significant, a trend towards a greater 
distance traveled in the open arms was observed with increasing levels of neurotrauma, 
evidence consistent with the percentage of time spent in the open arms (Figure 3.10).  
Conversely, a trend was also present regarding distance traveled in the closed arms with 
animals subjected to neurotrauma traveling less distance (Figure 3.10).  Post-hoc tests 
revealed no statistical significance when comparing sham to single injury groups but 
significance was reached when comparing sham to repetitively-injured animals (F2,33 = 
3.06 ; q = 3.47, p < 0.05). 
DISCUSSION 
While the clinical literature has been inundated with reports of CTE in athletes 
and soldiers alike, few experimental tools exist for investigating disease pathophysiology, 
establishing diagnostic criteria, and discovering preventative or therapeutic agents.  For 
these reasons, preclinical models of CTE are highly desirable.  In this work we 
demonstrate two preclinical models capable of generating some biochemical and 
behavioral hallmarks of CTE, namely tauopathy and impulsive-like behavior.  
Furthermore, this work illustrates the utility of two distinct models and injury paradigms, 
namely blast exposure versus a more traditional modified closed-head injury, and repeat 
versus single injury paradigms respectively. Likewise, the fact that this work was 
completed in two different species and builds upon prior work by both West Virginia 
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University and the University of Rochester laboratories validates the use of both mice 
and rats in the preclinical modeling of neurotrauma related neurodegeneration (Logsdon 
et al 2014, Petraglia et al 2014b, Petraglia et al 2014c).  The modified closed-head injury 
represents a helmeted design with controlled placement of the impact likely accounting 
for ipsilateral deficit. The tauopathy development period following modified controlled 
impact was not previously elucidated therefore warranting the 7-day time point. Petraglia 
and colleagues show that astrocyte activation and cell death occurs at 7 days post 
modified controlled impact (Petraglia et al 2014c). We previously reported that tauopathy 
following blast in rats does not develop until weeks after injury and is on the contralateral 
side due to coup/contra-coup injuries (Lucke-Wold et al 2015d).  
The potential utility of these, as well as other preclinical models of neurotrauma 
related neurodegeneration, is highly promising for investigation of disease 
pathophysiology, particularly as related to biochemical endpoints associated with CTE. 
To fully develop a CTE model, transgenic rodents will be needed that include amyloid, 
tau, and TDP43 pathology. The quest for elucidating the underlying mechanisms behind 
CTE development is ongoing. In previous work, we have shown blast causes substantial 
blood brain barrier disruption (Lucke-Wold et al 2014a), endoplasmic reticulum stress 
activation (Logsdon et al 2014), and oxidative stress (Lucke-Wold et al 2015a).   We 
show in this work the induction of hyperphosphorylated tau, conformational changes in 
tau, and more advanced precursors of NFT formation with the usage of CP13 and PHF-1 
antibodies. AT8 binds to serine 199 and 202 as well as threonine 205. AT270 binds to 
threonine 181, PHF binds to serine 396 and 404, and CP13 binds to serine 202. Serine 
396 and 202 are only exposed after tau undergoes conformational change (Lucke-Wold et 
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al 2014c). These changes are the ultimate result of tau hyperphosphorylation and protein 
misfolding/aggregation, and are likely related to dysregulation of the tau 
kinase/phosphatase system. Peclinical modeling of neurotrauma related 
neurodegeneration will allow for the elucidation of how and when these kinases and 
phosphatases become dysregulated, and will allow for increased understanding of the 
disease process.  Additionally, these studies will provide targets for direct or indirect 
therapeutic development.  Similarly, preclinical models may prove instrumental in 
identification of diagnostic and prognostic tests for establishing a diagnosis of CTE and 
tracking disease progression. There is a clinical need for a rapid, cheap, and reliable 
diagnostic test to predict severity of CTE. Currently neuropathological examination 
remains the gold standard for diagnosis with some studies purporting the use of PET-
based imaging for diagnosis (Gandy & DeKosky 2014, Mitsis et al 2014, Small et al 
2013).  It is possible that development and validation of these techniques, and others such 
as diffusion tensor imaging and magnetic resonance spectroscopy may be accelerated 
through the application to preclinical models. The current limitation is that advanced 
imaging is expensive, cumbersome, and requires expertise from subspecialty radiologists. 
Despite this work illustrating what we believe represents a clear step forward in 
the study of neurotrauma related neurodegeneration, it is clear that further study is 
warranted. Pre-clinical models must be utilized to more fully characterize behavioral, 
biochemical, imaging, and electrophysiological/functional changes associated with the 
development of CTE.  Future studies will likely address the development of 
behavioral/functional deficits in relation to biochemical changes temporally and assess 
the chronicity of changes based on the number, severity, and inter-injury interval of 
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neurotrauma-related events. The development of better transgenic models is critical as the 
field moves forward.  Performing studies such as these will allow for the questions raised 
in our accompanying review be addressed.  Specifically, what is the role of the 1) inter-
injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5) 
mechanism of impact, 6) genetics, 7) gender, and 8) effect of environment on the 
likelihood and/or progression of CTE development. 
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Figure 3.1: Schematic showing experimental design and behavioral experiments. Time 

















Figure 3.2: Schematic representation of the two injury models utilized within this work.  
(A) Experimental setup utilized at West Virginia University for the study of blast-induced 
neurotrauma.  The shock tube consists of a high-pressure driver section (nitrogen gas 
filled) and a low-pressure driven section (ambient air filled).  When the membrane 
dividing the chambers ruptures, the blast wave is formed and released, encountering the 
rat from the right side of the cranium. (B) Depiction of the model utilized at the 
University of Rochester in un-anesthetized mice.  An electromagnetic impactor used in 
CCI was modified with a rubber tip and a specially designed helmet was placed on the 







Figure 3.3: Blast and closed-head injury models both induced tau hyperphosphorylation.  
(A) Immunoblots show no significant difference in tau phosphorylation at serine sites 
199/202 and threonine site 205 (AT8) at one month after single and repeat blast 
exposures in the ipsilateral rat hippocampus.  (B) A significant increase in AT8 
expression was measured after single (*p<0.05 vs. CTRL) and repeat blast exposure 
(***p<0.001 vs. CTRL) in the contralateral rat hippocampus.  (C) AT8 expression was 
significantly increased at one month after closed-head injury in the ipsilateral mouse 
hippocampus (*p<0.05 vs. CTRL).  (D) No significant differences were observed in AT8 
expression in the contralateral mouse hippocampus.  (E) Immunoblots show no 
significant difference in tau phosphorylation at threonine site 181 (AT270) at one month 
after single and repeat blast exposure in the ipsilateral rat hippocampus.  (F) A significant 
increase in AT270 expression was measured at one month after repeat blast exposure 
(*p<0.05 vs. CTRL) in the contralateral rat hippocampus.  (G) No significant differences 
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were observed in AT270 expression in the ipsilateral mouse hippocampus, (H) or the 
contralateral mouse hippocampus after closed-head injury.  One-way ANOVA Tukey’s 

























Figure 3.4: Tau hyperphosphorylation is seen in microfoci throughout the contralateral 
superficial cortex. AT8 was significantly increased at 1 month post repetitive blast (t = 
4.455,  p < 0.001). AT270 was also significantly increased following repetitive blast (t = 
11.47, p < 0.001). AT270 was increased in a circular distribution. Tau 
hyperphosphorylation is an indicator of progressive pathology. Values were calculated 










Figure 3.5: Blast and closed-head injury models both induce conformational changes in 
tau proteins.  (A) Immunoblots show no significant difference in markers of tau 
conformational change at serine site 396/404 (PHF) at one month after single and repeat 
blast exposure in the ipsilateral rat hippocampus.  (B) A significant increase in PHF 
expression was measured after single (*p<0.05 vs. CTRL) and repeat blast exposure 
(*p<0.05 vs. CTRL) in the contralateral rat hippocampus.  (C) PHF expression was 
significantly increased at one month after closed-head injury in the ipsilateral mouse 
hippocampus.  (D) No significant differences were observed in PHF expression in the 
contralateral mouse hippocampus.  (E) Immunoblots show no significant difference in 
markers of tau conformational change at serine site 202 (CP13) at one month after single 
and repeat blast exposure in the ipsilateral rat hippocampus.  (F) A significant increase in 
CP13 expression was measured at one month after repeat blast exposure (*p<0.05 vs. 
CTRL) in the contralateral rat hippocampus.  (G) A significant increase in CP13 
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expression was measured at one month after closed-head injury in the ipsilateral mouse 
hippocampus (***p<0.001 vs. CTRL).  (H) No significant differences were observed in 
CP13 expression in the contralateral mouse hippocampus after closed-head injury.  One-























Figure 3.6: Tau conformational markers were increased throughout the contralateral 
superficial cortex. PHF was significantly increased at 1-month post repetitive blast (t = 
6.055, p < 0.001). CP-13 staining was also significantly increased following repetitive 
blast (t = 3.883, p < 0.01). CP-13 was increased in a perivascular distribution. Tau 
conformational change is required for the formation of neurofibrillary tangles. Values 











Figure 3.7: Tauopathy is seen in a perivascular distribution. PHF and AT8 were 
increased adjacent to longitudinal microvessels in human patients diagnosed with chronic 
traumatic encephalopathy. A neurofibrillary tangle stained with thioflavin was seen 
adjacent to a cut vessel lumen in the brain of a retired professional football player. 
Similarly, CP-13 was increased next to a cut vessel lumen in the contralateral cortex 1 
month following repeat blast in the rat. Arrows indicate tauopathy while arrowheads 









Figure 3.8: Blast-induced brain injury produces deficits in learning and memory in rats.  
(A) Spatial acquisition trials conducted on Days 21-26 post-injury revealed deficits in 
learning in single-injury animals on Days 22-24 and 26 in comparison to control.  
Repeat-injury was associated with deficits on Days 22-26 in comparison to control.  No 
differences were seen between single- and repeat-injury paradigms.  (B) The probe test 
on Day 27 revealed a statistically significant difference in time spent near the prior 
platform location between injured animals (single or repeat) and control animals.  No 
difference was seen between single- and repetitively-injured rats.  (C) Animals exposed 
to neurotrauma exhibited a trend towards increased thigmotaxis during spatial acquisition 






Figure 3.9: Track plots acquired across spatial acquisition and probe testing in rats.  (A-
D) Track plots generated from anesthetized control animals on Day 21, Day 23, Day 26, 
and during the probe test.  (E-H) Track plots generated from single-injured animals on 
Day 21, Day 23, Day 26, and during the probe test post-injury. (I-L) Track plots 
generated from repetitively-injured animals on Day 21, Day 23, Day 26, and during the 
probe test post-injury.  Injured animals appear to spend more time exhibiting thigmotaxis 
behaviors (circling edge of pool) on later days and in the probe trial fail to spend as much 
time as the anesthetized control animals within the probe region and the direct area 






Figure 3.10: Blast-induced brain injury in rats produces an increase in impulsive 
behavior based on the elevated-plus maze.  (A) A significant difference (p<0.05 vs. 
CTRL) was seen between anesthetized control animals and both single and repeat blasts 
with regards to the percentage of time spent in the open arm of the elevated-plus maze.  
No difference was measured between single and repeat-injury paradigms.  (B) While not 
reaching statistical significance, a trend towards greater distance traveled in open arms 
was seen with neurotrauma, a finding consistent with the documented increase in time 
spent in the open arms.  (C) Animals subjected to neurotrauma appeared to travel less 
distance in the closed arms of the maze, although this finding did not reach statistical 
significance.  (D) Track plot showing little exploration of the open arm by control 
animals.  (E) Track plot showing increased exploration of the open arms of the elevated-
plus maze by single-injured animals.  (F) Track plot showing increased exploration of the 





Bryostatin-1 Restores Blood Brain Barrier Integrity following Blast-Induced 
Traumatic Brain Injury 
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Recent wars in Iraq and Afghanistan have accounted for an estimated 270,000 
blast exposures amongst military personnel. Blast traumatic brain injury (TBI) is the 
‘signature injury’ of modern warfare. Blood brain barrier (BBB) disruption following 
blast TBI can lead to long-term and diffuse neuroinflammation. In this study, we 
investigate for the first time the role of bryostatin-1, a specific protein kinase C (PKC) 
modulator, in ameliorating BBB breakdown. 37 Sprague dawley rats were used for this 
study. We utilized a clinically relevant and validated blast model to expose animals to 
moderate blast exposure. Groups included: control, single blast exposure, and single blast 
exposure + bryostatin-1. Bryostatin-1 was administered i.p. 2.5 mg/kg after blast 
exposure. Evan’s blue, immunohistochemistry, and western blot analysis were performed 
to assess injury. Evan’s blue binds to albumin and is a marker for BBB disruption. Single 
blast exposure caused an increase in permeability compared to control (t=4.808, p<0.05), 
and a reduction back towards control levels when bryostatin-1 was administered 
(t=5.113, p<0.01). Three important PKC isozymes, PKC α, δ, and ε, were co-localized 
primarily with endothelial cells but not astrocytes. Bryostatin-1 administration reduced 
toxic PKCα levels back towards control levels (t=4.559, p<0.01), and increased the 
neuroprotective isozyme PKCε (t=6.102, p<0.01). Bryostatin-1 caused a significant 
increase in the tight junction proteins VE-cadherin, ZO-1, and occludin through 
modulation of PKC activity. Bryostatin-1 ultimately decreased BBB breakdown 
potentially due to modulation of PKC isozymes. Future work will examine the role of 
bryostatin-1 in preventing chronic neurodegeneration following repetitive neurotrauma. 
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INTRODUCTION 
1.7 million Americans experience a traumatic brain injury (TBI) each year in the 
United States (Kou & Vandevord 2014). Over 70% of those patients sustain some form 
of disability following TBI (Schneider et al 2014). The mechanisms by which TBI 
contributes to permanent homeostatic changes within the central nervous system (CNS) 
remain poorly understood. Recent evidence implicates disruption of the blood brain 
barrier (BBB) as an important indicator of brain injury (Puvenna et al 2014). Blast TBI, 
in particular, contributes to a vascular pressure surge that challenges BBB integrity 
(Simard et al 2014).  Blast TBI also causes significant alterations in ZO-1, occludin, and 
VE-cadherin, important tight junction proteins (Hue et al 2014). The disruption is not 
universal across vasculature however, with scattered lesions spread across the brain at 
specific microfoci (Yeoh et al 2013). Oxidative stress from damaged tissue causes 
increased BBB permeability at these microfoci (Abdul-Muneer et al 2013). The resulting 
BBB dysfunction contributes to inflammatory cascades and injury expansion (Perez-Polo 
et al 2013). The increase in blast-induced BBB permeability is transient with a return of 
tight junction function within 3 days, but the subsequent injury response is long-lasting 
(Readnower et al 2010).   
One possible reason for these long-lasting effects is changes in protein kinase C 
(PKC) isozyme activity after injury.  Some PKC isozymes, PKCα, β, and ε, translocate to 
the plasma membrane within 3 hours after TBI and remain active for days (Muscella et al 
!
84 
2008, Padmaperuma et al 1996, Yang et al 1993). PKCα activity has been linked to 
neuronal apoptosis following TBI (Chen et al 2012), and is closely tied with glutamate 
receptor signaling (Luo et al 2014b). PKCα and δ activity can cause an uncoupling of 
NMDA receptors from spectrin mediated through sigma-1 receptor activation leading to 
calcium oscillations (Geddes-Klein et al 2006, Giordano et al 2005, Roh et al 2010). The 
calcium oscillations contribute to mitochondrial dysfunction and cell death (Pandya et al 
2013). PKCα and δ can also hyperphosphorylate structural proteins such as tau and 
TBI61 within the hippocampus following injury (Yang et al 1994). Interestingly, PKC 
activity also decreases cerebral edema following TBI (Karasu et al 2010, Yang et al 
1993). Three important isozymes play important roles in cerebral vasculature.  PKCα 
regulates ZO-1 and occludin tight junction proteins (Kim et al 2010).  PKCδ activity 
regulates vessel constriction and vascular tone (Kizub et al 2014). PKCε decreases vessel 
tone and provides neuroprotection (Lin et al 2012). Despite these associations, the role of 
specific PKC isozymes in BBB disruption following blast TBI has yet to be elucidated.  
Although PKC activity has not been well studied in TBI, available evidence 
suggests that PKC isozymes play an important role in neural injury. An 80% increase in 
PKC activity was reported 3 hours after TBI and contributes to secondary neuronal injury 
(Yang et al 1993). Compounds that modulate PKC isozymes therefore warrant further 
investigation. The potent PKC modulator, bryostatin-1, has profound neuroprotective 
effects in animal models of neural injury. The single study using bryostatin-1 for 
treatment of mild TBI showed profound protection against learning and memory deficits 
in mice by increasing the α-secretase, ADAM10 (Zohar et al 2011). Although PKC 
modulation has not been extensively studied in TBI models, in an Alzheimer’s disease 
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model it increased PKCε, which facilitated amyloid β plaque degradation by increasing 
the enzyme neprilysin (Lim & Alkon 2014). It also enhanced gabaergic signaling 
improving learning and memory through PKCα modulation and decreased synaptic loss 
(Hongpaisan et al 2011, Xu et al 2014). Following ischemic stroke, bryostatin-1 
modulated PKCα and ε to enhance survival and reduce edema in aged Sprague-Dawley 
rats (Tan et al 2013). Although Alzheimer’s disease and stroke are vastly different than 
TBI, they do share similar secondary mechanisms of injury, such as PKC and microglia 
activation, that should be carefully investigated 
Herein, we show for the first time that PKC isozymes are increased after blast-
induced TBI, and are correlated with acute BBB breakdown and tight junction protein 
changes. Using our clinically relevant and validated blast model (Turner et al 2013), we 
observed statistically significant acute changes in BBB permeability 6 hours after single 
blast exposure. Interestingly, the PKC modulator bryostatin-1 reduced BBB permeability, 
decreased levels of the detrimental PKCα isozyme, and increased the beneficial PKCε 
isozyme. The mechanism of bryostatin-1’s beneficial effects is closely linked to 
regulation of tight junction proteins through specific modulation of PKC isozymes. 
Occludin closely interacts with the scaffolding proteins ZO-1 and VE-Cadherin (Morrow 
et al 2010), and our data show that bryostatin-1 significantly elevated levels of occludin, 
VE-Cadherin, and ZO-1. Increasing the levels of tight junction proteins has been shown 
to help maintain BBB integrity (Goncalves et al 2012). Modulation of PKC expression 





Animals and treatments 
Thirty-seven (37) young adult (300-350g) male Sprague Dawley rats (Hilltop Lab 
Animals, Inc.) were used for this study.  Animals were housed in pairs with 12h:12h dark 
to light cycle and food available ad libitum. The Institutional Animal Care and Use 
Committee of West Virginia University approved all procedures and experiments 
involving animals. The experiments were performed in accordance with the Guide for the 
Care and Use of Laboratory Animals. Ten (10) animals were used for Evan’s Blue (EB) 
absorbance analysis. Eighteen (18) animals were used for immunohistochemisty (IHC) 
staining and western blot analysis. Nine (9) animals were used for microvessel isolation 
and subsequent western blot analysis (Fig. 1). Bryostatin-1 was administered by 
intraperitoneal injection (2.5 mg/kg) (Tan et al 2013), 5 minutes after blast exposure for 
all blast + bryostatin-1 groups. Bryostatin-1 was dissolved in vehicle (10% ethanol in 
0.9% normal saline). Bryostatin-1 was obtained by Dr. Daniel Alkon from the National 
Cancer Institute, National Institutes of Health, Bethesda, MD. The dose of bryostatin-1 
was selected in accordance with animal protocols and according to a dose response curve 
showing that bryostatin-1 enters the brain but is maintained well below the maximal 
tolerated dose (Berkow et al 1993, Sun & Alkon 2006). Control animals were 
anesthetized and injected with vehicle. Bryostatin-1 is a potent modulator of PKC 
isozymes with selectivity for PKCα and ε (Sun et al 2014). 
Blast exposure 
The animal was oriented perpendicular to the blast apparatus, with the driver 
section placed near the right side of the skull. A polyvinyl chloride shield protected the 
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rest of the body.  We utilized a membrane with 0.005 inch thickness to generate a blast 
exposure with peak reflected overpressure of ~50 PSI, and peak incident overpressure of 
~15 PSI (Figure 4.1 B-C). The exposure produced moderate blast injury as previously 
characterized (Turner et al 2013). The primary extent of injury has been localized to the 
left hemisphere due to coup and counter-coup acceleration/deceleration mechanisms 
(Turner et al 2012b). Briefly, nitrogen gas builds pressure behind a clear polyester film 
that subsequently ruptures to produce a blast wave.  Piezoelectric sensors (Model 
102AO5; PCB Piezotronics) were placed in the reflected and incident positions at the exit 
of the shock tube and data was recorded with a data acquisition board (DAQ 23GF, 
National Instruments) and sensor signal conditioner (482C Series; PCB Piezotronics). 
LabView software version 12.0 (National Instruments) was used to reconstruct accurate 
pressure recording graphs (Figure 4.1 D). The short driver section generates brief-
duration waves comparable to those seen from improvised explosive devices when scaled 
properly for the rodents size based on principles previously highlighted by Bass and 
colleagues (Bass et al 2012, Panzer et al 2014b). 
Evan’s blue 
Groups for Evan’s Blue (EB) included: control (n=3), single blast (n=4), and 
single blast + bryostatin-1 (n=3). BBB permeability was assessed 6 hours after blast 
exposure using EB as a tracer molecule. EB binds to albumin, and albumin will only 
enter the brain if the BBB is compromised. Animals were anesthetized with inhaled 4% 
isoflurane (Halocarbon) and maintained with 2% isoflurane before normal saline 
containing EB (2%, 5ml/kg) (2% w/v in saline) was administered intravenously (femoral 
vein) 30 minutes prior to perfusion.  The rats were transaortally perfused with normal 
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saline for 10 minutes.  The brains were excised; meninges and ependymal organs 
removed, hemispheres separated, and left prefrontal cortex sectioned. The prefrontal 
cortex is one of the brain regions most susceptible to BBB disruption following injury 
(Yen et al 2013).  The left prefrontal cortex samples were then weighed, and 
homogenized in 1 ml of 50% trichloroacetic acid (TCA). The resulting suspensions were 
placed in 0.5mL aliquots. The aliquots were incubated for 24 hours at 37°, and 
centrifuged at 10,000 x g for 10 minutes. The supernatant was collected and measured by 
absorbance spectroscopy at 620 nm for EB determination.  Calculations were based on 
external standard readings (50µg/mL of EB dissolved in saline with 8 serial dilutions). 
The extravasated dye in brain tissue was expressed as ng EB/mg of brain tissue. 
Microvessel isolation 
 Rats were anesthetized with 4% isoflurane, decapitated, and the brain was 
removed. The brain was placed in 10 mL of MVI Buffer two (6.02 g/L NaCl, 0.35 g/L 
KCl, 0.37 g/L CaCl2, 0.16 g/L KH2PO4, 0.3 g/L MgSO4, and 3.57 g/L HEPES) with 
protease inhibitor cocktail. The meninges and choroid plexus were removed and the 
cerebral hemispheres were placed in a glass homogenization tube with 4 mL of MVI 
Buffer one (6.02 g/L NaCl, 0.35 g/L KCl, 0.37 g/L CaCl2, 0.16 g/L KH2PO4, 0.3 g/L 
MgSO4, 3.57 g/L HEPES, 2.1 g/L NaHCO3, 1.80 g/L Glucose, 0.11 g/L Na Pyruvate, 
and 10 g/L Dextran (64 K)) and protease inhibitor cocktail. MVI one and two were pH 
adjusted to 7.4. With a Teflon pestle, the tissue was homogenized and filtrate placed in a 
16 mL tube with 4 mL of 26% dextran. The tubes were centrifuged at 5,800 x g for 10 
min at 4°C. The supernatant was aspirated and the pellet was re-suspended in 5 mL of 
MVI buffer two with protease inhibitor cocktail. The homogenate was filtered through 
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100µm filter, and centrifuged at 5,800 x g for 5 min at 4°C. The supernatant was 
decanted and microvessel pellet saved for western blot analysis. 
Western blot 
Western blot analysis was performed similar to work previously published by our 
laboratory (Dinapoli et al 2010). Briefly, 24 hours after blast exposure, animals were 
anesthetized with 4% isoflurane, brains were removed by decapitation, and the brains 
were subsequently sectioned. Groups included: control, single blast, and single blast + 
bryostatin-1. Protein samples from the left prefrontal cortex were dissolved in 0.5 mL hot 
(85-95o C) 1% sodium docecyl sulfate (SDS), sonicated, and a Bicinchoninic Acid 
(BCA) protein assay kit (Thermo Fisher Scientific, Rockfield, IL) was used to determine 
protein concentration. The pre-stained standard SeeBlue® Plus2 (Life Technologies, 
Carlsbad, CA) was used. 2X Lammeli buffer combined with 30 µg of protein was loaded 
per well and run on a Bolt® Mini tank system (Life Technologies) with pre-cast Bolt® 
Bis-Tris Plus 10% 12-well gels (Life Technologies). PVDF membranes (Bio-Rad, Contra 
Costa, CA) were soaked in methanol and used for wet transfer (Bio-Rad) at 60 volts for 
2.5 hours. Primary antibodies used were occludin rabbit 1:1000 (Life Technologies), 
PKC α, δ, ε mouse 1:200 (Santa Cruz Biotechnology, Santa Cruz, CA), and VE-Cadherin 
rabbit 1:1000 (Cell Signaling, Danvers, MA). Microvessel isolation tissue was used to 
detect changes in PKC isozymes. LI-COR secondary antibodies IRDye® 800CW and 
IRDye® 680RD (LI-COR, Lincoln, NE) were used with an Odyssey fluorescent scanner 
at wavelengths 800 or 700, intensity 6.0, and 84 resolution with high image quality. 
Images were analyzed after background subtraction, and normalized to β-actin to give 




Experimental groups included control (n=3), single blast (n=3), and single blast + 
bryostatin-1 (n=3). Rats were anesthetized with 4% isoflurane and transcardially perfused 
with 0.9% saline followed by 4% paraformaldehyde at 24 hours after blast exposure.  The 
rats were decapitated, and brains were removed and stored in 4% paraformaldehyde until 
processing. The tissue was sectioned and paraffin embedded. 6µm slices from the left 
prefrontal cortex were cut with a Leica RM2235 microtome (Leica Microsystems, 
Wetzlar, Germany) and mounted on slides. Slides were washed in xylene, 100% EtOH 
and 95% EtOH for 5 minutes each in order to remove the paraffin, followed by 
rehydration in dH2O for 5 minutes.  Using 10% methanol and 10% H2O2 in Dulbecco’s 
phosphate buffered saline (DPBS), slides were quenched for 15 minutes, followed by 
three rinses in DPBS for 5 minutes each.  The slides were then added to permeabilizing 
solution (1.8% L-Lysine, 4% horse serum, and 0.2% Triton X-100 in DPBS) for 30 
minutes.  Slices were circumscribed and incubated overnight with a primary antibody and 
4% horse serum. The next day slides were rinsed and incubated for 3-hours with a 
fluorescent secondary antibody.  A second set of primary and secondary antibodies were 
used in the case of co-localization staining.  Slides were then fixed with Permount 
mounting media. Primary antibodies include: PKC α, δ, and ε mouse 1:500 (Santa Cruz 
Biotechnology), Claudin-5 mouse 1:200 (Life Technologies), occludin rabbit 1:200 (Life 
Technologies), VE-Cadherin rabbit 1:150 (Cell Signaling), ZO-1 Alexa Fluor® 488 
mouse 1:200 (Life Technologies), Glial Fibrillary Acidic Protein (GFAP) mouse 1:150 
(Cell Signaling), GFAP rabbit 1:500 (DAKO, Glostrup, Denmark), Neuronal/glia 
proteoglycan 2 (NG-2) rabbit 1:500 (Santa Cruz Biotechnology) and Von Willebrand 
!
91 
Factor (VWF) rabbit 1:200 (Sigma Aldrich, St. Louis, MO).  Secondary antibodies 
include Alexa Fluor 594 goat anti-mouse 1:1000 (Life Technologies), Alexa Fluor 594 
goat anti-rabbit 1:500 (Life Technologies), Alexa Fluor 488 donkey anti-mouse 1:500 
(Life Technologies), and Alexa 488 donkey anti-rabbit 1:1000 (Life Technologies). 20 
cells per slide were randomly selected, outlined, and measured with ImageJ software 
(NIH) by an observer blinded to experimental group. Density was adjusted per mean area 
to give corrected total cell fluorescence normalized to background for claudin-5, 
occludin, VE-Cadherin, ZO-1, and PKC α, δ, and ε. Co-localization was quantified with 
the ImageJ plugin Just Another Co-localization plugin to give Pearson’s coefficient for 
controls and overlap coefficient for treatment groups (Bolte & Cordelieres 2006). For 
percentage of co-localization, an observer blinded to experimental group counted 100 
cells and the ratio of positive cells to total cells was recorded. χ2 analyses was used to 
compare between groups. 
Statistical Analysis 
 Biochemical assay data were analyzed using GraphPad Prism 6.0 (GraphPad 
Software, Inc., La Jolla, CA) by an observer blinded to experimental group. A one-way 
ANOVA with Tukey’s post-hoc was used to compare across groups for EB absorbance, 
western blot analysis, and IHC quantification. Overlap coefficient was calculated via the 
ImageJ plugin with the following equation: k^2 = k1*k2 with all values adjusted to 
threshold. Pearson’s coefficient was obtained for controls. χ2 analyses was used to 
compare the percentages of positive co-localized cells between groups. P < 0.05 was 




Bryostatin-1 significantly modulates PKCα and ε but not PKCδ expression after blast 
 Bryostatin-1 has previously been shown to be neuroprotective following mild TBI 
in a murine model by reducing β-secretase and β amyloid production (Zohar et al 2011). 
Furthermore, our lab has published that bryostatin-1 decreases PKCα and increases 
PKCε following neural injury in an aged-female Sprague-Dawley model (Tan et al 2013). 
The role bryostatin-1 plays in regulating PKC activity at the neurovascular unit has yet to 
be determined. We examined perivascular regions of the left prefrontal cortex using 
quantitative IHC. A significant difference in PKCα was observed between groups 
(F(2,24) = 7.743, p<0.01) 24 hours after injury. Post-hoc comparison revealed a 
significant difference between control and single blast groups (t=5.043, p<0.01) and 
between single blast and single blast + bryostatin-1 groups (t=4.559, p<0.01) (Figure 4.2 
A-G). A significant difference in PKCδ was observed between groups (F(2,27) = 16.73, 
p<0.001) 24 hours after injury. Post-hoc comparison revealed a significant difference 
between control and single blast groups (t=8.049, p<0.001) and between control and 
single blast + bryostatin-1 groups (t=5.292, p<0.01) (Figure 4.2 H-N). No significant 
difference was seen between single blast and single blast + bryostatin-1, consistent with 
the notion that bryostatin-1 negligibly alters PKCδ expression. A significant difference in 
PKCε was observed between groups (F(2,27) = 14.73, p<0.001) 24 hours after injury. 
Post-hoc comparison revealed a significant difference between control and single blast + 
bryostatin-1 groups (t=7.509, p<0.001) and between single blast and single blast + 
bryostatin-1 groups (t=5.133, p<0.01) (Figure 4.2 O-U). We also examined changes in 
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PKC expression using western blot analysis. A significant difference between groups was 
observed for PKCα (F(2,14) = 7.672, p<0.01). Post-hoc comparison revealed a 
significant difference between control and single blast (t=4.576, p<0.05), and between 
single blast and single blast + bryostatin-1 (t=5.113, p<0.01) (Figure 4.3 A). A significant 
difference between groups was observed for PKCδ (F(2,6) = 13.25, p<0.01). Post-hoc 
comparison revealed a significant difference between control and single blast (t=7.197, 
p<0.01), and between control and single blast + bryostatin-1 (t=4.549, p<0.05) (Figure 
4.3 B). A significant difference between groups was observed for PKCε (F(2,15) = 10.05, 
p<0.01). Post-hoc comparison revealed a significant difference between control and 
single blast (t=4.546, p<0.05), and between control and single blast + bryostatin-1 
(t=6.102, p<0.01) (Figure 4.3 C).  
Bryostatin-1 maintained BBB integrity following blast exposure 
 BBB integrity can be measured by EB extravasation into the brain parenchyma 
(Abdul-Muneer et al 2013). EB binds to albumin, and albumin does not readily penetrate 
an intact BBB. NG-2 is a pericyte proteoglycan that is increased during BBB disruption 
and subsequent neovascularization (Girolamo et al 2013). Disruption of the BBB has 
multiple effects including neuroinflammation and formation of reactive oxygen species 
(Abdul-Muneer et al 2014). A significant difference between groups was observed for EB 
extravasation 6 hours after blast exposure (F(2,7) = 7.38, p<0.05) for the left prefrontal 
cortex (Figure 4.4 A). Post-hoc comparison was significant between control and single 
blast (t=4.808, p<0.05) and between single blast and single blast + bryostatin-1 (t=4.347, 
p<0.05). No significant difference was seen between control and single blast + 
bryostatin-1. Bryostatin-1 successfully preserved the integrity of the BBB apparent on 
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gross exam of the left hemisphere (Figure 4.4 B). A significant difference in NG-2 was 
observed 24 hours after blast exposure (F(2,27) = 20.42, p<0.001) for the left prefrontal 
cortex (Figure 4.4 C-H). Post-hoc comparison was significant between control and single 
blast (t=5.504, p<0.01), and between single blast and single blast + bryostatin-1 (t=8.961, 
p<0.001), but not between control and single blast + bryostatin-1. 
PKC modulation alters tight junction proteins at the BBB 
 Activation of PKC isozymes is thought to play a crucial role in BBB disruption 
(Shao & Bayraktutan 2014). PKCα, in particular, has been linked to redistribution of 
tight junction proteins leading to increased vascular permeability (Stamatovic et al 2006). 
PKCα is also known to activate sonic hedgehog protein leading to dysfunctional 
synthesis of tight junction proteins (Guo et al 2012, Xia et al 2013). Alternatively, 
increasing PKCε facilitates tight junction protein translocation from the nucleus to the 
plasma membrane (Chamorro et al 2009). Gross examination of the neurovascular unit 
(VWF co-localized with GFAP) revealed histological disruption of the BBB following 
blast injury but maintenance of barrier integrity when bryostatin-1 was administered 
following blast exposure (Figure 4.5 A-C). A significant difference between groups was 
not observed for Claudin-5 (Figure 4.5 D-J) using fluorescent IHC. A significant 
difference between groups was observed for VE-Cadherin (F(2,6) = 18.58, p<0.01) using 
western blot. Post hoc comparison revealed a significant difference between control and 
single blast (t=4.571, p<0.05), and between control and single blast + bryostatin-1 
(t=8.616, p<0.01) (Figure 4.6 A). A significant difference between groups was observed 
for occludin (F(2,6) = 49.02, p<0.001) using western blot. Post hoc comparison revealed 
a significant difference between control and single blast (t=6.955, p<0.01), between 
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control and single blast + bryostatin-1 (t=14, p<0.001), and between single blast and 
single blast + bryostatin-1 (t=7.048, p<0.01) (Figure 4.6 B). A significant difference 
between groups was observed for ZO-1 (F(2,26) = 35.68, p<0.001) using fluorescent 
IHC. Post hoc comparison revealed a significant difference between control and single 
blast + bryostatin-1 (t=11.45, p<0.001), and between single blast and single blast + 
bryostatin-1 (t=8.553, p<0.001) (Figure 4.6 C-I). Additionally, a significant difference 
between groups was observed for VE-Cadherin (F(2,27) = 5.9, p<0.05) using fluorescent 
IHC. Post hoc comparison revealed a significant difference between control and single 
blast (t=4.016, p<0.05), and between control and single blast + bryostatin-1 (t=4.375, 
p<0.05) (Figure 4.7 A-G). A significant difference was also observed between groups for 
occludin (F(2,27) = 79.88, p<0.001). Post hoc comparison revealed a significant 
difference between control and single blast (t=8.304, p<0.001), between control and 
single blast + bryostatin-1 (t=17.86, p<0.0001), and between single blast and single blast 
+ bryostatin-1 (t=9.557, p<0.001) (Figure 4.7 H-N). 
PKC α, δ, and ε are co-localized with endothelial cells but not astrocytes after blast 
exposure 
 The neurovascular unit and the associated BBB consists of endothelial cells, 
astrocytes, and pericytes that form a structural basement membrane (Amtul & Hepburn 
2014).  The unit acts as a consortium that dictates vascular constriction and dilation in 
response to stimuli (Muoio et al 2014). The role of PKC isozymes in mediating changes 
to vasculature tone following TBI has yet to be elucidated. We examined the extent of co-
localization for PKCα, δ, and ε with endothelial cells (VWF) or astrocytes (GFAP) in the 
left prefrontal cortex of control animals and single blast exposed animals 24 hours after 
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injury. The Pearson’s coefficient for control animals for PKCα and VWF was r = 0.395 
(Figure 4.8 A-F). The overlap coefficient for PKCα and VWF after single blast exposure 
(threshold A=20, threshold B=14) was r = 0.954 with k1=0.734 and k2=1.238 (Figure 4.8 
G-L). The Pearson’s coefficient for control animals for PKCα and GFAP was r = 0.351 
(Figure 4.8 M-R). The overlap coefficient for PKCα and GFAP after single blast 
exposure (threshold A=29, threshold B=22) was r = 0.379 with k1=0.768 and k2=0.187 
(Figure 4.8 S-X). The Pearson’s coefficient for control animals for PKCδ and VWF was r 
= 0.61 (Figure 4.9 A-F). The overlap coefficient for PKCδ and VWF after single blast 
exposure (threshold A=34, threshold B=14) was r = 0.88 with k1=0.444 and k2=1.744 
(Figure 4.9 G-L). The Pearson’s coefficient for control animals for PKCδ and GFAP was 
r = 0.029 (Figure 4.9 M-R). The overlap coefficient for PKCδ and GFAP after single 
blast exposure (threshold A=52, threshold B=20) was r = 0.449 with k1=0.227 and 
k2=0.89 (Figure 4.9 S-X). The Pearson’s coefficient for control animals for PKCε and 
VWF was r = 0.004 (Figure 4.10 A-F). The overlap coefficient for PKCε and VWF after 
single blast exposure (threshold A=44, threshold B=23) was r = 0.978 with k1=0.765 and 
k2=1.249 (Figure 4.10 G-L). The Pearson’s coefficient for control animals for PKCε and 
GFAP was r = 0.133 (Figure 4.10 M-R). The overlap coefficient for PKCε and GFAP 
after single blast exposure (threshold A=24, threshold B=22) was r = 0.394 with 
k1=0.286 and k2=0.543 (Figure 4.10 S-X). We examined the percentage of positive cells 
for PKCα co-localized with VWF in perivascular regions of the left prefrontal cortex 24 
hours after injury (Supplementary Figure 1). The ratio of positively stained cells to total 
cells for control was 18/100, for blast-exposed animals 57/100, and for blast exposed 
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animals treated with bryostatin-1 36/100. χ2=20.595 with two degrees of freedom and a 
two-tailed P value equal to 0.0001.   
DISCUSSION 
 Bryostatin-1 has been successfully used in numerous animal models of neural 
injury including TBI, ischemic stroke, auditory neurodegeneration, and Alzheimer’s 
disease, and is currently under investigation in clinical trials (Lallemend et al 2005, Sun 
& Alkon 2014, Sun et al 2009, Zohar et al 2011). Recent findings have shown that 
secondary injury mechanisms such as neuroinflammation, endoplasmic reticulum stress, 
and PKC activity are conserved despite the type of injury (Hoozemans & Scheper 2012, 
Lucke-Wold et al 2014d, Wu et al 2014). The timing of activity might vary but the 
pathways are similar and theoretically targeted in a similar fashion. For example, 
bryostatin-1 protects against loss of pre-synaptic synaptophysin and loss of post-synaptic 
spinophylin following TBI in mice (Zohar et al 2011). In an aged-female Sprague-
Dawley stroke model, bryostatin-1 improved survival and reduced ischemic damage (Tan 
et al 2013). Likewise, bryostatin-1 decreased apoptosis and prevented deficits in 
synaptogenesis in a global model of cerebral ischemia (Sun et al 2009, Sun et al 2008). 
Despite the different injury models bryostatin-1 was a successful therapeutic because it 
upregulates PKC activity early and downregulates activity when used at excess doses or 
at chronic time points (Sun & Alkon 2013). At the dose used in this study, it is possible 
that an early activation of PKCα is followed by a drastic downregulation observed at 24 
hours. PKCε may also be increased not only due to upregulation but also from increased 
synthesis (Hongpaisan et al 2011). Future studies will be required to look at PKC changes 
at both earlier time points and also the beneficial effects of bryostatin-1 when 
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administered at subacute time points. In Alzheimer’s disease early upregulation of PKC 
activity enhances neuronal repair and decreases amyloid mediated degeneration while 
maintaining long-term potentiation (Kim et al 2012a, Nelson & Alkon 2009). In addition, 
bryostatin-1 facilitates neurite outgrowth, maintains cognitive function (Lallemend et al 
2005), and enhances synaptic connectivity and spatial learning (Sun et al 2014). For 
affective disorders bryostatin-1 downregulates ERK dependent PKC activity at late time 
points, which can have beneficial effects for treating substance abuse, depression, and 
aversive emotional memories (Mogha et al 2012, Sun & Alkon 2014). Similar molecular 
PKC targets appear to be altered in TBI (Luo et al 2014b).The potential for bryostatin-1 
as a treatment for TBI warrants further investigation. The necessity for different dosing 
strategies as well as altering the timing of dosing must be carefully considered in a series 
of future studies. Furthermore, specific activation of select isozymes will offer 
compelling insight into their protective properties following TBI. In this study, we 
examined how a single 2.5 mg/kg dose of bryostatin-1 affects BBB integrity acutely 
following blast-induced TBI. 
 We found that a single moderate TBI significantly increased EB extravasation 
into the left prefrontal cortex six hours after injury. Bryostatin-1 administration 
ameliorated this disruption. A potential mechanism by which this occurs is through 
regulation of PKCα and PKCε, which subsequently increases the tight junction proteins 
VE-Cadherin, occludin, and ZO-1 at the BBB. It has been previously shown in an 
ischemic stroke model that inhibiting PKCα increases the tight junction proteins ZO-1, 
occludin, and VE-Cadherin (Yu et al 2012). PKCα has limited regulatory function for 
claudin-5 accounting for the non-significant findings observed. Tight junction proteins 
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overall are essential for maintaining limited and selective permeability into the brain 
parenchyma and preventing neuroinflammation (Chodobski et al 2011).  A switch to 
PKCα activation following TBI has been shown to accelerate neuroinflammation (Dai et 
al 2010). Our data show that bryostatin-1 decreased levels of PKCα when given after 
blast. A separate isozyme, PKCδ, mediates vasoconstriction, but its role in tight junction 
disruption is poorly understood (Novokhatska et al 2013). Our data show that bryostatin-
1 had a negligible effect on PKCδ levels. Another isozyme, PKCε is associated with 
neuroprotection in various models of brain injury (Feng et al 2013). Bryostatin-1 was 
previously shown to regulate tight junction proteins in vitro via modulation of PKCε 
(Yoo et al 2003). PKCε is essential for exportation of zona occluden proteins to the site 
of functional activity (Chamorro et al 2009). We found that bryostatin-1 significantly 
elevated PKCε when administered after blast injury.  
 Increasing VE-Cadherin, occludin, and ZO-1 strengthens the BBB therefore 
maintaining its integrity (Liu et al 2014a). Other therapeutic approaches for TBI such as 
hyperbaric oxygen and sevoflurane were previously shown to significantly increase tight 
junction protein expression (Chen et al 2014, Thal et al 2012). Our data provide 
compelling evidence that bryostatin-1 also increases tight junction proteins leading to 
maintenance of the BBB and decreased permeability after blast injury. Future work will 
examine the functional capacity of these tight junction proteins as well as their efficient 
means of trafficking (McCaffrey & Davis 2012). Utilizing in vitro modeling with 
astrocyte and endothelial co-culture may represent an effective way to examine 
functional capacity (Yang et al 2012). Designing an effective in vitro model of blast TBI 
and BBB dynamics is an area requiring focused investigation (Arun et al 2013b, Effgen 
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et al 2014). Another avenue requiring further investigation is how changes in PKC 
function affect the gliovascular unit. Our data show that PKC changes were localized to 
the endothelial cells not glia. What has yet to be discovered is how cytokines released 
from endothelial cells may alter the surrounding gliovascular unit (Alves 2014). In order 
to investigate this important area, specific PKC modulators such as (Alphatomega; H-
FKKQGSFAKKK-NH(2)) for PKCα and the PKCε peptide activator must be used in 
future investigative studies (Kang et al 2008, Teng et al 2008). A malfunctioning 
gliovascular unit can contribute to chronic neurodegeneration (Barzilai 2013).  
An area of ongoing research is how the progression of acute BBB disruption leads 
to chronic detrimental outcomes. Subtle changes can occur in a young developing brain 
post TBI that often take years to manifest into symptoms (Adelson et al 2013). 
Microbleeds from a disrupted BBB following TBI can cause long-term negative 
outcomes such as glial scarring and white matter degeneration (Glushakova et al 2014, 
Lucke-Wold et al 2014c, Wu et al 2012). These markers of injury have been associated 
with mid-to-late life diseases such as chronic traumatic encephalopathy, autoimmune 
encephalomyelitis, vascular dementia, and early onset Alzheimer’s disease (Marcelo & 
Bix 2014, Stein et al 2014, Turner et al 2012a). Interestingly, stabilization of the BBB 
through PKC modulation decreases chronic negative effects acutely (Lanz et al 2013). If 
BBB disruption does occur, calcium imbalance triggers a host of downstream events. 
Current understanding indicates that glia communicate with neurons through calcium 
signaling, and calcium signaling is often disrupted following TBI (De Bock et al 2014). 
Disrupted calcium signaling can lead to activation of endoplasmic reticulum stress and 
mitochondrial dysfunction (Naviaux 2014). Long term outcomes include the formation of 
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reactive oxygen species, amyloid pathology, and tau hyperphosphorylation (Eckert et al 
2013). PKC isozymes are known tau kinases that are increased in neurodegenerative 
disease (Kamat et al 2014). Long-term bryostatin-1 treatment has been shown to 
modulate tau hyperphosphorylation in a murine model of dementia (Ekinci & Shea 1997, 
Sun & Alkon 2014). A large prospective cohort study has recently shown that veterans 
diagnosed with TBI have a 1.57 adjusted hazard ratio for the onset of dementia compared 
to controls (Barnes et al 2014). Ongoing work will investigate the long-term role 
bryostatin-1 treatment plays in preventing neurodegeneration following repetitive blast 
exposure. Appropriate dosing strategies will be carefully developed for single and 
repetitive injury. The effects of bryostatin-1 are likely two fold: protection of BBB 
acutely and preservation of neuronal stability chronically. Timing and appropriate dosing 
is a necessity to tease out the most appropriate protective treatment windows. PKC 
modulation offers a promising therapeutic approach for preventing the chronic sequelae 
associated with neurotrauma.  
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Figure 4.2: Bryostatin-1 decreases PKCα and increases PKCε 24 hours after blast 
exposure. Our data show that bryostatin-1 has a profound effect after blast traumatic 
brain injury using fluorescent IHC. Scale bar = 100µm in left prefrontal cortex. PKCα 
control (A) with inlay (B) compared to single blast exposure (C) with inlay (D), and 
single blast exposure + bryostatin-1 (E) with inlay (F) showed significant difference 
between groups. Post hoc comparison between control and single blast (** p<0.01) and 
between single blast and single blast + bryostatin-1 (## p<0.01) as depicted in bar graph 
(G). PKCδ control (H) with inlay (I) compared to single blast exposure (J) with inlay 
(K), and single blast exposure + bryostatin-1 (L) with inlay (M) showed significant 
difference between groups. Post hoc comparison between control and single blast (*** 
p<0.001) and between control and single blast + bryostatin-1 (** p<0.01) as depicted in 
bar graph (N). PKCε control (O) with inlay (P) compared to single blast exposure (Q) 
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with inlay (R), and single blast exposure + bryostatin-1 (S) with inlay (T) showed a 
significant difference between groups. Post hoc comparison between control and single 
blast + bryostatin-1 (*** p<0.001) and between single blast and single blast + bryostatin-













Figure 4.3: Bryostatin-1 is a potent PKC modulator. It has been used to regulate PKC 
activity in a time-specific manner for multiple neural injury models. Protein 
concentrations were measured in the left prefrontal cortex 24 hours after blast expsoure 
using western blot analysis. A significant difference between groups was observed for 
PKCα. Post-hoc comparison between control and single blast (* p<0.05), and between 
single blast and single blast + bryostatin-1 (## p<0.01) (A). A significant difference 
between groups was observed for PKCδ. Post-hoc comparison between control and single 
blast (** p<0.01), and control and single blast + bryostatin-1 (* p<0.05) (B). A 
significant difference between groups was observed for PKCε. Post-hoc comparison 
between control and single blast (* p<0.05), and between control and single blast + 
bryostatin-1 (** p<0.01) (C). Bryostatin-1 significantly decreased PKCα levels and 





Figure 4.4: Bryostatin-1 preserves BBB integrity. Evan’s blue binds to albumin and is a 
widely used marker for detecting breaches in the BBB. NG-2 is a proteoglycan found in 
pericytes that will be increased when the BBB is disrupted. Scale bar = 100µm in left 
prefrontal cortex. A significant difference between groups was observed for EB 
absorbance in the brain after femoral vein injection post-blast. Post-hoc comparison 
revealed a significant difference between control and single blast (* p<0.05), and between 
single blast and single blast + bryostatin-1 (# p<0.05) (A). Gross examination revealed 
increased EB staining in the left hemisphere following blast exposure that was decreased 
when bryostatin-1 was given following blast (B). A significant difference between groups 
was observed for NG-2 IHC fluorescent staining (C-H). Post-hoc comparison revealed a 
significant difference between control and single blast (** p<0.01), and between single 




Figure 4.5: Vasculature disruption after blast exposure is independent of claudin-5 
regulation. PKCα specifically regulates occludin, ZO-1, and VE-Cadherin, but not 
claudin-5. Claudin-5 levels may therefore be independent of bryostatin-1 modulation. 
Scale bar = 5µm in the left prefrontal cortex (A-C). Scale bar = 100µm in the left 
prefrontal cortex (D-J).  VWF (green) was co-localized with GFAP (red) to give a visual 
representation of cerebral vasculature. Control vasculature in the left prefrontal cortex 
was visibly intact (A). 24 hours after blast exposure left prefrontal cortex vasculature was 
visibly disrupted as indicated by the sparse VWF staining (B). Bryostatin-1 preserved 
vasculature integrity when administered after blast exposure (C). No significant 




Figure 4.6: Bryostatin-1 significantly increases tight junction proteins. Our data show 
that bryostatin-1 significantly upregulated tight junction proteins leading to maintenance 
of BBB integrity following blast TBI. Scale bar = 100µm in left prefrontal cortex. A 
significant difference was observed between groups using western blot for VE-Cadherin 
with post hoc comparison showing significance between control and single blast (* 
p<0.05), and between control and single blast + bryostatin-1 (** p<0.01) 24 hours after 
blast exposure (A). A significant difference was observed between groups using western 
blot for occludin with post hoc comparison showing significance between control and 
single blast (** p<0.01), between control and single blast + bryostatin-1 (*** p<0.001), 
and between single blast and single blast + bryostatin-1 (## p<0.01) 24 hours after blast 
exposure (B). A significant difference was observed between groups using fluorescent 
IHC for ZO-1 with post hoc comparison showing significance between control and single 
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blast + bryostatin-1 (*** p<0.001), and between single blast and single blast + bryostatin-













Figure 4.7: Tight junction protein expression was increased by bryostatin-1 at 
vasculature. Tight junction protein return of function is necessary for restoration of BBB 
integrity. Scale bar = 75µm in left prefrontal cortex. A significant difference was 
observed between groups using fluorescent IHC for VE-Cadherin with post hoc 
comparison showing significance between control and single blast (* p<0.05), and 
between control and single blast + bryostatin-1 (* p<0.05) 24 hours after blast exposure 
(A-G). A significant difference was observed between groups using fluorescent IHC for 
occludin with post hoc comparison showing significance between control and single blast 
(*** p<0.001), between control and single blast + bryostatin-1 (**** p<0.0001), and 
between single blast and single blast + bryostatin-1 (### p<0.001) 24 hours after blast 





Figure 4.8: PKCα co-localized with endothelial cells but not astrocytes. Both astrocytes 
and endothelial cells are critical for maintenance of the BBB. PKCα activity within 
endothelial cells plays an intimate role in regulating extracellular tight junction proteins.  
Fluorescnt IHC red staining for PKCα, green staining for VWF (endothelial) or GFAP 
(astocyte), and yellow is overlay. Scale bar = 20µm in left prefrontal cortex. PKCα (A) 
with inlay (B) and VWF (C) with inlay (D) have a weak overlay with a Pearson’s 
coefficient of r=0.395 seen in (E) with inlay (F) for control animals. PKCα (G) with 
inlay (H) and VWF (I) with inlay (J) have a  very strong overlay with an overlap 
coefficient of r=0.954 seen in (K) with inlay (L) 24 hours post blast exposure. PKCα (M) 
with inlay (N) and GFAP (O) with inlay (P) have a weak overlay with a Pearson’s 
coefficient of r=0.351 seen in (Q) with inlay (R) for control animals. PKCα (S) with 
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inlay (T) and GFAP (U) with inlay (V) have a weak overlay with an overlap coefficient 




















Figure 4.9: PKCδ co-localized with endothelial cells but not astrocytes. PKCδ plays an 
important role in mediating vascular tone. Its role in regulation of tight junction proteins 
is not completely understood. Fluorescent IHC red staining for PKCδ, green staining for 
VWF (endothelial) or GFAP (astocyte), and yellow is overlay. Scale bar = 20µm in left 
prefrontal cortex. PKCδ (A) with inlay (B) and VWF (C) with inlay (D) have a moderate 
overlay with a Pearson’s coefficient of r=0.61 seen in (E) with inlay (F) for control 
animals. PKCδ (G) with inlay (H) and VWF (I) with inlay (J) have a  strong overlay with 
an overlap coefficient of r=0.88 seen in (K) with inlay (L) 24 hours post blast exposure. 
PKCδ (M) with inlay (N) and GFAP (O) with inlay (P) have a very weak overlay with a 
Pearson’s coefficient of r=0.029 seen in (Q) with inlay (R) for control animals. PKCδ (S) 
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with inlay (T) and GFAP (U) with inlay (V) have a moderate overlay with an overlap 




















Figure 4.10: PKCε co-localized with endothelial cells but not astrocytes. PKCε 
contributes to neuroprotection when increased after brain injury. PKCε has been 
associated with improved cognitive performance and decreased neurodegeneration. 
Fluorescent IHC red staining for PKCε, green staining for VWF (endothelial) or GFAP 
(astrocyte), and yellow is overlay. Scale bar = 20µm in left prefrontal cortex. PKCε (A) 
with inlay (B) and VWF (C) with inlay (D) have a very weak overlay with a Pearson’s 
coefficient of r=0.004 seen in (E) with inlay (F) for control animals. PKCε (G) with inlay 
(H) and VWF (I) with inlay (J) have a  strong overlay with an overlap coefficient of 
r=0.978 seen in (K) with inlay (L) 24 hours post blast exposure. PKCε (M) with inlay 
(N) and GFAP (O) with inlay (P) have a weak overlay with a Pearson’s coefficient of 
r=0.133 seen in (Q) with inlay (R) for control animals. PKCε (S) with inlay (T) and 
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GFAP (U) with inlay (V) have a weak overlay with an overlap coefficient of r=0.394 



















Supplementary Figure 4.1: Blast exposed animals have greater number of cells co-
localized with PKCα and VWF. Staining for groups: red=PKCα, green=VWF, and 
yellow=overlay. Regions analyzed for ratio of positive cells to total cells. Representative 
section for control group PKCα (A) with inlay (B), VWF (C) with inlay (D), and overlay 
(E) with inlay (F). Representative section for single blast exposed group PKCα (G) with 
inlay (H), VWF (I) with inlay (J), and overlay (K) with inlay (L). Representative section 
for single blast + bryostatin-1 group PKCα (M) with inlay (N), VWF (O) with inlay (P), 
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Object: Chronic traumatic encephalopathy is a progressive neurodegenerative disease 
characterized by neurofibrillary tau tangles following repetitive neurotrauma. The 
underlying mechanism linking traumatic brain injury to chronic traumatic 
encephalopathy has not been elucidated. We investigate the role of endoplasmic 
reticulum stress as a link between acute neurotrauma and chronic neurodegeneration.  
Methods: We used pharmacological, biochemical, and behavioral tools to assess the role 
of endoplasmic reticulum stress in linking acute repetitive traumatic brain injury to the 
development of chronic neurodegeneration. Data from our clinically relevant and 
validated rodent blast model was compared to post-mortem human chronic traumatic 
encephalopathy pathology from a National Football League player and World Wrestling 
Entertainment wrestler.  
Results: Our results demonstrate strong correlation of endoplasmic reticulum stress 
activation with subsequent tau hyperphosphorylation. Various endoplasmic reticulum 
stress markers were increased in human chronic traumatic encephalopathy specimens, 
and the endoplasmic reticulum stress response was associated with an increase in the tau 
kinase, glycogen synthase kinase three β. Docosahexaenoic acid, an endoplasmic 
reticulum stress inhibitor, improved cognitive performance in our rat model 3 weeks after 
repetitive blast exposure. Our data show that docosahexaenoic acid administration 
substantially reduced tau hyperphosphorylation (t = 4.111, P < 0.05), improved cognition 
(t = 6.532, P < 0.001), and inhibited endoplasmic reticulum stress activation (t = 5.631, P 
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< 0.01), and for the first time that endoplasmic reticulum stress is involved in the 
pathophysiology of chronic traumatic encephalopathy.  
Conclusion: Docosahexaenoic acid therefore warrants further investigation as a potential 
therapeutic for the prevention of chronic traumatic encephalopathy. 
KEY WORDS: chronic traumatic encephalopathy, blast traumatic brain injury, 
endoplasmic reticulum stress, hyperphosphorylated tau, docosahexaenoic acid 
INTRODUCTION 
Chronic traumatic encephalopathy (CTE) is a progressive tau-dependent 
neurodegenerative disease associated with a history of concussive and/or subconcussive 
injury in sports or from exposure to blast waves in military personnel (Stein et al 2014). 
Several progressive neuropsychiatric symptoms such as impulsive behavior, depression, 
loss of executive function, and cognitive decline have been reported with this progressive 
tauopathy (McKee et al 2014). Alarmingly, the number of sports-related concussions has 
risen to three-hundred-thousand per year in the United States, and the number of military 
service personnel exposed to blast traumatic brain injury (TBI) during the recent wars in 
Iraq and Afghanistan was estimated at two-hundred-seventy thousand (Noble & 
Hesdorffer 2013, Sosa et al 2013). Although several case reports and case series have 
examined the underlying pathology of CTE, few studies have looked at pathways that 
link TBI to chronic neurodegeneration (McKee et al 2010, Omalu et al 2010a, Omalu et 
al 2010b, Watanabe et al 2010). As such, the pathophysiology of CTE development 
remains poorly understood and no viable therapeutics are under development due to the 
lack of identified therapeutic targets (Yokobori et al 2013). To address this lack of 
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understanding, we investigated one component of the pathophysiology linking acute 
neurotrauma to chronic neurodegeneration. 
We propose that the endoplasmic reticulum (ER) stress response may play an 
important role in linking acute neurotrauma to chronic tau-dependent neurodegeneration 
(Lucke-Wold et al 2014c). The ER stress response consists of three arms: protein kinase 
RNA-like ER kinase (PERK), inositol requiring enzyme one α (IRE1α), and activating 
transcription factor six (ATF6). The arms are activated when binding immunoglobulin 
protein (BiP) dissociates from the ER membrane signaling an increase in unfolded 
proteins (Kang et al 2013). While arm one (PERK) is generally neuroprotective, it can 
elevate C/EBP homology protein (CHOP) above threshold at extended time points 
leading to apoptosis (Hiramatsu et al 2014). Arm two (IRE1α) and arm three (ATF6) 
likewise increase CHOP and trigger pro-apoptotic pathways (Shoulders et al 2013). Arm 
two can also lead to the phosphorylation of c-Jun N-terminal kinase (JNK) (Zhu et al 
2014). ER stress markers are acutely increased following TBI in rodent models (Larner et 
al 2004). Recent findings have shown that ER stress increases following cortical 
contusion in a rat model with changes in amyloid precursor protein and tau (Begum et al 
2014). Weight-drop TBI has been shown to increase intracellular calcium and result in 
the activation of the ER stress response in mice (Rubovitch et al 2011). Controlled 
cortical impact also increases ER stress and triggers apoptosis in rats acutely after injury 
(Farook et al 2013). While these studies demonstrate the role of ER stress in acute 
pathophysiological events after TBI, how ER stress contributes to persistent 
neurodegeneration remains unclear. Abisambra and colleagues have ascertained that tau 
from neurofibrillary tangles perpetually activates the ER stress response (Abisambra et al 
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2013). Conversely the ER stress pathway can activate tau kinases such as apoptosis signal 
regulating kinase one, JNK, and glycogen synthase kinase three Beta (GSK3β) (Chen et 
al 2011, Placido et al 2014, Song et al 2014). These important co-stimulatory interactions 
connect ER stress in interplay with chronic neurodegenerative diseases. In addition, 
phosphorylated-PERK has been co-localized with tau in diseases such as Alzheimer’s 
disease and supranuclear palsy (Stutzbach et al 2013). 
Herein, we provide compelling evidence that the ER stress response is not only 
activated acutely following neurotrauma but is involved in the development and 
progression of CTE-like findings in an animal model and post-mortem specimens 
previously described as having CTE (Omalu et al 2010b). Furthermore, we show that the 
development of CTE-like findings following repetitive concussive blast in rats is 
prevented by administration of docosahexaenoic acid (DHA). DHA, an important 
component of omega three fatty acids, has recently been shown to decrease ER stress by 
lowering intracellular calcium (Begum et al 2014). Our data show that DHA 
administration decreases tau kinases, tau hyperphosphorylation, and improves cognitive 
performance 3 weeks after repetitive blast injury. Modulation of ER stress responses may 
therefore represent a promising preventative and therapeutic strategy in the field of 
neurotrauma. 
METHODS 
Animals and human samples 
 All experiments involving animals were approved by the Institutional Animal Care 
and Use Committee of West Virginia University and were performed according to the 
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principles of the Guide for the Care and Use of Laboratory Animals.  Eighty-eight (88) 
young-adult male rats (Hilltop Lab Animals, Inc.) were used for this study based on 
power analysis calculations (DSS Research). We used twenty-four (24) rats for Morris 
water maze behavioral testing, thirty-two (32) rats for immunohistochemistry (IHC) 
staining, and thirty-two (32) rats for western blot analysis. Human sections from the 
entorhinal cortex of a National Football League (NFL) player with diagnosed CTE, 
World Wrestling Entertainment (WWE) wrestler with diagnosed CTE, and age-matched 
(44-year-old male) control were used for immunohistochemical studies. 
 The case of the WWE wrestler was previously documented and published in 2010 
(Omalu et al 2010b). Briefly, he was 40 years of age at the time of death. Death was ruled 
a suicide with the manner of death by asphyxiation resulting from hanging. The patient 
had a history of repetitive brain trauma that included a car collision and mild traumatic 
brain injury at 6 years of age and at least fifteen self-reported concussions throughout his 
career in wrestling. Prior to his death, he suffered from depression and memory loss. The 
patient also had a history of presumed anabolic steroid use and suspected prescription 
drug dependency (narcotics).  
 The case of the NFL player was previously documented and published in 2010 
(Omalu et al 2010a). Briefly, he was 36 years of age at time of death. Death was the 
result of a head on motor vehicle collision with a tanker truck. The patient had a history 
of repetitive head trauma from 4 years of collegiate football and eight seasons in the 
NFL. Prior to his death, he suffered from cognitive and neuropsychiatric symptoms. The 
patient also had a history of parasuicidal behavior. 
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Experimental groups, blast exposure, and drug treatments 
 Groups for 24-hour post-injury IHC study: control, single blast, and repeat blast. 
Groups for 24-hour post- injury western blot study: control, single blast, single blast + 
DHA, and DHA alone. Groups for 3-week post-injury western blot and IHC study: 
control, repeat blast, and repeat blast + DHA. Groups for 3-week post-injury behavioral 
study: control, repeat blast, and repeat blast + DHA. All groups receiving repeat blast 
exposure had one blast administered every other day for two weeks (six total blasts). 
DHA (Zone Labs Inc.) was delivered i.p. 16mg/kg 5 minutes following each blast 
exposure for the DHA + repeat blast groups, and subsequently every other day until 
Morris water maze testing (Begum et al 2014). 
Blast exposure 
A scaled moderate intensity blast wave(s) (~50.72 PSI peak reflected over 
pressure) was released perpendicular to the right side of the animal’s head with a shield 
of polyvinyl chloride protecting the body. Blast exposures were generated using a novel 
shock tube described in our prior work (Turner et al 2013). The shock tube was designed 
with a short driver section in order to generate a short-duration wave, a characteristic 
deemed clinically relevant based on extensive work demonstrating scaling principles 
associated with blast across species.  The overpressure was recorded using piezoelectric 
sensors (Model 102AO5; PCB Piezotronics) placed in the reflected and incident positions 
at the exit of the shock tube. Data was then recorded using a sensor signal conditioner 
(482C Series; PCB Piezotronics) and a data acquisition board (DAQ 23GF; National 
Instruments).  Data was then recorded on the computer using a customized program 
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written with LabView version 12.0 (National Instruments).  A representation of the 
experimental setup can be seen in supplementary figure 5.1. 
Biochemistry preparation 
Animals used for western blot analysis were sacrificed by decapitation with a 
sharpened guillotine after being anesthetized by inhalation of 4% isoflurane 
(Halocarbon). For western blot, the brains were immediately placed in a lysate buffer 
containing: (10 mM Tris, pH 7.4, 320 mM sucrose, 1% Triton X-100, 1% CHAPS and 
0.025% NaN3) with phosphatase and protease inhibitors (1 mM EDTA, 1 mM EGTA, 50 
mM sodium fluoride, 2 mM sodium orthovanadate, 0.1 mM ammonium molybdate, 0.2 
mM phenylarsine oxide, and Roche Complete tablets) (Plattner et al 2006). Bilateral 
dissections of cortex, hippocampus, striatum, and cerebellum were performed, and tissue 
was subsequently flash frozen in liquid nitrogen and stored at -80o C for current and 
future studies. Animals used for immunohistochemistry were anesthetized with 4% 
isoflurane (Halocarbon) and transcardially perfused with ice-cold 0.9% saline followed 
by 10% formalin for a total of 10 min. The brains were dissected and placed in 10% 
formalin. Brains were block-sectioned into 4 coronal sections, paraffin-embedded, and 
serially sliced with a Leica RM2235 microtome (Leica Microsystems, Wetzlar, Germany) 
for immunofluorescent, diaminobenzadine, and hematoxylin and eosin staining. 
Western blot 
Western blot procedures were performed similar to previous work published by 
our lab (Dinapoli et al 2010). Hippocampal protein samples were dissolved in 0.5 mL hot 
(85-95o C) 1% sodium docecyl sulfate (SDS), sonicated, and assayed with a 
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Bicinchoninic Acid (BCA) protein assay kit (Thermo Fisher Scientific, Rockfield, IL). 30 
µg of protein per well was run with 2X Lammeli buffer on pre-cast Bolt® Bis-Tris Plus 
10% 12-well gels (Life Technologies, Carlsbad, CA) using a Bolt® Mini tank system 
(Life Technologies). A SeeBlue® Plus2 pre-stained Standard (Life Technologies) was 
used.  Nitrocellulose membranes (Bio-Rad, Contra Costa, CA) were used for wet transfer 
(Bio-Rad) at 60 volts for 2.5 hours. Imaging was conducted with a LI-COR fluorescent 
scanner at wavelength 700 or 800, intensity 6.0, and resolution eighty-four. Images were 
converted to gray scale and analyzed after background subtraction (Odyssey Processing 
Software). Values were normalized to β-actin to give relative overall intensity. 
The following primary antibodies were used: AT270, growth arrest and DNA 
damage-inducible protein 34 (GADD34) (Thermo), BiP, CHOP, p-JNK (Cell Signaling), 
p-GSK3β (Santa Cruz), and CP-13 (kindly gifted by Dr. Peter Davies, Albert Einstein 
College of Medicine) all at a concentration of 1:1000.  Anti-rabbit or anti-mouse IRDye 
secondary antibodies (LI-COR) were used at a concentration of 1:2000. A β-actin rabbit 
monoclonal antibody (Cell Signaling) was used as an endogenous control at a 
concentration of 1:10,000. Imaging was conducted with a LI-COR fluorescent scanner 
and analyzed after background subtraction (Odyssey Processing Software). Values were 
normalized to β-actin to give relative overall intensity.  
Immunohistochemistry  
Qualitative and quantitative staining was completed for this paper that utilized 
previously described techniques for hematoxylin and eosin, bright-field imaging with 
diaminobenzadine (DAB), and fluorescent imaging (Robson et al 2014, Turner et al 
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2013). Briefly, in order to remove paraffin, slides were washed for 5 minutes in xylene, 
100% EtOH, and 95% EtOH followed by 5 minute rehydration in dH2O.  The slides were 
then quenched with 10% methanol and 10% H2O2 in Dulbecco’s phosphate buffered 
saline (DPBS) for 15 minutes. After quenching, slides were rinsed two times in DPBS for 
10 minutes each. The slides were then placed in permeabilizing solution (1.8% L-Lysine, 
4% horse serum, and 0.2% Triton X-100 in DPBS) for 30 minutes. For fluorescent 
staining, brain slices were circumscribed, incubated with primary antibody overnight 
followed by a fluorescent secondary for three hours, and fixed with a coverslip. If 
staining for co-localization, a second set of primary and secondary antibody was applied 
prior to fixing the coverslip. For diaminobenzadine staining, primary antibody, secondary 
antibody, strepavidin-HRP, and then DAB was applied before fixing with the coverslip. 
The hematoxylin and eosin protocol consisted of dissolving off paraffin with 5 minute 
washes in xylene, 100% EtOH, and 95% EtOH. The slides were then stained in Harris 
Hematoxylin Solution for 2 minutes and 15 seconds. The slides were rinsed in running 
tap water and then dipped in differentiating solution (0.25 mL concentrated HCl in 100 
mL of 70% EtOH). The slides were rinsed again in running tap water and placed in 
Scott’s Tap Water substitute (2g of NaHCO3 and 20 g MgSO4 in 1 L of tap water) for 1 
minute. Slides were placed in 95% EtOH for 0.5 minutes and stained with Eosin Y 
Solution for 0.5 minutes. The slides were dehydrated with 5-minute washes in 95% 
EtOH, 100% EtOH, and xylene and then a coverslip was fixed with Permount.  
Primary antibodies were CHOP, IRE1α, x-box binding protein one (XBP1), 
phosphorylated eukaryotic initiation factor two alpha (p-eIF2α), p-PERK, ATF6 (Cell 
Signaling), AT100, AT270, GSK3β (Thermo), and MCI, paired helical filament (PHF), 
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and CP-13 (kindly gifted by Dr. Peter Davies, Albert Einstein College of Medicine). 
Secondary antibodies for fluorescent imaging were Alexa Fluor 488 and 594 (Life 
Technologies) tagged with the corresponding species to the primary antibody. Imaging 
was done with a Zeiss Axio Imager two (Carl Zeiss Microscopy, Thϋringen, Germany). 
For quantification of DAB staining, perivascular regions were randomly selected from 
hippocampus region for rats and entorhinal cortex for humans. An observer blinded to 
experimental group randomly selected 100 total cells. The number of positive cells was 
reported as a fraction of total cells counted.  For fluorescent staining, twenty cells per 
slide (hippocampus rat) (entorhinal cortex human) were randomly selected by blinded 
observer, outlined, and measured. Fluorescent density was compared to background 
readings, corrected with ImageJ software, and quantified. Co-localization quantification 
with the Just Another Co-localization plugin for ImageJ was used to determine overlap 
coefficient or Pearson’s coefficient (Bolte & Cordelieres 2006). Overlap coefficient was 
calculated using k^2 = k1*k2 with values adjusted to threshold. 
Morris water maze 
Animals were assessed beginning two weeks after final blast exposure. The pool 
was ~180 cm in diameter with a 10 cm x 10 cm platform submerged 2.5 cm below water 
(20°C). The training paradigm consisted of 6 days of spatial acquisition with a hidden 
platform followed by a probe day where the platform was removed. On acquisition days, 
rats were placed into the maze apparatus four times from different pre-determined 
locations. The animals were allowed 2 minutes per trial to locate the platform. Timing 
stopped once platform was found. If the animal did not find the platform, it was placed on 
the platform for 15 seconds to facilitate acquisition before starting the next trial. On the 
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probe day, animals were placed in the apparatus for 1 minute at a novel entrance point. 
The time the animal spent exploring an area encompassing 300% of where the platform 
had been was recorded. Any-maze video tracking software (Stoelting Co., Wood Dale, 
IL) was used to record distance traveled as well as latency to reach platform for all 
studies. Tracking plots for each animal were recorded (Supplementary Figure 5.2). 
Statistical analysis 
A blinded observer performed all quantification for IHC and western blot. One-
way Analysis of Variance (ANOVA) was used for IHC, western blot, and Morris water 
maze. Bonferroni post-hoc comparison was used to determine differences between 
groups. For DAB staining, a chi-square analysis was used to compare between groups. 
For co-localization studies, Pearson’s coefficient was obtained for control sections. 
Overlap coefficient was obtained for experimental groups to determine extent of same-
cell protein expression. Two-way ANOVA was used to determine time dependent 
acquisition for Morris water maze learning trials. GraphPad Prism 5.0 (GraphPad 
Software, Inc., La Jolla, CA) was used for statistical analysis.  P < 0.05 was considered 
statistically significant for all data analyzed. 
RESULTS 
Tau pathology is evident in blast-injured animals and human CTE 
 Key pathologic findings for CTE include tau hyperphosphorylation and neuritic 
threads. The pathology is commonly located in subcortical and perivascular foci (McKee 
et al 2013). DAB staining revealed increased tau markers, PHF and CP-13, after repeat 
blast in perivascular areas adjacent to the hippocampus in Sprague Dawley rats 3 weeks 
post-injury, but not in control or repeat blast + DHA animals (Figure 5.1 A-L). Ratio of 
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positive PHF stained cells for control = 0/100, repeat blast = 18/100, and repeat blast + 
DHA = 3/100.  χ2 = 26.571 with 2 degrees of freedom and p<0.0001. Ratio of positive 
CP-13 stained cells for control = 0/100, repeat blast 17/100, and repeat blast + DHA = 
4/100. χ2 = 22.571 with 2 degrees of freedom and p<0.0001. In addition, hematoxylin and 
eosin staining revealed heterogeneous appearance, chromatolysis, vacuolization, and 
degenerating neurons 3 weeks post repetitive blast but not in control or repeat blast + 
DHA animals (Figure 5.1 M-R). Likewise, DAB staining revealed increased MCI, PHF, 
and CP-13 in the entorhinal cortex of human subjects exposed to repeated head trauma 
(CTE diagnosis) as compared to age-matched control specimens without a history of head 
trauma (Figure 5.2 A-R). Ratio of positive MCI stained cells for control = 2/100, NFL 
23/100, and WWE 25/100. χ2 = 19.7 with 2 degrees of freedom and p<0.0001. Ratio of 
positive PHF stained cells for control = 2/100, NFL 29/100, and WWE 32/100. χ2 = 26 
with 2 degrees of freedom and p<0.0001. Ratio of positive CP-13 stained cells for control 
= 2/100, NFL 27/100, and WWE 26/100. χ2 = 21.794 with 2 degrees of freedom and 
p<0.0001. MCI, PHF, and CP-13 mark a progression in tauopathy. MCI is an altered 
form of tau that appears after injury, whereas PHF (serine 396 and 404) is a precursor to 
tau oligomers, and CP-13 marks pre-tangle tau at serine 202.  
ER stress is increased in blast-injured animals and human CTE 
The ER stress response is an important indicator for an injured cell with all three 
arms of the response modulating cell survival. Acutely the ER stress response enhances 
survival, but chronic activation triggers apoptosis (Hetz & Mollereau 2014). The ER 
stress response has been implicated in both acute injuries, such as TBI, as well as chronic 
neurodegenerative disease development, such as AD (Hoozemans & Scheper 2012). We 
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examined all three arms of the ER stress pathway with IHC in both our animals exposed 
to single and repeat blast injury and in human CTE samples. Arm one, represented by p-
eIF2α, was increased 24 hours after blast injury in the Sprague Dawley rats (F(2,12) = 
4.07, P < 0.05) (Figure 5.3 H-N). Post-hoc comparison was significant between control 
vs. single blast injury (t = 2.852, P < 0.05). One-way ANOVA revealed no statistical 
significance for arm two, represented by XBP1, 24 hours after single or repeat blast 
injury in Sprague Dawley rats (Figure 5.3 O-U). The one-way ANOVA for arm three, 
represented by ATF6, was statistically significant (F(2,12) = 4.8, P < 0.05) for blast 
animals, and Bonferroni post-hoc comparison revealed a significant difference between 
control and repeat blast groups (t =  2.710, P < 0.05) (Figure 5.3 M-R). p-eIF2α was 
increased in the National Football League (NFL) and World Wrestling Entertainment 
(WWE) CTE brains (F(2,12) = 13.08, P < 0.001) (Figure 5.4 H-N). Post-hoc comparison 
was significant between control vs. NFL brain (t = 3.798, P < 0.01) and control vs. WWE 
brain (t = 4.866, P < 0.001).  XBP1 was also increased in the CTE brains (F(2,12) = 
38.55, P < 0.001) (Figure 5.4 A-G). Post-hoc comparison was significant between control 
vs. NFL brain (t = 8.647, P < 0.001) and control vs. WWE brain (t = 2.998, P < 0.05). 
Furthermore, ATF6 was increased in the CTE brains (F(2,12) = 9.935, P < 0.01) (Figure 
5.4 O-U). Post-hoc comparison was significant between control vs. NFL brain (t = 4.369, 
P < 0.01) and control vs. WWE brain (t = 2.951, P < 0.05). CHOP was significantly 
elevated in human CTE brains (F(2,12) = 24.17, P < 0.001) (Figure 5.5 A-G). Post-hoc 
comparison was significant between control vs. NFL brain (t = 6.849 P < 0.001). CHOP 
was also significantly elevated 24 hours after blast injury in Sprague Dawley rats (F(2,12) 
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= 4.161, P < 0.05) (Figure 5.5 H-N). Post-hoc comparison was significant between 
control vs. single blast injury (t = 2.875, P < 0.05). 
ER stress is associated with tau hyperphosphorylation 
 Tau hyperphosphorylation is an important precursor for the development of CTE 
(Mez et al 2013). Currently, the mechanism of CTE development is not known, but ER 
stress offers to be a promising candidate based on prior work in neurotrauma showing an 
acute elevation of ER stress and chronic elevation of ER stress in neurodegenerative 
disease such as Alzheimer’s disease. We co-stained for ER stress activation, IRE1α, and 
tau hyperphosphorylation, AT270, in human CTE brains as well as Sprague Dawley rats 
exposed to blast injury (Figure 5.6). IRE1α was used to represent the second arm of ER 
stress and has been co-localized with other tauopathies (Hoozemans & Scheper 2012). 
Pearson’s coefficient for human control brain was low (r = 0.173), but overlap coefficient 
was high for the NFL brain (r = 0.881, k1 = 0.548 and k2 = 1.416 with threshold A = 16 
and B = 19) and the WWE brain (r = 0.881, k1 = 0.615 and k2 = 1.261 with threshold A 
= 35 and B = 20). Similarly, Pearson’s coefficient for the Sprague Dawley control was 
low (r = 0.068), but overlap coefficient was high for single blast (r = 0.931, k1 = 0.704 
and k2 = 1.231 with threshold A = 16 and B = 14) and repeat blast (r = 0.887, k1 = 0.518 
and k2 = 1.518 with threshold A = 21 and B = 15).  
Tau kinase activity and hyperphosphorylation is increased with repetitive blast injury 
 GSK3β is activated by the ER stress response and contributes to chronic 
neurodegeneration (Hoozemans & Scheper 2012). GSK3β is responsible for over one 
third of all tau hyperphosphorylation and can lead to neuronal apoptosis (Yang et al 
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2013). We propose that ER stress activates GSK3β in a biphasic manner both acutely and 
chronically (Liu et al 2012). An initial spike in activity is seen acutely which resolves, 
but over time GSK3β activity continually rises in conjunction with neurodegeneration. 
GSK3β was co-stained with a marker for tau hyperphosphorylation, AT100, in human 
CTE brains and Sprague Dawley rats exposed to blast injury (Figure 5.7). AT100 is a 
marker of tau hyperphosphorylation at threonine 212 and serine 214, and GSK3β is 
known to phosphorylate at those sites (Cavallini et al 2013). Pearson’s coefficient for 
human control brain was low (r = 0.286), but overlap coefficient was high for the NFL 
brain (r = 0.846, k1 = 1.44 and k2 = 0.497 at threshold A = 2 and B = 2) and WWE brain 
(r = 0.904, k1 = 2.316 and k2 = 0.353 at threshold A = 2 and B = 2). Pearson’s coefficient 
for Sprague Dawley control was low (r = 0.374), but overlap coefficient was high for 
single blast (r = 0.934, k1 = 0.566 and k2 = 1.543 at threshold A = 6 and B = 6) and 
repeat blast (r = 0.807, k1 = 0.566 and k2 = 1.543 at threshold A = 6 and B = 6). 
Pharmacologic modulation of ER stress alters tau hyperphosphorylation 
 24 hours post-blast we examined protein expression changes from arms 1 and 2 of 
the ER stress response for single blast injured animals with and without DHA. A 
significant difference in GADD34 protein expression was seen (F(3,12) = 10.17, P < 
0.01). Post hoc analysis revealed a significant difference between control and single blast 
groups (t = 6.009, P < 0.01), between single blast and single blast + DHA groups (t = 
5.92, P < 0.01), and between single blast and DHA only groups (t = 6.848, P < 0.01) 
(Figure 5.8 A). A significant difference in p-JNK was seen (F(3,12) = 9.779, P < 0.01). 
Post hoc analysis revealed a significant difference between control and single blast 
groups (t = 6.221, P < 0.01), between single blast and single blast + DHA groups (t = 
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6.634, P < 0.01), and between single blast and DHA only groups (t = 6.04, P < 0.01) 
(Figure 5.8 B).  In addition, we looked at BiP expression changes 3 weeks post repetitive 
blast exposure, and how ER stress activation contributes to phosphorylation of tau 
kinases. A significant difference in BiP expression was seen (F(2,6) = 8.445, P < 0.05). 
Post hoc analysis revealed a significant difference between control and repeat blast 
groups (t = 4.867, P < 0.05), and between repeat blast and repeat blast + DHA groups (t 
= 5.185, P < 0.05) (Figure 5.9 A). A significant difference in phosphorylation of GSK3β 
at tyrosine 216 was seen (F(2,6) = 31.73, P < 0.001). Post hoc analysis revealed a 
significant difference between control and repeat blast groups (t = 10.31, P < 0.001), and 
between repeat blast and repeat blast + DHA groups (t = 9.085, P < 0.01) (Figure 5.9 B). 
All three arms of the ER stress response are known to increase CHOP (Hoozemans & 
Scheper 2012). CHOP is an important protein linking ER stress to neurodegeneration via 
the activation of tau kinases. A significant difference in CHOP protein expression 
between groups was seen 24 hours after blast exposure (F(2,13) = 9.8, P < 0.01). Post hoc 
analysis revealed a significant difference between control and single blast groups (t = 
5.29, P < 0.05) and between single blast and single blast + DHA groups (t = 5.361, P < 
0.01). DHA reduced CHOP back toward control levels (Figure 5.10 A). AT270 is a 
marker of tau hyperphosphorylation at threonine 181. The threonine 181 residue is 
commonly phosphorylated only when tau has translocated to the cell soma (Kester et al 
2014). A significant difference in AT270 between groups was seen 3 weeks after repeat 
blast exposure (F(2,9) = 6.451, P < 0.05) (Figure 5.10 B). Post hoc analysis revealed a 
significant difference between control and repeat blast groups (t = 4.81, P < 0.05) and 
between repeat blast and repeat blast + DHA groups (t = 4.111, P < 0.05). CP-13 signals 
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a change in tau hyperphosphorylation towards pre-tangle tau. A significant difference in 
CP-13 was seen 3 weeks after repeat blast exposure (F(2,6) = 13.23, P < 0.01) (Figure 
5.10 C). Post hoc analysis revealed a significant difference between control and repeat 
blast groups (t = 5.778, P < 0.05) and between repeat blast and repeat blast + DHA 
groups (t = 6.714, P < 0.05). 
Repeat blast exposure induces CTE-like behavioral changes alleviated by DHA 
administration 
 CTE can lead to cognitive deficits and dementia (Stein et al 2014). We sought to 
reproduce CTE-like behavioral changes, in addition to the pathological changes described 
above, using a clinically relevant blast model. Using Morris water maze, a hippocampal-
dependent cognitive performance test, we specifically evaluated changes post-blast in 
order to determine potential deficits in memory acquisition and retention (Petraglia et al 
2014a). In addition, we evaluated DHA, a proposed ER stress modulator, as a potential 
preventative/therapeutic agent. We found DHA administration 5 minutes following each 
blast and subsequent every other day administration attenuated learning deficits from 
repeat blast exposure. A significant difference in learning across trial days (F(5,126) = 
19.68, P < 0.001) and between groups (F(2,126) = 38.53, P < 0.001) was observed. Post 
hoc analysis revealed a significant difference between control and repeat blast groups for 
latency to platform on day two (t = 3.633, P < 0.01), day three (t = 3.455, P < 0.01), day 
four (t = 4.057, P < 0.001), day five (t = 3.079, P < 0.01), and day six (t = 3.149, P < 
0.01). A significant difference in latency to platform was also seen between repeat blast 
and repeat blast + DHA groups on day two (t = 3.855, P < 0.001), day three (t = 3.918, P 
< 0.001), day four (t = 4.415, P < 0.001), day five (t = 3.442, P < 0.01), and day six (t = 
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3.283, P < 0.01) (Figure 5.10 D). The probe trial revealed a significant difference 
between groups (F(2,21) = 16.17, P < 0.001) on time exploring an area 300% of where 
the platform had been located prior (Figure 5.10 E). Post-hoc comparison revealed 
significant difference between control and repeat blast groups in time spent exploring an 
area 300% of platform  (t = 7.331, P < 0.001) as well as between repeat blast and DHA + 
repeat blast (t = 6.532, P < 0.001).  
DISCUSSION 
 
ER stress has recently been implicated in chronic neurodegeneration (Moreno et 
al 2013). Tauopathies are the result of aggregated and mutated proteins that cause 
immunoexcitotoxicity, and ER stress activation (Blaylock & Maroon 2011). The ER 
responds to toxic buildup of proteins by shutting down protein synthesis and inhibiting 
protein folding (Ron & Harding 2012). The ER stress response may accelerate tauopathy 
by facilitating tau hyperphosphorylation and rapid tau aggregration that leads to 
neurofibrillary tangles (Hoozemans & Scheper 2012). CTE is unique amongst 
tauopathies in that its onset and progression is thought to be associated with repetitive 
head injury (Aungst et al 2014a, Macdonald et al 2014). Currently, diagnostic and 
treatment options are unavailable for this disease, although improving with the use of the 
[18F]FDDNP PET imaging probe (Small et al 2013). The growing number of athletes 
and soldiers experiencing CTE, characterized by symptoms of impulsivity, cognitive 
decline, and depression, urges renewed focus into understanding disease mechanism and 
disease progression (Turner et al 2012a). It has long been postulated that TBI leads to 
chronic neurodegeneration (Miyauchi et al 2014, Nakagawa et al 2011, Smith et al 2012). 
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Recent findings have confirmed that changes in tau, amyloid, and cognition can result 
from neurotrauma (Dapul et al 2013, Omalu et al 2011a, Stern et al 2011). The 
mechanisms underlying how these changes develop is currently unknown. 
 We show for the first time that ER stress is intimately associated with CTE in 
human clinical post-mortem specimens and in the development of CTE-like pathology 
and behavioral deficits in an animal model of repetitive neurotrauma. ER stress is acutely 
triggered by rapid changes in intracellular calcium following brain injury (Kaufman & 
Malhotra 2014). All three arms of the ER stress response were significantly elevated in 
human CTE brains indicating that not only does neurotrauma lead to acute increases in 
ER stress, but also that tau pathology likely contributes to persistent elevations in ER 
stress during chronic neurodegeneration. CHOP, a downstream target of ER stress, was 
increased in the NFL CTE brain but not in the WWE CTE brain. The WWE CTE case 
had more severe neurofibrillary tangle pathology whereas the process of tau 
hyperphosphorylation was ongoing in the NFL CTE brain. Therefore, CHOP may be 
associated with active changes in the tau phosphorylation state. Begum and colleagues 
have shown that p-eIF2α is increased 24 to 48 hours after TBI, but downstream 
components of arm two of the ER stress response were not increased until 3 to 7 days 
after injury (Begum et al 2014). These findings likely account for why we didn’t observe 
a statistically significant increase in XBP1 following single and repeat blast exposure at 
24 hours after injury. The other branch of arm 2, p-JNK, was however increased at 24 
hours, but the expression was reduced when DHA was given. ATF6 was significantly 
increased 24 hours following repeat blast indicating an appropriate cleavage from the 
membrane due to an accumulation of unfolded proteins (Ye et al 2000). Future work will 
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examine the effects of repeat blast on ER stress activation at subacute (3-7 day) time 
points. The CHOP increase was not statistically significant for repeat blast vs. control 
groups 24 hours post-injury. It is likely that CHOP will be increased after repeat blast 
starting 3 days post-injury. The initial lack of change is likely due to inflammatory 
preconditioning from the short interval between blast exposures.  
Using our clinically relevant and validated blast model, we examined active 
changes in tau following blast induced TBI, and correlated these changes with human 
CTE pathology. The ER stress activated tau kinase, GSK3β, was significantly increased 
after repetitive blast injury, and subsequent tau hyperphosphorylation was co-localized 
within the same cells where ER stress activation was occurring. The activating 
phosphorylation of GSK3β at tyrosine 216 was reduced by DHA administration. Future 
work will focus on teasing out exactly how an increase in CHOP may activate GSK3β 
and in which specific cell types these changes are occurring. Interestingly, ATF6 from 
arm three of the ER stress pathway has been shown to significantly elevate Akt (Zhou et 
al 2014). Since GSK3β triggers apoptosis, Akt is necessary in order to directly inhibit 
GSK3β and promote cell survival. Neuronal survival is required for trans-synaptic tau 
propagation (Pooler et al 2013). Akt is a well-known tau kinase that fosters the trans-
synaptic spread of tau tangles over time (Sadik et al 2009a). We plan to investigate these 
interactions between Akt and GSK3β in follow up studies. It is likely that ATF6 is 
continually activated at extended time points in the injury cascade compared to arm one 
and two of the ER stress response, which would account for the initial increase we 
observed in GSK3β following blast exposure. 
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 Many of the experimental drugs that target the ER stress response have high 
affinity for a single arm of the pathway at upstream targets. While beneficial acutely, 
these compounds fail to address the compensatory response of the remaining arms of the 
ER stress response and subsequent crosstalk between the arms. The crosstalk is what 
allows CHOP to be pushed above threshold and apoptosis and tau hyperphosphorylation 
to ensue (Hetz & Mollereau 2014). The ER stress response is a cellular defense 
mechanism. If protein folding can’t be restored quickly, the ER triggers the cell to 
undergo apoptosis. Too much activation of any arm of the ER stress response can 
accelerate this process and contribute to chronic neurodegeneration (Fonseca et al 2013). 
DHA acutely inhibits all three arms of the ER stress response after injury by limiting the 
intracellular calcium surge (Begum et al 2013). DHA reduced GADD34 and p-JNK 
acutely, but also decreased BiP 3 weeks following repeat blast. By acting at a target step 
above ER stress activation and BiP dissociation, DHA prevents the compensatory 
reverberation from other arms of the ER stress pathway allowing little to no acute protein 
regulation resulting from injury. In addition, DHA has recently been shown to readily 
enter the brain and inhibit neurofibrillary tangle formation in a murine model of 
Alzheimer’s disease (Freund Levi et al 2014, Lebbadi et al 2011). Linking these two 
important properties of DHA is a topic of ongoing investigation.  
CONCLUSION 
Markers of ER stress were increased in both Sprague Dawley rat samples and 
human CTE specimins. These markers were co-localized with tau pathology in 
hippocampal neurons. Sprague Dawley rats showed similar pretangle tau changes 
comparable to human CTE 3 weeks post repetitive blast. Most importantly, we show that 
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the omega-3 derivative, DHA, reduced ER stress mediated CHOP expression, GADD34 
expression, and p-JNK at 24 hours and additionally reduced tau hyperphosphorylation, 
BiP dissociation, and phosphorylation of GSK3β at three weeks post-injury. DHA also 
decreased cognitive decline measured by Morris Water Maze when given 5 minutes after 
each blast exposure. DHA appears to have pharmacotherapeutic potential as a 
preventative treatment against the development of CTE and may be a promising 
treatment for various other forms of neurotrauma (Hasadsri et al 2013). 
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Figure 5.1: Robust tau changes 3 weeks post repetitive blast exposure. Non-transgenic 
rodents do not develop neurofibrillary tau tangles. Tau hyperphosphorylation can occur 
after traumatic neurotrauma however indicating acute changes similar to human 
pathology. Abbreviations: CTRL = control, and DHA = docosahexaenoic acid. In the 
Sprague Dawley rodent model, DAB staining revealed that PHFs were present in 
perivascular regions of the hippocampus for repeat blast animals (18/100) (C) 20x, scale 
bar 100µm, and inlay (D) 63x, but not in control (0/100) (A) 20x, scale bar 100µm, and 
inlay (B) 63x and reduced in DHA + repeat blast animals (3/100) (E) 20x, scale bar 
100µm, and inlay (F) 63x. Similarly, CP-13 was increased in repeat blast animals 
(17/100) (I) 20x, scale bar 100µm, and inlay (J) 63x, but not in control (0/100) (G) 20x, 
scale bar 100µm, and inlay (H) 63x and reduced in DHA + repeat blast animals (4/100) 
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(K) 20x, scale bar 100µm, and inlay (L) 63x. In addition H&E staining revealed nuclear 
chromatolysis, vacuolization, and degeneration after repeat blast (O) 20x, scale bar 
100µm, and inlay (P) 63x, but not in control (M) 20x, scale bar 100µm, and inlay (N) 























Figure 5.2: Human CTE: characterized by distinct changes in tau hyperphosphorylation. 
The level of phosphorylation is dependent on the structural organization of tau and 
additionally on tau aggregation. PHFs are precursors to tau oligomers and indicate 
intrasomatic accumulation of tau. Abbreviations: CTRL = control, NFL = National 
Football League, WWE = World Wrestling Entertainment. DAB staining revealed that 
PHFs were not present in the entorhinal cortex of an age matched control (2/100) (A) 
20x, scale bar 100µm, and inlay (B) 63x, but were present in the entorhinal cortices of a 
NFL player (29/100) (C) 20x, scale bar 100µm, and inlay (D) 63x and a WWE wrestler 
(32/100) (E) 20x, scale bar 100µm, and inlay (F) 63x. CP-13 is a precursor for tau 
neurofibrillary tangles with a balanced 3R:4R ratio. DAB staining revealed that CP-13 
was not present in the entorhinal cortex of an age matched control (2/100) (G) 20x, scale 
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bar 100µm, and inlay (H) 63x, but was present in the entorhinal cortices of a NFL player 
(27/100) (I) 20x, scale bar 100µm, and inlay (J) 63x and WWE wrestler (26/100) (K) 
20x, scale bar 100µm, and inlay (L) 63x. MCI detects a distinct mutated version of tau 
that is present in neurodegenerative tauopathies. DAB staining revealed no MCI in the 
entorhinal cortex of an age matched control (2/100) (M) 20x, scale bar 100µm, and inlay 
(N) 63x, but MCI was present in the entorhinal cortices of a NFL player (23/100) (O) 
20x, scale bar 100µm, and inlay (P) 63x and a WWE wrestler (25/100) (Q) 20x, scale bar 















Figure 5.3: ER stress as a defense mechanism. The ER stress response is a robust cellular 
mechanism that can help protect the cell from injury or toxic insult and restore 
homeostatic processes after injury. Arm 1 in particular provides vigorous neuroprotection 
after trauma. While acute increases in intracellular calcium trigger a modest ER stress 
response, the accumulation of unfolded proteins with time can enhance the vitality of the 
cellular ER response incorporating the detrimental arms 2 and 3. Abbreviations: CTRL = 
control, SB = single blast, and RB = repeat blast.  XBP1, arm 2 of the ER stress response, 
was not significantly elevated in single blast exposed animals (C) 20x, scale bar 75µm, 
and inlay (D) 63x or in repeat blast exposed animals (E) 20x, scale bar 75µm, and inlay 
(F) 63x compared with control (A) 20x, scale bar 75µm, and inlay (B) 63x as depicted in 
the bar graph (G). P-eIF2α, arm 1 of the ER stress response, was significantly elevated in 
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the single blast exposed animals (P < 0.05) (J) 20x, scale bar 75µm, and inlay (K) 63x 
but not in the repeat blast exposed animals (L) 20x, scale bar 75µm, and inlay (M) 63x 
compared with control (H) 20x, scale bar 75µm, and inlay (I) 63x as depicted in the bar 
graph (N). ATF6, arm 3 of the ER stress response, was not significantly elevated in single 
blast exposed animals (Q) 20x, scale bar 75µm, and inlay (R) 63x but was significantly 
elevated in repeat blast exposed animals (P < 0.05) (S) 20x, scale bar 75µm, and inlay 
(T) 63x compared with control (O) 20x, scale bar 75µm, and inlay (P) 63x as depicted in 















Figure 5.4: Tauopathy implicated in the activation of the ER stress response. Since tau 
tangles are accumulations of aggregated protein, the cell recognizes an intracellular 
disturbance that triggers the release of calcium. The calcium rush is directly responsible 
for ER stress activation as well as initiating the ER stress response. All three arms of the 
ER stress cascade were increased in human CTE samples. XBP1, arm 2 of the ER stress 
response, was significantly elevated in the NFL CTE brain (P < 0.001) (C) 20x, scale bar 
75µm, and inlay (D) 63x and in the WWE CTE brain (P < 0.05) (E) 20x, scale bar 75µm, 
and inlay (F) 63x compared with control (A) 20x, scale bar 75µm, and inlay (B) 63x as 
depicted in the bar graph (G). P-eIF2α, arm 1 of the ER stress response, was significantly 
elevated in the NFL CTE brain (P < 0.01) (J) 20x, scale bar 75µm, and inlay (K) 63x and 
in the WWE CTE brain (P < 0.001) (L) 20x, scale bar 75µm, and inlay (M) 63x 
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compared with control (H) 20x, scale bar 75µm, and inlay (I) 63x as depicted in the bar 
graph (N). ATF6, arm 3 of the ER stress response, was significantly elevated in NFL 
CTE brain (P < 0.01) (Q) 20x, scale bar 75µm, and inlay (R) 63x and in the WWE CTE 
brain (P < 0.05) (S) 20x, scale bar 75µm, and inlay (T) 63x compared with control (O) 

















Figure 5.5: CHOP: an important component of ER stress. A baseline level of CHOP is 
necessary in order for a cell to return to homeostasis. If CHOP is pushed above threshold, 
apoptosis and tau hyperphosphorylation can occur. CHOP was significantly elevated in 
the NFL CTE brain (P < 0.001) (C) 20x, scale bar 75µm, and inlay (D) 63x but not in the 
WWE CTE brain (E) 20x, scale bar 75µm, and inlay (F) 63x compared to control (A) 
20x, scale bar 75µm, and inlay (B) 63x as depicted in the bar graph (G). CHOP was also 
significantly elevated in single blast exposed animals (P < 0.05) (J) 20x, scale bar 75µm, 
and inlay (K) 63x but not in repeat blast exposed animals (L) 20x, scale bar 75µm, and 
inlay (M) 63x compared to control (H) 20x, scale bar 75µm, and inlay (I) 63x as depicted 







Figure 5.6: AT270 co-localized with IRE1α. AT270 is a marker for tau 
hyperphosphorylation at threonine 181. Tau hyperphosphorylation occurs after tau has 
dissociated from tubulin and transported from the axon to the soma. What is unknown is 
if ER stress occurs in the same cells where tau hyperphosphorylation is present. We show 
that IRE1α, marker of arm 2 of the ER stress response, has a strong overlap coefficient 
with AT270 for NFL CTE brain (r = 0.846) and WWE brain (r = 0.904) compared to 
weak Pearson’s coefficient for control (r = 0.286). Control has minimal AT270 (red) (A) 
20x, scale bar 75µm, and inlay (B) 63x, IRE1α (green) (M) 20x, scale bar 75µm, and 
inlay (N) 63x, and overlap (yellow) (Y) 20x, scale bar 75µm, and inlay (Z) 63x. NFL 
CTE brain has apparent AT270 (red) (C) 20x, scale bar 75µm, and inlay (D) 63x, IRE1α 
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(green) (O) 20x, scale bar 75µm, and inlay (P) 63x, and overlap (yellow) (Aa) 20x, scale 
bar 75µm, and inlay (Bb) 63x. WWE CTE brain has apparent AT270 (red) (E) 20x, scale 
bar 75µm, and inlay (F) 63x, IRE1α (green) (Q) 20x, scale bar 75µm, and inlay (R) 63x, 
and overlap (yellow) (Cc) 20x, scale bar 75µm, and inlay (Dd) 63x. IRE1α also has 
strong overlap coefficient with AT270 for single blast exposed animals (r = 0.934) and 
repeat blast exposed animals (r = 0.807) compared to weak Pearson’s coefficient for 
control (r = 0.374). Control has minimal AT270 (red) (G) 20x, scale bar 75µm, and inlay 
(H) 63x, IRE1α (green) (S) 20x, scale bar 75µm, and inlay (T) 63x, and overlap (yellow) 
(Ee) 20x, scale bar 75µm, and inlay (Ff) 63x. Single blast exposed animal has apparent 
AT270 (red) (I) 20x, scale bar 75µm, and inlay (J) 63x, IRE1α (green) (U) 20x, scale bar 
75µm, and inlay (V) 63x, and overlap (yellow) (Gg) 20x, scale bar 75µm, and inlay (Hh) 
63x. Repeat blast exposed animal has apparent AT270 (red) (K) 20x, scale bar 75µm, and 
inlay (L) 63x, IRE1α (green) (W) 20x, scale bar 75µm, and inlay (X) 63x, and overlap 











Figure 5.7: AT100 is a marker of tau hyperphosphorylation at threonine 212 and serine 
214. Tau is phosphorylated after injury by a select few kinases. GSK3β is by far the most 
important of these kinases accounting for over 1/3 of all tau hyperphosphorylation. We 
show that GSK3β has a strong overlap coefficient with AT100 for NFL CTE brain (r = 
0.881) and WWE brain (r = 0.881) compared to weak Pearson’s coefficient for control (r 
= 0.173). Control has minimal AT100 (red) (A) 20x, scale bar 75µm, and inlay (B) 63x, 
GSK3β (green) (M) 20x, scale bar 75µm, and inlay (N) 63x, and overlap (yellow) (Y) 
20x, scale bar 75µm, and inlay (Z) 63x. NFL CTE brain has apparent AT100 (red) (C) 
20x, scale bar 75µm, and inlay (D) 63x, GSK3β (green) (O) 20x, scale bar 75µm, and 
inlay (P) 63x, and overlap (yellow) (Aa) 20x, scale bar 75µm, and inlay (Bb) 63x. WWE 
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CTE brain has apparent AT100 (red) (E) 20x, scale bar 75µm, and inlay (F) 63x, GSK3β 
(green) (Q) 20x, scale bar 75µm, and inlay (R) 63x, and overlap (yellow) (Cc) 20x, scale 
bar 75µm, and inlay (Dd) 63x. GSK3β also has strong overlap coefficient with AT100 
for single blast exposed animals (r = 0.931) and repeat blast exposed animals (r = 0.887) 
compared to weak Pearson’s coefficient for control (r = 0.068). Control has minimal 
AT100 (red) (G) 20x, scale bar 75µm, and inlay (H) 63x, GSK3β (green) (S) 20x, scale 
bar 75µm, and inlay (T) 63x, and overlap (yellow) (Ee) 20x, scale bar 75µm, and inlay 
(Ff) 63x. Single blast exposed animal has apparent AT100 (red) (I) 20x, scale bar 75µm, 
and inlay (J) 63x, GSK3β (green) (U) 20x, scale bar 75µm, and inlay (V) 63x, and 
overlap (yellow) (Gg) 20x, scale bar 75µm, and inlay (Hh) 63x. Repeat blast exposed 
animal has apparent AT100 (red) (K) 20x, scale bar 75µm, and inlay (L) 63x, GSK3β 
(green) (W) 20x, scale bar 75µm, and inlay (X) 63x, and overlap (yellow) (Ii) 20x, scale 












Figure 5.8: DHA reduces acute ER stress markers. Arms 1 and 2 of the unfolded protein 
response are increased acutely after injury. GADD34 is a downstream marker of the first 
arm of the ER stress response and p-JNK is downstream of the second arm. A significant 
difference between groups for the acute markers was observed 24 hours after blast 
exposure. (A) The single blast group had increased expression of GADD34 compared to 
control (** P < 0.01), compared to DHA + single blast group (## P < 0.01), and 
compared to DHA alone group (!! P < 0.01). (B) The single blast group had increased 
phosphorylation of JNK compared to control (** P < 0.01), compared to DHA + single 





Figure 5.9: ER stress plays an important role in activation of tau kinases. Tau 
hyperphosphorylation feeds back and activates the ER stress response by causing the 
dissociation of BiP from the ER membrane. A significant difference between groups was 
observed 3 weeks post repetitive blast exposure for BiP. (A) The repeat blast group had 
increased levels of BiP compared to control (* P < 0.05), and compared to the repeat 
blast + DHA group (# P < 0.05). Activation of the tau kinase GSK3β can lead to 
increased tau pathology following TBI. A significant difference between groups was 
reported for p-GSK3β. (B) The repeat blast group has increased phosphorylation of 
GSK3β at tyrosine 216 compared to control (*** P < 0.001), and compared to the repeat 




Figure 5.10: DHA decreases ER Stress and tau while preventing cognitive decline. 
CHOP is a key downstream target of all three arms of the ER stress pathway. Among its 
many roles, CHOP contributes to apoptosis, activation of tau kinases, and disruption of 
the mitochondria. A significant difference between groups was observed 24 hours after 
blast exposure. (A) The single blast group had a significant increase in CHOP (P < 0.01) 
compared to control. The DHA + blast group had a significant reduction in CHOP (P  < 
0.01) compared to the single blast group only. AT270 is a marker of tau 
hyperphosphorylation that symbolizes the transition phase for tauopathy development. 
(B) Repeat blast increased AT270 compared with control (P < 0.05). DHA + repeat blast 
significantly reduced AT270 (P < 0.05) compared with repeat blast only. (C) Repeat blast 
increased CP-13 compared with control (P < 0.05). DHA + repeat blast significantly 
reduced CP-13 (P < 0.05) compared with repeat blast only. Morris water maze is a test of 
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cognitive performance and the ability to learn. The protocol used for this experiment 
consisted of 6 learning trial days followed by a probe trial on day 7. For each learning 
trial session, the animal was placed into the maze at 4 different start positions. Latency to 
platform was measured from each start position for up to 2 minutes. If the animal did not 
reach the platform in 2 minutes, they were placed on it for 15 seconds. On probe trial day 
the platform was removed and the animal was put into the maze at a novel start position 
and allowed to swim for 1 minute. Time spent in an area 300% of where the platform had 
been was recorded. (D) A significant difference in learning across trial days (P < 0.001) 
and between groups (P < 0.001) was observed. A significant difference between control 
and repeat blast groups for latency to platform was observed on day 2 (t = 3.633, P < 
0.01), day 3 (t = 3.455, P < 0.01), day 4 (t = 4.057, P < 0.001), day 5 (t = 3.079, P < 
0.01), and day 6 (t = 3.149, P < 0.01). A significant difference in latency to platform was 
also seen between repeat blast and repeat blast + DHA groups on day 2 (t = 3.855, P < 
0.001), day 3 (t = 3.918, P < 0.001), day 4 (t = 4.415, P < 0.001), day 5 (t = 3.442, P < 
0.01), and day 6 (t = 3.283, P < 0.01). (E) A significant difference between control and 
repeat blast groups (P < 0.001) and between repeat blast and repeat blast + DHA groups 









Supplementary Figure 5.1: Representative set-up of blast model. (A) blast model with 
piezoelectric sensor and driver section. (B) polyvinyl tube that protects the animal’s body 
from blast wave. (C) sensor signal conditioner. (D) graph showing peak overpressure 









Supplementary Figure 5.2: Representative track plots for Morris water maze on probe 
trial day. (A) track plot for control animal. (B) track plot for repeat blast animal. (C) track 
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1.7 million traumatic brain injuries (TBIs) occur each year in the United States, 
but available pharmacologic options for the treatment of acute neurotrauma are limited. 
Oxidative stress is an important secondary mechanism of injury that can lead to neuronal 
apoptosis and subsequent behavioral changes. Utilizing a clinically relevant and validated 
rodent blast model, we investigated how NADPH oxidase expression and associated 
oxidative stress contributes to cellular apoptosis following single and repeat blast injuries. 
Nox4 forms a complex with p22phox following injury, forming free radicals at neuronal 
membranes. Using immunohistochemical-staining methods, we found a visible increase 
in Nox4 following single blast injury in Sprague Dawley rats. Interestingly, Nox4 was 
also increased in post-mortem human samples obtained from athletes diagnosed with 
chronic traumatic encephalopathy (CTE). Nox4 activity correlated with an increase in 
superoxide formation. Alpha lipoic acid, an oxidative stress inhibitor, prevented the 
development of superoxide acutely, and increased anti-apoptotic markers Bcl-2 (t = 
3.079, p<0.05) and heme oxygenase 1 (t = 8.169, p<0.001) after single blast. Subacutely, 
alpha lipoic acid treatment reduced pro-apoptotic markers Bax (t=4.483, p<0.05), caspase 
12 (t=6.157, p<0.001), and caspase 3 (t=4.573, p<0.01) following repetitive blast, and 
reduced tau hyperphosphorylation indicated by decreased CP-13 and PHF staining. Alpha 
lipoic acid ameliorated impulsive-like behavior 7 days after repetitive blast injury 
(t=3.573, p<0.05) compared to blast exposed animals without treatment. TBI can cause 
debilitating symptoms, and psychiatric disorders. Oxidative stress is an ideal targets for 
neuropharmacologic intervention, and alpha lipoic acid warrants further investigation as a 




KEY WORDS: Blast traumatic brain injury, NADPH oxidative stress, lipoic acid, 
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INTRODUCTION 
  Traumatic brain injury (TBI) remains an immense public health burden in the 
United States, and continues to be a leading cause of morbidity and mortality in 
individuals under the age of 45-years-old (Bruns & Hauser 2003). Mild TBI can lead to 
progressive motor, cognitive, and behavioral decline (Bramlett & Dietrich 2014). These 
long-term outcomes result in enormous societal costs (Maas et al 2008). In particular, 
blast-induced TBI has been classified as the ‘signature injury’ of the recent wars in Iraq 
and Afghanistan. National and international emphasis has been placed on how acute 
neurotrauma leads to chronic neurodegeneration over time. The progression depends on 
both severity and number of exposures. In order to investigate the pathologic process that 
contributes to neurodegeneration, scaled injury in animal models must be ideally utilized. 
A blast wave injury has three primary effects: wave transport through tissue, 
acceleration/deceleration causing axonal shearing, and disruption of the blood brain 
barrier (BBB). Typically, the primary damage of TBI is followed by secondary injury, 
which can develop at a later date. The initial insult can lead to major brain damage and 
loss of functional outcome. Secondary injury, on the other hand, triggers a cascade of 
biochemical events leading to neuroinflammation, brain edema, and delayed neuronal cell 
death and neurodegeneration (Zhang et al 2012). 
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  Delayed neuronal cell death is carefully mediated through the process of 
apoptosis. When the cell is damaged beyond repair, a signaling cascade is initiated, which 
can lead to cell destruction. Many pathways contribute to apoptosis activation in the cell, 
but one of the main methods is the development and propagation of free radical oxygen 
species (ROS). The creation of ROS has been linked to the activation of NADPH 
oxidase. In a non-injury state, NADPH oxidase participates in cellular host defense 
through cytokine signaling, gene expression regulation, posttranslational processing of 
protein, endoplasmic reticulum stress response, and tissue homeostasis (Gao et al 2012). 
Only after injury or infection does the NADPH oxidase pathway contribute to ROS 
formation. Inhibiting the NADPH oxidase, Nox2, with apocynin following TBI has 
provided beneficial behavioral and histopathologic results (Loane et al 2013, Lu et al 
2014). Lipoic acid is another readily available supplement that can inhibit the formation 
of ROS, but does not cross mitochondrial membranes thereby targeting plasma 
membrane NADPH activity (Gomes & Negrato 2014). Although the mechanism is not 
fully known, alpha lipoic acid can reduce toxic free radicals and decrease NADPH 
oxidase activity (Park et al 2014). We sought to investigate the effect of lipoic acid on the 
less well-studied NADPH oxidase pathway, Nox4, which is found at neuronal plasma 
membranes (Supplementary Fig. 1). 
  The Nox4 pathway can lead to the generation of the superoxide radical (O2−) 
(Zhang et al 2012). The superoxide radical is produced when an oxygen molecule gains a 
single electron from another substance. Excess O2− can form the toxic hydroxyl radical 
(OH−) through interaction with hydrogen peroxide (H2O2). The hydroxyl radical can 
eventually combine with nitric oxide to form peroxynitrite (ONO2−) (Zhang et al 2012). 
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Peroxynitrite has devastating effects on cellular membranes. Historically, mitochondria 
dysfunction has been postulated as the primary source of free radical species generation, 
but recent evidence has shown that NADPH oxidase can also contribute to reactive 
species development. NADPH oxidase is a composite membrane enzyme made up of 
Nox and phox subunits that associate with a series of supporting proteins (Bedard & 
Krause 2007, Sorce & Krause 2009). The Nox subunits come in one of five isoforms, and 
each isoform is heavily concentrated in a specific organ. Nox4 is one of the isoforms 
most heavily concentrated within the central nervous system. Nox4 is constitutively 
active and produces large amount of superoxide following injury. Through interaction 
with cellular components, Nox4 generates hydrogen peroxide and subsequently the 
potent hydroxyl radical (Gao et al 2012). Nox4 has not been previously studied for its 
role in ROS formation following blast injury, therefore opening an important avenue for 
investigating a novel and potentially important therapeutic target.    
  Oxidative stress induction and the consequential damage that occurs as a result of 
blast exposure is likely profound, but the full extent of injury has yet to be elucidated. In 
this work, we investigate the effects of NADPH oxidase, specifically Nox4 activity, in 
the progression towards apoptosis and tau hyperphosphorylation following a moderate 
blast injury 24 hours after blast exposure and 2 weeks after repetitive blast exposure. We 
selectively targeted the Nox4 response at the neuronal plasma membrane using the anti-
oxidant alpha-lipoic acid. Alpha lipoic acid is a natural occurring compound found in 
multiple cell types that acts as a co-factor in oxidative metabolism reactions (Wei et al 
2015). It is thioctic acid with a disulfide bond, chirality, and a dithialone ring (Reljanovic 
et al 1999). The bioavailability is 30% and it is metabolized to 5 metabolites by the liver, 
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which are then cleared primarily by catabolism (Teichert et al 2005).  It acts as a free-
radical scavenger when administered peripherally and readily passes through the BBB 
and neuronal membranes but not mitochondrial membranes (Ozbal et al 2015). In 
particular, it has been shown to be a carbonyl scavenging compound following TBI (Hall 
et al 2010). Supplementation in humans following TBI has provided reduction in adverse 
symptoms (Curtis & Epstein 2014). It reduces susceptibility for seizures as well as 
excitotoxicity (Meyerhoff et al 2004). We investigate its role in modulation of Nox4 for 
the prevention of the chronic sequelae associated with neurotrauma.  
MATERIALS AND METHODS 
The paper conforms to all relevant guidelines for human and animal research. 
Animals 
  All procedures involving live animals were approved by the Institutional Animal 
Care and Use Committee of West Virginia University and were performed according to 
the principles of the Guide for the Care and Use of Laboratory Animals (NIH). This work 
used (40) forty 350 g male Sprague-Dawley rats acquired from Hilltop Lab Animals 
(Hilltop Lab Animals, Inc.). The method used to calculate the number of animals needed 
for a given study was determined using information from the book, Guidelines for the 
Care and Use of Mammals in Neuroscience and Behavioral Research. The number of 
animals was based on effect size, standard deviation, power, and significance. The 
equation to be used to calculate sample size is: n=1+[2C(s/d)2], where C is a value 
dependent upon the a and b values chosen. For our studies a=0.05 and b=0.2 for a power 
of 1-b=0.8. C(0.05, 0.8)=7.85 (obtained from table). Effect size and standard deviation 
expected are variable per assay and were calculated based on numbers from previous 
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work. Animals were acclimated for 1 week prior to experimental use and were housed 
under 12-hour light/12-hour dark conditions with food and water available ad libitum. 
Human brain sections 
Post-mortem formalin fixed brain sections were obtained from the entorhinal 
cortex of a retired professional football player and professional wrestler as well as an age 
and sex matched control. Descriptions of the chronic traumatic encephalopathy (CTE) 
cases have been previously described (Omalu et al 2010a, Omalu et al 2010b). Briefly, 
the professional wrestler committed suicide at age 40. No atrophy or necrosis was 
observed in the brain. Neurofibrillary tau tangles were frequently scattered, and he had 
the apolipoprotein E3/E3 allele. The professional football player died from traumatic 
injury at age 36. The brain was grossly intact with widely spread tauopathy. No other 
neurodegenerative disease diagnostic features were found in either case. The age and sex 
matched control did not have a known history of neurotrauma and no evidence of tau 
pathology. 
Blast exposure 
Rats were exposed to traumatic brain injury via a moderate blast wave exposure 
characterized previously by our lab (Turner et al 2013). Briefly, the animals were 
anesthetized with 4% isoflurane prior to blast exposure. Animals were then oriented with 
the long axis of the animal perpendicular to the blast front. The blast was delivered 
perpendicular to the head with the wave encountering the right side of the head (directly) 
before passing through the skull and exiting the left side (indirectly). The thorax and 
abdomen were protected using rigid shielding. The design allows for acceleration and 
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deceleration to occur freely because the head is not fixed, similar to battlefield exposure. 
Animals were divided into the following groups for the 24 hour study: control (n=4), 
lipoic acid only (n=4), moderate blast exposure only (n=4), and moderate blast exposure 
along with lipoic acid treatment (n=4). Immediately following blast, the animals were 
returned to a holding cage with a homeothermic heating blanket with rectal thermometer 
to maintain body temperature at 37°C. Once reflexes were restored, animals were 
returned to the home cage.  
For repetitive blast exposure, animals received blast every other day for a total of 
six blast exposures over a two-week period. The groups used for this study were control 
(n=8), repeat blast (n=8), and repeat blast along with lipoic acid treatment (n=8). The 
animals were exposed to the same intensity blast wave as the animals from the 24-hour 
experimental group.  Animals were returned to a holding cage for monitoring before 
being placed in their home cage. Animals were anesthetized with 4% isoflurane before 
every blast exposure. Animals were sacrificed 2 weeks after final blast exposure.  
Alpha lipoic acid treatment(s) 
  Alpha lipoic acid was obtained from Sigma Aldrich. It was dissolved in sterile 
saline solution with 10% ethanol (0.1 mL/10 g body weight) (Teknova, Fisher Scientific, 
Pittsburgh, PA). For animals that were part of the drug treatment group, the animals were 
administered 10 mg/kg alpha lipoic acid 5 minutes after each blast exposure via i.p. 
injection. Animals receiving blast injury only or controls received an i.p. injection of 
saline after each blast. Animals were closely monitored and upon full recovery were 
returned to the home cage. 
Elevated plus maze 
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  The EPM was elevated 60cm from the floor. The two open arms intersected 
perpendicular to the two closed arms. Each arm was 50cm by 10cm. The closed arms 
were encased by black wood siding 30cm tall on all exposed sides. Elevated plus maze 
assessment was conducted 7 days after repetitive blast exposure according to procedures 
outlined by Walf and Frye (Walf & Frye 2007). The rats were placed in the center of the 
maze facing an open arm. Each animal was recorded for a total of 5 minutes with open 
access to every arm. ANY-Maze Version 4.63 video tracking software (Stoelting Co.) 
was used to record the number of entries into the open arm, time spent in the open arm, 
and distance traveled in the open arm. The ANY-Maze software settings were as follows: 
test duration 300 seconds and percentage of body to be considered in arm 90%. 
Immunoblotting 
  Protein was isolated from each respective sample by sonication in 500 µL of hot 
(85-95o C) 1% sodium docecyl sulfate (SDS) as previously described (O'Callaghan & 
Sriram 2004). Samples were run using 50 µg of protein/well using Tris-Glycine 10% self-
poured 10-well gels in combination with 5X Lammeli sample buffer. Gels were run using 
a mini-PROTEAN system (Bio-Rad) and transferred to polyvinylidene fluoride (PVDF) 
membranes (Bio-Rad) using wet electrophoretic transfer cells (Bio-Rad). Primary 
antibodies used were anti-Bcl-2 (rabbit) and anti-HO-1 (goat) at 1:200 (Santa Cruz 
Biotechnology, Santa Cruz, CA).  An HRP-conjugated β-actin rabbit monoclonal 
antibody (Cell Signaling) was used as an endogenous control for all samples at a 
concentration of 1:10,000. Molecular weight determination was conducted using 
SeeBlue® Plus2 (Life Technologies, Carlsbad, CA). LI-COR secondary antibodies 
IRDye® 800CW (goat anti-rabbit) and IRDye® 680RD (goat anti-mouse) (LI-COR, 
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Lincoln, NE) were used with an Odyssey fluorescent scanner at wavelengths 800 or 700, 
intensity 6.0, and 84 resolution with high image quality. Images were converted to gray 
scale, analyzed after background subtraction, and normalized to β-actin to give relative 
overall intensity. 
Samples used for carbonyl detection were isolated and sonicated in 6% SDS. 
Control samples were mixed with derivation control solution and treatment samples were 
mixed with 1X DNPH solution. The samples were incubated for 15 minutes followed by 
mixing with a neutralization solution. The samples were loaded 20µl per well and ran on 
a 10% gel as outlined above. The primary antibody and standards were from an OxyBlot 
Protein Oxidation Detection Kit (Millipore). 
Reactive oxygen species detection 
  Brain tissue was harvested from each treatment group including control, single 
blast, and single blast with lipoic acid and prepared in accordance to procedures outlined 
in the ROS Detection kit manual.  Briefly, tissue was homogenized and cells were 
isolated by incubation in collagenase at 2mg/ml for approximately 30 minutes.  Cells 
were then separated by enzyme digestion and manual disruption with repeated pipetting.  
Cells were strained through a 70nm nylon cell strainer followed by centrifugation at 
400xg for 5 minutes.  The pellet was then resuspended to a concentration of 0.5x106-
1.0x106 cells/ml in Dulbecco’s Modified Eagle Medium.  
  Total ROS and Superoxide were detected using a Total ROS/Superoxide 
Detection kit (Enzo Life Sciences) according to manufacturer’s instructions for a 
fluorescent microplate assay.  In brief, 100µl of suspended cells were added to each well 
of a dark walled 96 well plate with a clear bottom. The cells were incubated overnight at 
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37°C in Dulbecco’s Modified Eagle Medium.  Media was then removed the following 
day and 100µl of ROS/Superoxide Detection Solution, prepared using kit reagents, was 
added to each well and incubated in the dark for 60 minutes.  Total concentrations of 
ROS determined by a glutathione based reaction (green) and Superoxide determined by a 
xanthine oxidase reaction (red/yellow) were detected at an excitation/emission of 
488/520nm and 550/610nm respectively using a Biotek Synergy H1 Hybrid Reader. Data 
was collected using Gen5 2.01 software.  
Histological preparations 
  Animals were anesthetized as described above and perfused transcardially with 
cold 0.9% saline followed by 10% formalin for a total of ten minutes. The brain was then 
extracted and placed into fresh 10% formalin for a minimum of 24 h. After the fixation, 
the brain was blocked into sections and paraffin embedded as previously described 
(Turner et al 2012b). Briefly, tissues were processed using the Tissue-Tek Q4 170 VIP 5 
automatic tissue process (Sakura Finetek) and embedded in paraffin using the Tissue-Tek 
TEC 5 embedding system (Sakura Finetek). Tissues were sliced using a Leica RM2235 
microtome (Leica Microsystems) and slices mounted on slides for staining. Standard 
fluorescent and DAB staining protocols were utilized for staining for iron (Sigma 
Aldrich), 8-hydroxy-2-deoxyguanosine, Nox4, p22phox, and Bax (Santa Cruz), caspase 3 
and caspase 12 (Cell Signaling), and PHF, MC1, and CP-13 (Kind gift from Dr. Peter 
Davies). 
  Images were acquired from the S1BF region of the cortex (10 slides per animal). 
Imaging was performed using a Zeiss Axio Imager 2 for brightfield images and Zeiss 
Axio Observer Z1 for fluorescent images shown. For fluorescent staining, 10 cells per 
!
173 
slide were randomly selected, outlined, and measured with ImageJ software (NIH) by an 
observer blinded to experimental group. Density was adjusted per mean area to give 
corrected total cell fluorescence normalized to background. For DAB and iron staining, 
an observer blinded to experimental group selected 100 random cells per slide and 
recorded the ratio of positive cells to total cells.  
Data analysis 
  Data was analyzed using GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA). 
A one-way ANOVA with Tukey’s post-hoc test for multiple comparisons was used for 
Western blot, fluorescent IHC, and elevated plus maze. Tukey’s post-hoc multiple 
comparisons test is a pair wised comparison between each group with every other group. 
The graphs show the comparisons that were statistically significant. χ2 analyses were 
used for DAB and iron staining. A p-value < 0.05 was considered statistically significant 
for all data analyzed.  
RESULTS 
An increase is seen in intraparenchymal iron, Nox4 and p22phox after single blast 
  Iron staining revealed an increase in intracellular iron deposition (19/100) 24 
hours following blast injury in the left prefrontal cortex compared to control (2/100) 
(Figure 6.1 A). Free iron induces oxidative stress, which is toxic to neuronal plasma 
membranes (Uranga et al 2009). Lipoic acid administered 5 minutes post-blast leads to 
decreased intracellular accumulation of iron (11/100) compared to blast only animals 
with a χ2=40.594, p<0.0001. Nox4 is found at plasma membranes and contributes to free 
radical formation (Zhang et al 2009). Nox4 was visibly increased (29/100) 24 hours 
following blast injury in the left prefrontal cortex compared to control (8/100) (Figure 6.1 
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B). Lipoic acid visibly reduced Nox4 (12/100) when given 5 minutes post-blast with 
χ2=29.079, p<0.0001. P22phox forms an activation complex with Nox4 to regulate 
downstream genetic markers. P22phox was also visibly increased (23/100) 24 hours after 
single blast in the left prefrontal cortex compared to control (6/100). Likewise, alpha 
lipoic acid treatment 5 minutes post-blast decreased p22phox (13/100) with χ2=24.031, 
p<0.0001. Therefore, iron-mediated toxicity possibly acting through Nox4 oxidative 
stress is mitigated by alpha lipoic acid treatment. 
Nox4 activity increases superoxide formation but not total ROS after single blast 
  The Nox4/P22phox complex can lead to the generation of superoxide. Superoxide 
can damage the cell if not readily cleared. Blast only animals had a visible increase in 
superoxide 24h post-blast compared to control (Figure 6.2 A). Lipoic acid administered 5 
minutes post-blast visually decreased superoxide back to control levels. Fluorescent 
intensity measurement revealed a significant difference between groups for superoxide 
(F(2,15) = 30.93, p<0.001). Post-hoc comparison revealed that single blast exposure 
significantly increased superoxide compared to control (q = 9.1, p<0.001), but lipoic acid 
administered 5 minutes after single blast ameliorated this response (q = 10.09, p<0.001) 
(Figure 6.2 B). No significant difference was seen between groups for total ROS (F(2,15) 
= 3.568, p=0.054) lending credence to a NADPH specific response verse mitochondria 
dependent response.  
Lipoic acid prevents formation of oxidative stress byproducts 
  Previous studies have shown that byproducts of oxidative stress are significantly 
increased following TBI (Cheng et al 2013). In particular, 8-hydroxy-2-deoxyguanosine 
and carbonyls are elevated post-injury (Ferguson et al 2010). We found a significant 
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difference between groups for 8-hydroxy-2-deoxyguanosine in the cortex 24 hours post 
blast (F(2,27)=28.18, p<0.001) (Figure 6.3 A). Tukey’s post-hoc comparison showed a 
significant difference between control and blast (q=10.53, p<0.001) and blast and blast + 
lipoic acid (q=4.074, p<0.05).  We found a significant difference between groups for 
carbonyls (F(3,16)=10.63, p<0.001) (Figure 6.3 B). Tukey’s post-hoc comparison 
showed a significant difference between control and blast (q=6.429, p<0.01), lipoic acid 
and blast (q=4.226, p<0.05), and blast and blast + lipoic acid (q=7.302, p<0.001). Lipoic 
acid significantly reduced oxidative stress byproducts.  
A decrease in anti-apoptotic markers is seen 24 hours post-blast but lipoic acid restores 
towards baseline 
  Western blot investigation showed significant changes to anti-apoptotic makers in 
the left prefrontal cortex following a single blast exposure. Bcl-2 is an important anti-
apoptotic oncogene that provides neuroprotection when increased (Indharty 2013). A 
significant difference was seen between groups 24 hours post-blast (F(3,12) = 4.637, 
p<0.05). Post-hoc comparison revealed that single blast exposure significantly decreased 
Bcl-2 compared to lipoic acid only (q = 3.079, p<0.05) (Figure 6.4 A). The multiple 
comparisons between other groups showed no significant difference. Heme oxygenase 1 
(HO-1) is an inducible enzyme that degrades toxic heme following oxidative stress. 
Pharmacologic upregulation of HO-1 following TBI leads to improved neuronal survival 
by preventing apoptosis (Ding et al 2014). A significant difference was seen between 
groups for HO-1 24 hours post-blast (F(3,12) = 11.33, p<0.001). Post-hoc comparison 
revealed that lipoic acid only increased the level of HO-1 expression when compared to 
control (q = 4.826, p<0.05) (Figure 6.4 B). Post-hoc comparison also showed that the 
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expression of HO-1 decreased significantly between the lipoic acid only and single blast 
(q = 8.169, p<0.001) animals. The level of expression also increased significantly 
between single blast and single blast treated with lipoic acid groups (q = 4.417, p<0.05) 
back towards control levels. The overall increase in anti-apoptotic markers following 
lipoic acid treatment suggests a protective mechanism limiting Nox4-induced oxidative 
stress damage. 
Mild changes in pro-apoptotic markers were seen 24 hours post-blast 
  Fluorescent immunohistochemistry of the left prefrontal cortex showed mild 
changes of pro-apoptotic markers 24 hours following single blast exposure. Bax is the 
pro-apoptotic regulator of Bcl-2 that is often increased following TBI (Ghadiri et al 
2014). Not surprisingly, a significant difference between groups was seen for Bax 
(F(2,27) = 3.604, p<0.05). Post-hoc comparison revealed a significant difference between 
animals exposed to a single blast compared to control (q = 3.724, p<0.05) (Figure 6.5 A). 
No other significant expression changes were seen between the other experimental 
groups. Caspase 12 is a pro-apoptotic marker that can lead to the activation of caspase 3. 
A significant difference was seen between groups (F(2,27) = 4.325, p<0.05). Post-hoc 
comparison revealed a decrease in the expression of caspase 12 in animals exposed to a 
single blast with alpha lipoic acid treatment compared to control (q = 4.056, p<0.05) 
(Figure 6.5 B). No other changes in expression were seen between any other groups. 
Caspase 3 is an important down stream regulator of apoptosis. If caspase 3 is active, 
apoptosis will occur. No significant change in caspase 3 expression was seen between 
experimental groups (F(2,33) =1.985, p = 0.1535 (Figure 6.5 C).  
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No appreciable difference in anti-apoptotic markers were observed 2 weeks post repeat 
blast 
  Repeat injury is a growing concern in the field of neurotrauma. Repetitive 
concussions have been linked to CTE and other tauopathies (Lucke-Wold et al 2014c). 
An area in need of further investigation is the development of treatment options to 
prevent chronic neurodegeneration following acute TBI. We sought to investigate the 
beneficial effects of lipoic acid administration given 5 minutes after each blast (6 blasts 
total every other day for 2 weeks). Western blot analysis of the left prefrontal cortex was 
performed to determine expression changes in anti-apoptotic markers two weeks after 
repetitive blast exposure. No significant difference between groups was observed for Bcl-
2 (F(3,12) = 2.538, p = 0.1057) (Figure 6.6 A). Likewise, no significant difference was 
observed between groups for HO-1 (F(3,12) = 0.2129, p = 0.8855) (Figure 6.6 B). 
Expression of all markers was shown to remain consistent across all treatment groups. 
The data support that no changes in anti-apoptotic markers were seen sub-acutely post-
repeat injury. 
Lipoic acid reduced pro-apoptotic markers 2 weeks post-repetitive blast 
  Apoptosis is an important indicator of neurodegeneration (Tajes et al 2014). We 
examined three pro-apoptotic markers in the left prefrontal cortex two weeks following 
repetitive blast. A significant difference was seen in the expression of Bax between 
groups (F(2,27) = 7.93, p<0.01). Post hoc comparison showed an increase in Bax with 
repetitive blast animals compared to control (q = 5.194, p<0.01), but the increase was 
ameliorated when lipoic acid was given after each blast (q = 4.483, p<0.05) (Figure 6.7 
A). No significant difference existed between the control and repetitive blast treated with 
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alpha lipoic acid groups. A significant difference between groups was noted for caspase 
12 (F(2,27) = 11.96, p<0.001). Post-hoc comparison revealed a significant increase in 
expression between repetitive blast animals compared to control (q = 5.809, p<0.001), 
but lipoic acid administration after each blast negated this response (q = 6.157, p<0.001) 
(Figure 6.7 B). No significant difference existed between the control and repetitive blast 
treated with alpha lipoic acid groups. A significant difference in caspase 3 expression was 
noted between groups (F(2,27) = 12.6, p<0.001). Post-hoc comparison revealed a 
significant increase in caspase 3 for animals exposed to repetitive blast compared to 
control animals (q = 6.989, p<0.001), but repetitive blast animals treated with alpha lipoic 
acid had a reduced response (q = 4.573, p<0.01) (Figure 6.7 C). Lipoic acid effectively 
decreases expression of pro-apoptotic markers at subacute time points (2 weeks) 
following repetitive blast.  
NADPH oxidase markers and pro-apoptotic markers are increased in human CTE 
samples 
  We examined the NADPH markers, Nox4 and p22phox, in human CTE samples 
obtained from a professional football player and professional wrestler that were then 
compared to an age and sex matched control. A visible increase in Nox4 was observed in 
the football player (32/100) and wrestler (27/100) samples compared to control (6/100) 
with χ2=26.527, p<0.0001 (Figure 6.8 A). Likewise, a visible increase in p22phox was 
observed for the football player (17/100) and wrestler (24/100) samples compared to 
control (3/100) with χ2=34.585, p<0.0001 (Figure 6.8 B).  The visual evidence suggests 
that concussive injuries lead to an increase in the expression of NADPH markers at 
extended time points. This increase is likely associated with the production of free 
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radicals that can lead to permanent tissue damage. The response to tissue damage in a 
diseased brain is often impaired. A significant difference between groups was observed 
for the anti-apoptotic marker Bcl-2 (F(2,27) = 23.8, p<0.001). Post hoc comparison was 
significant between football player and control (q = 7.302, p<0.001), and between 
wrestler and control (q = 9.255, p<0.001) (Figure 6.9 A). Neurofibrillary tangles have 
been proposed to spread between intact cells. These cells must be able to avoid apoptosis 
when injured. A significant difference was also seen between groups for the pro-
apoptotic marker Bax (F(2,27) = 23.38, p<0.001). Post hoc comparison was significant 
between football player and control (q = 5.424, p<0.01), between wrestler and control (q 
= 4.221, p<0.05), and between football player and wrestler (q = 9.645, p<0.001) (Figure 
6.9 B). The football player case was a less severe form of CTE indicating that apoptosis 
may play a role in the early disease stages. The wrestler case had severe CTE pathology 
and showed that apoptosis maybe less likely to play a role in late disease stages. 
Tau pathology increased following repetitive blast in rodents and in human CTE 
specimens 
  Following injury, tau becomes hyperphosphorylated and can undergo 
conformational changes leading to neurofibrillary tangles. CP-13 is a marker of pre-
tangle tau whereas MCI is a conformational configuration of tau seen primarily in 
neurodegenerative disease. Paired helical filament is a dimerized form of tau that 
precedes the formation of oligomers. A significant difference between groups was 
observed for CP-13 in blast exposed animals (F(2,27) = 8.15, p<0.01). Post hoc 
comparison showed a significant increase in CP-13 for the repeat blast group compared 
to control (q = 5.54, p<0.01), but lipoic acid ameliorated this change when administered 
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post blast (q = 3.967, p<0.05) (Figure 6.10 A). A significant difference was not observed 
between groups for MCI in blast exposed animals (F(2,27) = 2.492, p=0.1016) (Figure 
6.10 B). A significant difference between groups was observed for PHF in blast exposed 
animals (F(2,27) = 18.01, p<0.001). Post hoc comparison showed a significant increase in 
PHF for the repeat blast group compared to control (q = 7.865, p<0.001), but lipoic acid 
ameliorated this change when administered post blast (q = 6.703, p<0.001) (Figure 6.10 
C). A significant difference was observed for CP-13 in human specimens (F(2,27) = 
20.31, p<0.001). Post hoc comparison revealed a significant difference between the 
football player and control (q = 6.406, p<0.001), and between the wrestler and control (q 
= 8.695, p<0.001) (Figure 6.11 A). A significant difference was observed for MCI in 
human specimens (F(2,27) = 24.41, p<0.001). Post hoc comparison revealed a significant 
difference between the football player and control (q = 9.88, p<0.001), and between the 
wrestler and control (q = 4.838, p<0.01) (Figure 6.11 B). A significant difference was 
observed for PHF in human specimens (F(2,27) = 51.21, p<0.001). Post hoc comparison 
revealed a significant difference between the football player and control (q = 10.58, 
p<0.001), and between the wrestler and control (q = 13.64, p<0.001) (Figure 6.11 C).  
Blast injury results in an increase of impulsivity-like behavior 
  Elevated plus maze has been used as a test for impulsivity (Kim et al 2012b). 
Animals spending more time in the open arm exhibit decreased risk aversion. The closed 
arms represent a darkened environment, which is a preference for nocturnal rodents. A 
significant difference between groups was noted for time spent in the open arm at 7 days 
post repetitive blast (F(2,21) = 4.327, p<0.05). Post-hoc comparison revealed that rats 
exposed to repetitive blast exhibited an increase in impulsive-like behavior spending 
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more time in the open arms compared to the control group (q = 3.632, p<0.05), and 
repetitive blast + lipoic acid treatment group brought the exploratory behavior back 
towards control levels (q = 3.573, p<0.05) (Figure 6.12 A). We wanted to test if animals 
receiving repetitive blast were overly active by measuring total distance traveled. 
Notably, no difference was observed between groups for overall distance traveled during 
the 5-minute interval within the apparatus (F(2,21) = 0.3174, p = 0.7315) (Figure 6.12 B).  
DISCUSSION 
  We show for the first time that alpha-lipoic acid reduced Nox4 and p22phox 
following blast TBI. Alpha-lipoic acid acutely increased anti-apoptotic markers 24 hours 
after injury. In addition, alpha-lipoic acid decreased pro-apoptotic markers both acutely 
and sub-acutely following blast exposure as well as decreasing tau hyperphosphorylation. 
Animals exposed to repeat blast exposure had increased impulsive-like behavior on 
elevated plus maze (EPM) that was decreased when alpha-lipoic acid was administered 
following blast. Alpha lipoic acid, a naturally available supplement, has been used in 
previous neural injury studies for its role as an anti-oxidant and for decreasing 
neuroinflammation (Rocamonde et al 2013, Rocamonde et al 2012, Toklu et al 2009). It 
has recently been suggested that lipoic acid would be a promising therapeutic for TBI 
treatment, but experimental preclinical studies are limited (Hall et al 2010). We 
investigated for the first time the beneficial effects of alpha lipoic acid on NADPH 
oxidative stress reduction following blast TBI. We hypothesize that alpha lipoid acid 
reduces Nox4 complex formation with p22phox. Because lipoic acid does not cross the 
mitochondrial membrane, we propose it acts peripherally at the neuronal membrane to 
decrease superoxide formation, carbonyls, and 8-hydroxy-2-deoxyguanosine. The free 
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radical damage is likely due to surrounding microglia activation and peripheral immune 
infiltration.  
  The blast exposure set up used for this study has previously been shown to 
produce substantial neural injury to the left cortex due to acceleration/deceleration 
dynamics with little damage to the right cortex (Turner et al 2013). We provide 
reasonable evidence that alpha lipoic acid reduces the NADPH oxidase Nox4 in the 
contralateral left prefrontal cortex, and subsequently inhibits the Nox4 complex 
formation with p22phox at 24 hours post-blast. Nox4 has been shown to peak near 
contusion sites in humans 24-48 hours following TBI (Li et al 2014b). Nox4 is 
predominately located in neurons and is mediated by specific inducible mRNA (Peng et 
al 2013). The Nox4 pathway can produce toxic free radicals that may lead to cellular 
apoptosis (Li et al 2014a). We observed a significant reduction in superoxide, carbonyls, 
and 8-hydroxy-2-deoxyguanosine but not total ROS. Lipoic acid passes through the 
neuronal membrane but not the mitochondrial membrane (Wada et al 1997). ROS 
generated by mitochondria are not the primary target of lipoic acid. Preventing Nox4 
activation may therefore have profound effects on reducing neural injury expansion and 
oxidative stress byproducts over time at the plasma membrane. Inhibiting another 
NADPH oxidase, Nox2, following TBI has already proved promising in previous studies 
with apocynin (Choi et al 2012, Ferreira et al 2013). Continued investigations into the 
Nox4 and Nox2 pathways and their relation to TBI are warranted. 
  Not surprisingly, lipoic acid treatment increased expression of the anti-apoptotic 
markers, Bcl-2 and HO-1, 24 hours following single blast injury. Enhancing Bcl-2 
activity following TBI has been shown to decrease apoptosis and improve cognitive 
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performance (Leeds et al 2014). Likewise, increasing HO-1 activity facilitates the 
degradation of toxic heme and prevents plasma membrane damage and the induction of 
inflammatory cascades (Okubo et al 2013). HO-1 also has been shown to reduce toxic 
iron mediated damage likely accounting for the decrease in free iron observed in the 
lipoic acid treated group (Wagener et al 2013). HO-1 converts toxic iron protoporphyrin 
into stable Fe(2+) that can be readily cleared from the brain (Gozzelino et al 2010). At 
two weeks following repetitive blast (6 blasts over the time course of 2 weeks), lipoic 
acid treatment decreased pro-apoptotic markers Bax, caspase 12, and caspase 3. Bax and 
caspase 3 trigger rapid and sustained apoptosis following TBI (Ghadiri et al 2014). Bax 
deactivates Bcl-2 while caspase 3 triggers the final common pathway of apoptosis. 
Caspase 12 is readily increased when toxic free radicals damage the endoplasmic 
reticulum (Liu et al 2014b). Caspase 12 can interact with pro-apoptotic factors released 
from damaged mitochondria to facilitate activation of caspase 3 (Chen et al 2013). 
Reducing pro-apoptotic markers following TBI can decrease neurodegeneration 
(Supplementary Figure 6.1). We showed that lipoic acid reduced pathologic 
conformational changes of tau following repetitive blast. 
  The link between apoptosis and subsequent tauopathy is likely due to chronic 
neuroinflammation. A recent study suggests that peripheral immune cells enter the brain 
via a caveolin dependent mechanism (Badaut et al 2015). Caveolin increases ICAM-1 
binding affinity for leukocytes post-injury causing increased diapedesis across damaged 
endothelial cells (Xu et al 2013). The peripheral immune cells that enter the brain release 
cytokines that trigger a robust gliosis response (Freeman & Ting 2015). The 
inflammatory storm can cause activation of NADPH oxidases, which further damage 
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neurons and contribute to apoptosis (Ho et al 2015). Overtime nuclear factor kappa B is 
translocated to the nucleus triggering a chronic state of inflammation (Ahmad et al 2013). 
This chronic inflammation can contribute to the formation of tauopathy (Breunig et al 
2013). By targeting NADPH oxidase activity, lipoic acid can be used to disrupt this 
cycle. Further studies are warranted to investigate the long-term effects of targeting 
NADPH activity on chronic neuroinflammation. We provide evidence that lipoic acid 
improves behavior following multiple injuries.  
  A behavioral alteration often seen in soldiers exposed to blast injury is impulsivity 
(James et al 2014). Impulsivity has been linked to brain degeneration and tauopathy in 
human CTE (Stein et al 2014). Impulsivity and aggression can lead to personal 
relationship and work problems (Booth-Kewley et al 2010). In severe cases, impulsivity 
can lead to death due to unnecessary risk-taking behavior (Lopez-Castroman et al 2014). 
A behavioral measure of impulsive-like behavior in rodents is the elevated plus maze 
(Steimer & Driscoll 2003). Rats with impulsive tendencies spend increased time in the 
open arms of the maze. We observed a significant increase in impulsive-like behavior 
that was ameliorated by lipoic acid administration 7 days following repetitive blast 
injury. Repetitive blast injury did not however increase overall mobility. The mechanism 
behind lipoic acid’s beneficial effects is likely due to its anti-oxidant and anti-apoptotic 
properties. Future research will examine how lipoic acid affects cognitive function and 
apoptosis within the hippocampus. The current findings correlate well with the tauopathy 
changes we report. By decreasing apoptosis, lipoic acid can potentially mitigate the 




  CTE is an important neurodegenerative disease of growing prevalence and 
importance, yet the pathophysiology is still poorly understood. A lack of prospective 
studies and post-mortem diagnosis limits investigation into disease progression and 
treatment targets (Baugh et al 2014). The use of new PET scans with a radioligand, which 
labels both amyloid and tau, is improving diagnostic capabilities for living individuals 
but further work needs to be done (Small et al 2013). We present for the first time that the 
Nox4/p22phox pathway may play an important role in CTE pathology. Human samples 
from a professional football player and wrestler had increased levels of Nox4 and 
p22phox in comparison to age and gender-matched controls. Additionally, the CTE 
samples showed disrupted apoptotic signaling mechanisms and abundant tauopathy. Bcl-
2 was significantly increased in both the football player and wrestler samples. Pure 
tauopathies, unlike amyloid β mediated Alzheimer’s disease, have decreased apoptosis in 
late stages of the disease. Hyperphosphorylated tau increases Bcl-2 allowing for effective 
transfer of neurofibrillary tangles between living cells (Wang et al 2010). Tauopathies 
also often have reduced pro-apoptotic markers. We observed that while Bax was 
increased in the football player brain, it was reduced in the more severely affected 
wrestler brain. The wrestler brain had neurofibrillary tangles and neuropil threads 
throughout the cortex, deep nuclei, and brain stem indicating the most advanced stage of 
CTE (Omalu et al 2010b). As long as tau phosphatases are still active, tau 
dephosphorylation can cause an increase in Bax and trigger apoptosis in injured cells (Liu 
et al 2010). At some point during the progression of CTE, tau phosphatases may decrease 
substantially and the levels of Bax are markedly reduced. Nox4 fits into the picture by 
producing free radicals that can derange signaling pathways. These deranged pathways 
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typically trigger apoptosis, but in neurodegenerative disease they lead to 
hyperphosphorylation of tau and conformational changes (Giraldo et al 2014). 
Hyperphosphorylated tau acts in a positive feedback loop ramping up oxidative stress 
(Borza 2014).  
  Lipoic acid may therefore have multiple beneficial effects when used as a 
treatment for neurotrauma. Acutely, lipoic acid could decrease apoptosis by limiting 
oxidative stress. Chronically after CTE has developed, lipoic acid could target the 
positive tau feedback loop limiting excess tau hyperphosphorylation and conformational 
change thereby slowing the progression of CTE. Many studies remain to be done in order 
to investigate the beneficial properties of lipoic acid at chronic time points. Continued 
supplementation following injury will probably have the most successful results. In order 
to advance towards clinical trial, it will be necessary to utilize models that are more 
representative of human disease pathology. Approaches such as a transgenic animals or 
the use of a species closely related to humans on the evolutionary tree will likely be 
necessary. Additionally, scaling blast injury for these new species must be considered in 
order to accurately represent human injury exposure. Clinical safety studies are 
advancing for lipoic acid’s use in the treatment of other disorders (Kates et al 2014). 
Considerations regarding lipoic’s acid use for neurotrauma must be focused upon blood 
brain barrier transport, effective dosing, and appropriate timing of administration.  
CONCLUSIONS  
  In summary, lipoic acid provided acute neuroprotection in our clinically relevant 
and validated blast TBI model. It decreased Nox4 and p22phox while increasing anti-
apoptotic markers acutely. Subacutely it decreased pro-apoptotic markers, decreased tau 
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conformational changes, and improved impulsive behavior. CTE samples from a football 
player and wrestler also showed signs of increased Nox4 activity. The Nox4 pathway 
produces hydrogen peroxide and superoxide radicals that damage mitochondria, cellular 
DNA, proteins, and lipid membranes (Lobo et al 2010). Long-term consequences include 
neurodegenerative disease, tauopathy, and neuropsychiatric changes. Considering the 
limitations to diagnosis and the incomplete understanding of CTE pathophysiology, Nox4 
mediated oxidative stress should be more closely investigated. Oxidative stress 
contributes to an important interplay with tau hyperphosphorylation. Ongoing projects 
conducted by our laboratory will investigate the Nox4 pathway as well as lipoic acid 
modulation at extended time points. Lipoic acid is a widely used supplement that has 
already begun to be evaluated in clinical trials for the treatment of other chronic 
disorders. Lipoic acid might be a worthwhile treatment option for TBI as well and 
potentially offers a break through for an injury paradigm that has limited treatment 
options. The mechanism of lipoic acid neuroprotection are not fully known and must be 
further investigated going forward. 
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Figure 6.1: Increased intracellular iron and NADPH oxidase in the left prefrontal cortex 
24 hours post-blast. Scale bar for whole images = 50µm. Scale bar for inlay images = 
20µm. (A) The amount of intracellular iron accumulation increased 24 hours following 
single blast (19/100) compared to control (2/100). When alpha lipoic acid was given 5 
minutes post-blast the amount of intracellular iron decreased (11/100) compared to single 
blast indicating preserved plasma membrane integrity. (B) DAB staining for Nox4 shows 
an increase in expression in the left prefrontal cortex 24 hours following single blast 
(29/100) compared to control (8/100). The increased level of Nox4 suggests an elevated 
production of reactive oxygen species. Alpha lipoic acid treatment decreased Nox4 back 
towards control levels (12/100). (C) DAB staining of p22phox, which forms an activation 
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complex with Nox4, showed increased expression in single blast (23/100) compared to 
control (6/100). Alpha lipoic acid treatment 5 minutes post-blast decreased p22phox 

















Figure 6.2: Lipoic acid reduces the generation of superoxide in the left prefrontal cortex 
post-blast. The Nox4 pathway can lead to the generation of free radicals at the plasma 
membrane. In particular, NADPH leads to generation of superoxide. This radical can 
damage intracellular organelles, which contributes to apoptosis. (A) A visual 
representation of superoxide staining shows an increase following single blast that is 
reduced by lipoic acid administration post blast. (B) A significant increase in superoxide 
between single blast and control groups was detected with fluorescent scanning at 24 
hours post-blast (q = 9.01, p<0.001) but was ameliorated by lipoic acid administration (q 
= 10.09, p<0.001). *** = p<0.001 SB vs. CTRL. ### = p<0.001 SB vs. LA + SB. No 





Figure 6.3: Lipoic acid significantly reduces oxidative stress byproducts. 8-hydroxy-2-
deoxyguanosine and carbonyls have been showng to be increased following TBI. (A) a 
significant increase in 8-hydroxy-2-deoxyguanosine was seen 24 hours post blast 
compared to control (q=10.53, p<0.001). Lipoic acid administration prevented this 
increase (q=4.074, p<0.05). (B) a significant increase in carbonyls was seen between 
control and blast (q=6.429, p<0.01). Other significant comparisons were seen between 
the lipoic acid and blast groups (q=4.226, p<0.05) and the blast group and blast + lipoic 
acid group (q=7.302, p<0.001). *=significance between control and blast, !=significance 







Figure 6.4: Anti-apoptotic markers from left prefrontal cortex 24 hours post-injury. (A) 
A decrease in Bcl-2 expression was seen in single blast compared to lipoic acid only (q = 
3.079, p<0.05). No significant difference is seen when comparing other experimental 
groups. * p<0.05 LA vs. SB. (B) Significant differences were seen between groups when 
probing for Heme Oxygenase 1 (HO-1). An increase in HO-1 was seen between control 
compared to lipoic acid only (q = 4.826, p<0.05). A decrease was seen between lipoic 
acid only and single blast (q = 8.169, p<0.001), and an increase was seen between single 
blast compared to single blast treated with lipoic acid (q =4.417, p<0.05). No significant 
difference was seen when comparing the other experimental groups. * p<0.05 CTRL vs. 
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LA. ### p<0.001 LA vs. SB. ! p<0.05 SB vs. LA + SB. CTRL = control, LA = lipoic 










































Figure 6.5: Immunohistochemistry of pro-apoptotic markers in the left prefrontal cortex 
at 24 hours post-blast. Scale bar = 100µm. (A) Bax expression is increased in animals 
exposed to single blast compared to control (t=3.724, p<0.05). No change is seen 
between the other groups. * p<0.05 CTRL vs. SB. (B) A decrease is seen in the 
expression of caspase 12 in animals treated with alpha lipoic acid following blast 
compared to control (t=4.056, p<0.05). No change is seen between other experimental 
groups. * p<0.05 CTRL vs. SB + LA. (C) Caspase 3 expression shows no change 






Figure 6.6: Immunoblot of anti-apoptotic markers in the left prefrontal cortex 2 weeks 
post repetitive blast exposure. Animals were exposed to 6 blasts total over the time 
course of two weeks. No significant differences between groups were observed for (A) 
Bcl-2 or (B) HO-1. CTRL = control, LA = lipoic acid, RB = repeat blast, LA + RB = 
lipoic acid treatment 5 minutes post each blast, Bcl-2 = B-cell lymphoma 2, and HO-1 = 






Figure 6.7: Immunohistochemistry of pro-apoptotic markers 2 weeks post repetitive blast 
exposure. Scale bar = 100µm. (A) A significant increase in Bax expression is seen 
between animals exposed to repetitive blast compared to control (t=5.194, p<0.01). 
Lipoic acid treatment administered 5 minutes post each blast reduced Bax expression 
back towards control levels compared to the repeat blast group (t=4.483, p<0.05). No 
change is seen between the other groups. ** p<0.01 CTRL vs. RB. # p<0.05 RB vs. RB + 
LA. (B) An increase in the expression of caspase 12 was seen for animals exposed to 
repetitive blast compared to control (t=5.809, p<0.001). Alpha lipoic acid treatment 
reduced caspase 12 levels back towards control compared to the repeat blast group 
(t=6.157, p<0.001). No change is seen between the control and the repetitive blast with 
alpha lipoic acid treatment groups.  *** p<0.001 CTRL vs. RB. ### p<0.001 RB vs. RB 
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+ LA. (C) An increase is seen in the expression of caspase 3 in the repetitive blast group 
compared to the control group (t=6.989, p<0.001). A significant reduction was noted 
when alpha lipoic acid was administered following blast compared to the repetitive blast 
group (t=5.459, p<0.01). No change is seen between the control and repetitive blast 
treated with lipoic acid groups. *** p<0.01 CTRL vs. RB. ## p<0.01 RB vs. RB + LA. 















Figure 6.8: NADPH oxidase marker expression in human CTE samples. Samples 
obtained from the cortex of a professional football player, professional wrestler, and age 
and sex matched control. Scale bar for whole images = 50µm. Scale bar for inlay images 
= 20µm. (A) Nox 4 staining shows increased expression in tissue of the football player 
(32/100) and professional wrestler (27/100) when compared to control tissue (6/100). The 
increase of Nox4 can lead to formation of reactive oxygen species that cause cellular 
damage. (B) P22phox forms a complex with Nox4 that leads to increased NADPH 
oxidase activity within the cell. An increase in the expression of p22phox was seen in the 
samples from the football player (17/100) and wrestler (24/100) compared to control 






Figure 6.9: Pro-apoptotic marker expression in human CTE samples. Scale bar = 100µm. 
(A) Bcl-2 is a protective protein that is increased in order to prevent cellular apoptosis. In 
the human tissue, Bcl-2 expression is greater in football player tissue compared to control 
(t=7.302, p<0.001). Bcl-2 expression is also significantly increased between wrestler 
tissue compared to control (t=9.255, p<0.001). *** p<0.001 CTRL vs. football player and 
CTRL vs. wrestler. The increase in Bcl-2 could be a mechanism by which neurons 
survive to propogate tau. (B) Bax is known to initiate the cellular apoptosis process. A 
significant difference was seen between the football player tissue sample and control 
(t=5.424, p<0.01). A significant difference was also seen between the wrestler tissue 
sample and control (t=4.221, p<0.05). A significant difference in Bax was also seen 
between the football player sample and wrestler sample (t=9.645, p<0.001). ** p<0.01 
CTRL vs. football player. * p<0.05 CTRL vs. wrestler. ### p<0.001 football player vs. 
wrestler. The wrestler sample had more severe CTE pathology compared to the football 
player sample indicating that apoptosis may play an important role in acute disease 
progression but not as much of a role once it has fully developed. Tauopathy progression 
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is reliant on this disrupted apoptotic signaling. CTRL = control, NFL = football player, 


















Figure 6.10: Lipoic acid reduces pathologic conformational changes in tau two weeks 
following repetitive blast exposure. Scale bare = 100µm. CP-13 marks a form of 
pretangle tau and MCI is a unique conformational configuration of tau found only in 
neurodegenerative disease. PHF is a paired configuration of tau marking the transition 
towards tau accumulation in the soma. (A) a significant increase in CP-13 was noted in 
the prefrontal cortex following repetitive blast exposure compared to control (q = 5.54, 
p<0.01), but the response was ameliorated by lipoic acid administration post-blasts (q = 
3.967, p<0.05). ** = p<0.01 RB vs. CTRL. # = p<0.05 RB + LA vs. RB. (B) no 
significant differences between groups were observed for MCI. (C) a significant increase 
in PHF was noted in the prefrontal cortex following repetitive blast exposure compared to 
control (q = 7.865, p<0.001), but was ameliorated by lipoic acid administration post-
!
203 
blasts (q = 6.703, p<0.001). *** = p<0.001 RB vs. CTRL. ### = p<0.001 RB + LA vs. 












































Figure 6.11: Tauopathy in human chronic traumatic encephalopathy brains. Scale bar = 
100µm. Tauopathy is the characteristic finding of CTE. Hyperphosphorylated tau causes 
conformational changes, which facilitate the transition towards neurofibrillary tangles. 
(A) a significant increase in CP-13 was seen between control and football player brains (q 
= 6.406, p<0.001), and between control and wrestler brains (q = 8.695, p<0.001). *** = 
p<0.001. (B) a significant increase in MCI was seen between control and football player 
brains (q = 9.88, p<0.001), and between control and wrestler brains (q = 4.838 = p<0.01). 
*** = p<0.001. ** = p<0.01. (C) a significant increase in PHF was seen between control 
and football player brains (q = 10.58, p<0.001), and between control and wrestler brains 





Figure 6.12: Effect of repetitive blast on impulsive-like behavior using the elevated plus 
maze assessment. (A) Animals exposed to repetitive blast spent more time in the open 
arms compared to control (t=3.632, p<0.05). Time spent in open arm is a representation 
of impulsive-like behavior in rodents. Alpha lipoic acid treatment following blast 
decreased time spent in open arm compared to repetitive blast exposed animals (t=3.573, 
p<0.05). * p<0.05 CTRL vs. RB. # p<0.05 RB vs. RB + LA. (B) The groups did not 







Supplementary Figure 6.1: Schematic showing Nox4 pathway post- blast. Free iron 
damages the intracellular membrane and leads to activation formation of the Nox4 and 
P22phox complex. The Nox4 complex generates superoxide, which can decrease anti-
apoptotic markers acutely and increase pro-apoptotic markers subacutely. Ultimately, this 
pathway contributes to apoptosis and neurodegeneration. Lipoic acid has potential to 
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Despite the extensive media coverage associated with the diagnosis of chronic 
traumatic encephalopathy (CTE), our fundamental understanding of the disease 
pathophysiology remains in its infancy.  Only recently have scientific laboratories and 
personnel begun to explore CTE pathophysiology through the use of preclinical models 
of neurotrauma.  Some studies have shown the ability to recapitulate some aspects of 
CTE in rodent models, through the use of various neuropathologic, biochemical, and/or 
behavioral assays. Many questions related to CTE development however remain 
unanswered.  These include the role of impact severity, the time interval between 
impacts, the age at which impacts occur, and the total number of impacts sustained.  
Other important variables such as the location of impacts, character of impacts, and effect 
of environment/lifestyle and genetics also warrant further study.  In this work we attempt 
to address some of these questions by exploring work previously completed using single 
and repetitive injury paradigms.  Despite some models producing some deficits similar to 
CTE symptoms, it is clear that further studies are required to understand the development 
of neuropathological and neurobehavioral features consistent with CTE-like features in 
rodents.  Specifically, acute and chronic studies are needed that characterize the 
development of tau-based pathology. 
KEY WORDS: Chronic traumatic encephalopathy, preclinical models, 






Corsellis described the original case series of chronic traumatic encephalopathy 
(CTE) in boxers (Corsellis et al 1973). The disease consisted of brain atrophy, dilated 
ventricles, a cavum septum pellucidum, and pallor of the substantia nigra. Chronic 
traumatic encephalopathy was reintroduced into the medical lexicon by Dr. Bennet 
Omalu in 2005 (Omalu et al 2005). Omalu described a progressive tauopathy that was 
seen in the brains of deceased football players. In recent years, McKee, Goldstein, and 
Stern have defined clinical and pathologic features of the disease. These include 
behavioral disturbances such as impulsivity, depression, and lack of oversight (Corsellis 
et al 1973, Mez et al 2013). Pathologic criteria include neurofibrillary tangles in a 
perivascular distribution and within superficial cortical areas with occasional amyloid and 
TDP-43 protein aggregations (Baugh et al 2014). Stern recently expanded the CTE 
criteria further by describing young vs. old onset based on symptom manifestation (Stern 
et al 2013). Interestingly, blast traumatic brain injury has been linked to CTE following a 
single exposure, where athletes develop the disease following repetitive head injury 
(Lucke-Wold et al 2014c).  
CTE has been defined as a slowly progressive disease that takes years to decades 
to develop, often providing a significant latent period between when the neurotrauma 
occurs and when symptoms develop.  A few cases involve athletes/soldiers as early as 
late teen’s to early twenties (Omalu et al 2011a, Tartaglia et al 2014).  The reason for the 
discrepancies in age of presentation observed is currently unknown but is likely due to 
the age at which impacts were sustained and the severity of the injury.  Prior studies have 
shown that children with TBI have inadequate development of social cognition (Ryan et 
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al 2014) and that adolescents can develop post-traumatic headaches. Very rarely however 
do either of these groups experience symptoms of CTE (Dubrovsky et al 2014).  Early 
behavioral symptoms of CTE usually do not appear until the mid-thirties, and cognitive 
impairment does not begin until the early sixties (Baugh et al 2014). Recent evidence 
suggests that neurotrauma may be linked to other neurodegenerative diseases such as 
Alzheimer’s disease (AD) as well (Johnson et al 2010b). 
CTE and AD, despite both being tauopathies, have generally been viewed as 
separate diseases. Each disease has distinct clinical presentations and unique clinical risk 
values.  This view has gradually been changing with some reports showing that CTE can 
develop within the context of AD. The relationship between these two conditions 
however is poorly understood.  Prior studies have indicated that TBI is a risk factor for 
development of cognitive impairment and AD (Guskiewicz et al 2005), but whether the 
conditions are additive or synergistic remains unclear (Weber 2007). Recent evidence 
suggests that neurotrauma may both increase the likelihood of disease development and 
accelerate the development of AD (Barnes et al 2014).  Notably, the wealth of AD 
pathology observed in preclinical neurotrauma models supports the idea of disease 
acceleration (Tran et al 2011).  In addition to AD, some groups have presented a possible 
link between CTE and a variant of amyotrophic lateral sclerosis that has been termed 
‘chronic traumatic encephalomyelopathy’ (CTEM) (McKee et al 2010).  Therefore, it is 
clear that neurotrauma may have many lasting deleterious consequences, including the 
potential for increased risk and accelerated development of neurodegenerative diseases 
such as AD, CTE, and CTEM.  While the data on these studies is preliminary in nature 
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and not prospective, these findings demonstrate the need for further investigation with 
both preclinical models and clinical trials. 
THE QUEST FOR THE IDEAL CTE MODEL 
The search for ideal preclinical models to study CTE remains an area of ongoing 
investigation with a relative paucity of prior studies.  Of those published previously, the 
majority of studies fail to recapitulate the extensive neuropathologic and neurobehavioral 
aspects of injury (Goldstein et al 2012, Ojo et al 2015).  Post-mortem identification of 
neurofibrillary tangles are a key diagnostic marker used clinically (Baugh et al 2012). 
Therefore, the development of hyperphosphorylated tau in animals following injury must 
be an important component in establishing a CTE model. Tau hyperphosphorylation 
appears to correlate with the emergence of neuropathologic and neuropsychiatric deficits 
representative of neurotrauma related neurodegeneration (Petraglia et al 2014c). By 
modeling CTE in rodents, we can better understand disease development and discover 
potential therapeutic avenues.  Similarly, little justification is given to injury severity, 
number of impacts, interval between impacts, and age at which the impacts occur.  Few 
studies have also evaluated secondary mechanisms of injury.  In the following sections, 
we discuss the advancements and shortcomings of prior research while highlighting areas 
in need of further investigation. 
Proper controls to use when studying CTE 
One of the challenges in creating a preclinical model for CTE is the establishment 
of proper controls comparing sham to TBI animals (Weber 2007).  Specifically, sham 
animals must undergo the exact same procedure each day of the injury paradigm. They 
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must be anesthetized for the same duration as injured animals. The age of the animal 
must also be considered.  Control animals should be the same age as experimental 
animals at time of sacrifice. This is an important consideration in designing extended 
studies with behavioral assays. Biochemical time courses also require control animals for 
each time point. Numerous questions must be addressed in planning experiments while 
considering the implications of each decision in terms of experimental question addressed 
and potential complications (Figure 7.1).  
Available tools to study CTE 
One of the current weaknesses of clinical investigation of CTE is that the disease 
remains a neuropathological diagnosis.  Some advancement has been made in ligand-
based PET imaging. The imaging was used in a cohort of patients with an extensive 
history of neurotrauma, but the modality is not readily available (Small et al 2013).  
Consequently, clinical observations are largely retrospective in nature and it is nearly 
impossible to investigate disease onset and progression.  These clinical shortcomings can 
be readily addressed through the use of adequately designed preclinical models.  
The first step in creating a preclinical model of CTE is to choose a model that can 
be used to generate a combination of biochemical and behavioral changes post-injury 
consistent with the CTE-like phenotype.  Specifically, tauopathy or a precursor of 
tauopathy (tau hyperphosphorylation), must be present. The changes in tau must be 
inducible in genetically unaltered animals and then must be verified with transgenic 
rodents.  Behavioral changes must be induced by neurotrauma. These changes should 
persist or worsen at chronic time points post-injury.  Assessment of behavior should 
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include tests capable of evaluating behavioral symptoms reported in clinical CTE cases. 
In particular, tests for cognition, depressive-like behavior, and impulsive-like behavior 
should be used.  Cognition can be measured using Morris water maze (MWM) whereas 
depressive-like behavior can be assessed with the forced swim test or tail suspension test.  
Impulsivity can be elucidated with the elevated-plus maze (EPM). 
Once a model is established, biochemical, electrophysiological, and advanced 
imaging techniques can be employed to assess neural injury.  Biochemical mechanisms 
of potential interest include those related to cell survival/death, regulation of tau 
phosphorylation/dephosphorylation (kinases/phosphatases), bioenergetics, and 
propagation of tau-based changes.  Electrophysiological studies can be performed to 
identify effects of injury and CTE development both on individual synapses and larger 
tracts such as the Schaffer collaterals within the hippocampus. Imaging modalities such 
as magnetic resonance imaging (MRI), functional MRI (fMRI), spectroscopy (MRS), and 
PET studies have the unique advantage of being able to be performed longitudinally with 
multiple assessments of the same animal at different time points.  Taken together, 
integration of biochemical, behavioral, electrophysiological, and imaging modalities may 
provide insight into the mechanisms and time course of CTE development.  This 
approach will also allow for more definitive evidence to be gathered. This evidence will 
provide a stepping-stone in addressing key questions about the effect of inter-injury 
interval, injury severity, and number of cumulative injuries necessary for the 
development of CTE.  The answers garnered from this potential work may then influence 
the design of clinical trials that dictate return-to-play decisions.  Baseline monitoring may 
become required in sports arenas and battlefields with high incidences of neurotrauma.  
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The monitoring may assist in detecting cumulative subthreshold injury levels and be used 
to decrease the overall level of concussions.  
IMPLICATIONS FOR MODELING CTE: RESULTS FROM PRIOR CTE 
MODELING STUDIES 
Perhaps one of the most promising studies, with regards to demonstrating CTE-
like disease in a rodent model, was performed by Luo, et al.  In this study, the authors 
developed a closed head model of neurotrauma utilizing an electromagnetic stereotaxic 
impact device.  The authors showed that enhanced force of injury or using repeat injury 
increased GFAP-tagged luciferase.  Intriguingly, when this same repeat injury paradigm 
was applied to wild-type mice, spatial learning and memory deficits were observed 2 to 6 
months after injury and were accompanied by increased hyperphosphorylated tau and 
astrogliosis (Luo et al 2014a). The gliosis response in human CTE has not been well 
characterized, but the findings by Luo and colleagues show that GFAP was increased 
near areas of tauopathy.  Similar findings have been seen by Petraglia and colleagues 
who performed a rigorous investigation of the behavioral effects of both single and 
repetitive closed head injury in wild-type mice (Petraglia et al 2014b).  The authors found 
that a single injury, in un-anesthetized animals, produced notable short-term 
abnormalities in behavior similar to a post-concussive state.  Repetitive injury (42 
impacts total: 6 impacts per day over 7 days) produced chronic deficits, particularly with 
regards to depressive-like and risk-taking behaviors as well as spatial learning and 
memory (Petraglia et al 2014b).  This same group published a recent follow-up study 
demonstrating the presence of hyperphosphorylated tau, a precursor of neurofibrillary 
tangle (NFT) development, in repetitively injured animals (Petraglia et al 2014c).  The 
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model produces several of the same behavioral symptoms reported by patients suspected 
of having CTE. We recently show that endoplasmic reticulum stress contributes to 
tauopathy and CTE-like behavioral deficits following repeat blast injury (Lucke-Wold et 
al 2015d).   
Other studies, conducted by Mouzon and colleagues report both behavioral and 
neuropathologic changes following repetitive neurotrauma in mice.  Specifically, 5 
injuries administered 48 hours apart, produced durable cognitive deficits, learning 
disabilities, diminished rotarod performance, and changes in anxiety-like behavior on 
elevated-plus maze.  Notably, these behavioral changes occurred in conjunction with 
persistent neuroinflammatory changes and disruption of white matter integrity.  No 
changes in Aβ and tau phosphorylation were seen at the chronic time points of 6 and 12 
months post-neurotrauma, likely because rodents don’t naturally develop neurofibrillary 
tangles (Mouzon et al 2014).  Rodents do however demonstrate acute tau changes due to 
phosphorylation and cleavage following injury (Huber et al 2013). Liu and colleagues 
found that tau hyperphosphorylation was increased in rats acutely post-injury and triggers 
caspase activation in rat cortices (Liu et al 2011). The activation of cell death can lead to 
circuit dysfunction and behavioral deficits (Abisambra & Scheff 2014). Goldstein and 
colleagues show that tauopathy contributes to mitochondrial dysfunction and microtubule 
injury that ultimately leads to apoptosis. In this study, they found that tau modulation is a 
potential avenue for therapeutic intervention (Kondo et al 2015). We recently report that 
caspase activation was increased in human CTE brains near sites of neurofibrillary tangle 
formation (Lucke-Wold et al 2015a). 
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Other repeat-injury studies have investigated changes in tau and amyloid post-
injury with the goal being to more clearly elucidate the relationship between TBI and 
neurotrauma related neurodegeneration. One report showed an increase in neuronal tau 
immunoreactivity (Kanayama et al 1996) and another showed elevated amyloid precursor 
protein (APP) (Dobrowolska & Gibson 2005, Weber 2007) at a variety of time points 
post-injury.  A final study by Zhang and colleagues showed that monoacylglycerol lipase 
can lead to behavioral deficits and tauopathy characteristic of a CTE-like phenotype 
(Zhang et al 2015). These findings were further verified in other studies using transgenic 
models of amyloidosis and tauopathy in which repetitive injury paradigms produced 
elevated amyloid and tau levels with increased deposition.  Single injury however failed 
to produce changes above control levels (Conte et al 2004, Uryu et al 2002).  Using a T44 
tau Tg mouse line, Yoshiyama and colleagues sought to study dementia pugilistica (DP), 
a condition sharing many features with modern day CTE, but with several key 
differences.  DP by definition occurs only in boxers and has more severe gross 
anatomical changes that are not always present in CTE.  The Yoshiyama group found that 
4 impacts per day given once a week for 4 weeks produced only modest neuropathology 
with only 1 mouse demonstrating CTE or DP characteristics out of a total of 18 Tg mice 
and 24 wild-type mice (Weber 2007, Yoshiyama et al 2005). The affected mouse 
displayed neuropathologic changes that included heightened tau burden, the presence of 
neurofibrillary tangles, and cognitive deficits (Yoshiyama et al 2005).  While it remains 
unclear why only one mouse developed such pathology, neuropathological findings from 
this one animal demonstrated that iron deposition was increased and associated with 
blood-brain barrier disruption.  Iron deposition, associated with degradation of heme, 
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activates oxidative stress-related pathways.  Importantly, this oxidative stress is then 
associated with accelerated neurofibrillary tangle formation in these perivascular locales 
(Yoshiyama et al 2005).   
Notably, even single injury paradigms have been shown to produce tauopathy in a 
variety of injury models including blast (Goldstein et al 2012), fluid percussion (Hawkins 
et al 2013), and controlled cortical impact, findings consistent with prior clinical reports 
(Begum et al 2014, Rubenstein et al 2014).  Goldstein and colleagues demonstrated that 
tauopathy following single blast injury was associated with hippocampal-dependent 
learning and memory deficits at subacute and chronic time points.  These changes were 
also associated with electrophysiological alterations in long-term potentiation (Goldstein 
et al 2012). Therefore, even a single mild to moderate injury may induce 
neurodegeneration and neurological deficits leading to impaired cognition and disrupted 
synaptic transmission (Goldstein et al 2012). Single injury has also been shown to 
contribute to blood brain barrier disruption (Glushakova et al 2014).  This is a significant 
finding considering the numerous concussive and subconcussive injuries occurring in 
athletics and on the battlefield. Other studies using single injury models have also 
demonstrated activation of numerous pathological processes and behavioral changes 
associated with neurodegeneration. Modeling neurotrauma related neurodegeneration is a 
key component in the search for a model of CTE (Logsdon et al 2014, Lucke-Wold et al 
2014a, Smith et al 1995).  While the importance of repeat injury in CTE modeling cannot 
be overstated, some single injury studies have led to advances in the ability to detect 
phospho-tau in serum at weeks to months post-injury.  These advances indicate the 
potential role of biomarkers in monitoring and understanding disease pathophysiology 
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(Rubenstein et al 2014).  The development of animal based models that exhibit similar 
characteristics of CTE will afford researchers the opportunity to characterize the acute 
and chronic effects of injury on the phosphorylation of tau in controlled experimental 
conditions. In vitro models may even be beneficial in elucidating changes at the cellular 
level (Zander et al 2015). Evaluating imaging modalities, potential biomarkers, such as 
phosphorylated tau, and proposed therapeutics in a controlled context will promote 
advancement towards clinical applications and could be instrumental for monitoring and 
understanding disease pathophysiology in the future. 
IMPLICATIONS FOR MODELING CTE: LEARNING FROM PAST 
SHORTCOMINGS WITH TBI MODELS 
Despite these notable advancements in CTE modeling as outlined above, the vast 
majority of repeat injury studies fail to address the role of injury severity, inter-injury 
interval, and the total number of impacts needed to reproduce a CTE-like state 
(Goddeyne et al 2015, Prins et al 2010). Most studies simply describe features of TBI 
without relating the findings to neurodegeneration (Loane & Kumar 2015).  Furthermore, 
because CTE is a neuropathologic diagnosis, any study claiming to serve as a model of 
CTE must demonstrate the hallmark neuropathologic changes (tau hyperphosphorylation 
and neurofibrillary tangles) and show that these changes persist at delayed time points 
and coexist with behavioral deficits. Few studies have looked at amyloid, tau, or TDP43 
accumulation following injury. 
One of the most common omissions from repetitive injury paradigms is the lack 
of consideration for inter-injury interval.  Work by Longhi and colleagues directly 
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explored this issue, demonstrating that in a mouse model of closed-head injury (CHI), 
mice had a period of vulnerability estimated between 3 and 5 days where the effect of 
injuries was additive and produced deficits in cognition.  When the inter-injury interval 
was lengthened to 7 days, these deficits were not present (Longhi et al 2005).  While the 
focus of that study was elucidating differences in the inter-injury interval, other groups 
employing a repeat injury paradigm should consider how the inter-injury interval may 
relate to their findings. Inter-interval design will be an important consideration in 
developing CTE models.  Attempting to provide a clinical context for these decisions 
would be desirable, with the interval between severe concussive-type impacts ideally 
being longer than that between mild subconcussive-type impacts.  This would expand 
scientific insight for “return-to-play” guidelines that require players to be asymptomatic 
following a diagnosed concussion prior to returning to contact sports.  These types of 
questions have generally not been considered in preclinical work, with most studies using 
brief inter-injury intervals, often ranging from minutes to 24 hours with poor justification 
for timing (Creeley et al 2004, Genovese et al 2013, Klemenhagen et al 2013, Petraglia et 
al 2014b, Shitaka et al 2011, Wang et al 2014). 
Another important limitation related to interpretation of injury severity and 
neuropathologic outcome, is the sensitivity of detecting neuropathology using current 
scientific approaches.  Shitaka and colleagues demonstrated previously that silver 
staining was more reliable for detecting axonal injury and pathology in comparison to 
routine histological analysis, assessment of neuronal cell loss, and amyloid precursor 
protein (APP) immunohistochemistry (Shitaka et al 2011).  It may be increasingly 
important, particularly in studies of repetitive subconcussive impacts, to utilize measures 
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of high sensitivity for injury detection.  Silver staining, which has been shown repeatedly 
to exhibit a higher degree of sensitivity in detecting axonal injury than many 
immunohistochemical techniques; electron microscopy; or other markers with these 
characteristics may prove promising (Shitaka et al 2011). It has not yet been determined 
if neurofibrillary tangles accumulate around sites of axonal shearing.  
KEY QUESTIONS GOING FORWARD 
Improving experimental models will enhance the quest for developing therapeutic 
agents that can be used to prevent and treat CTE.  The search for a model of CTE raises a 
number of questions that are important clinically.  These questions include issues such as 
length of the inter-injury interval, the number and severity of impacts, and the age at time 
of impacts, as well as the mechanism of impact, the gender of the patient, and what role 
genetic predisposition may play in the development of neurodegenerative disease 
following neurotrauma.  Another important question that must be addressed is does a 
history of neurotrauma and potential presence of CTE accelerate the development of 
Alzheimer’s disease?  Furthermore, how can the period of susceptibility following 
neurotrauma be identified most readily?  In the following sections we attempt to address 
these questions based upon available evidence. We also provide suggestions for handling 
shortcomings going forward.  Studies upon which these sections are based are referenced 
in Tables 7.1-7 for quick reference. 
Inter-injury interval 
The effect of inter-injury interval on outcome following TBI has only recently been 
investigated.  Studies have explored a variety of intervals ranging from 2 minutes apart 
!
221 
(in vitro) to a few hours (in vivo) to as long as 30 days apart (in vivo).  Using a novel 
approach assessing vasoreactivity in TBI, Fujita and colleagues demonstrated that 
administration of seemingly mild injuries at brief intervals (3 hours apart) produced 
dramatic declines in vasoreactivity and axonal pathology.  When the inter-injury interval 
was lengthened to 5 hours, the magnitude of these changes was diminished substantially 
with complete dissolution of changes in both pathology and vasoreactivity at 10 hours 
(Fujita et al 2012). 
Other studies that have investigated longer inter-injury intervals have identified 
periods of susceptibility following an initial impact at periods ranging from 24 hours to a 
few weeks (Bolton & Saatman 2014, Mannix et al 2013, Meehan et al 2012, Weil et al 
2014).  Bolton and colleagues demonstrated with a CHI model that a single impact 
produced extensive gliosis bilaterally in the hippocampi and entorhinal cortices.  Repeat 
injury after 24 hours produced a more severe injury consisting of hemorrhage in the 
entorhinal cortices as well as heightened measures of neurodegeneration, gliosis, and 
neuroinflammation (Bolton & Saatman 2014).  When the experimental paradigm was 
changed such that impacts were given with a 48-hour inter-injury interval, the 
histopathology resembled that of a single impact suggesting enhanced susceptibility when 
a second impact was administered within 24 hours (Bolton & Saatman 2014).   
Mannix and colleagues performed one of the most rigorous investigations of the 
effect of inter-injury interval on outcomes associated with TBI. These studies included 
measures of both cognition and neuropathology related to the development of 
neurodegenerative diseases such as CTE and AD.  In this study, the investigators showed 
that animals who received daily or weekly injuries with weight-drop had persistent 
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cognitive deficits up to 1 year post-injury (Mannix et al 2013).  This was in contrast to 
when animals were injured biweekly or monthly, which failed to produce deficits at such 
a chronic time point (Mannix et al 2013).  Notably, the cognitive deficits seen in the 
daily- and weekly-injured animals did not correlate with elevations in tau 
phosphorylation or amyloid-β when measured by ELISA nor brain volume loss when 
measured by MRI (Mannix et al 2013).  This finding may indicate that in addition to 
inter-interval time, injury severity must be considered. Tauopathy is essential for 
modeling CTE therefore an appropriate inter-injury interval might be best characterized 
in transgenic animals. Weight drop produces variable injury based on the height of the 
drop.  A more severe TBI can produce cognitive deficits but may not be representative of 
the concussive and subconcussive injuries associated with CTE.  A mild TBI with a 
transgenic animal will likely produce the most relevant deficits. 
Meehan and colleagues performed a similar study with primarily behavioral 
assays.  The investigators subjected mice to a CHI via weight-drop for a total of 5 
impacts at various intervals.  These intervals included daily, weekly, and monthly 
intervals.  Mice receiving 5 impacts total at daily or weekly intervals were impaired in the 
MWM compared to sham animals (Meehan et al 2012).  This was not the case when 
injuries were delivered at monthly intervals, as these animals exhibited no impairment in 
the MWM (Meehan et al 2012).  Interestingly, at one month post-injury, the daily- or 
weekly-injured animals still exhibited deficits in the MWM and this deficit persisted in 
daily-injured animals out to 1 year (Meehan et al 2012).  This finding may represent why 
football lineman who experience daily subconcussive injuries appear more likely to 
develop CTE based on the clinical cases reported. It is still necessary to establish if 
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tauopathy is the driving mechanism behind behavior.  The findings confirm and expand 
upon the inter-interval studies completed by Longhi and colleagues (Longhi et al 2005).  
Longhi reported that shorter inter-interval injuries produce worse outcomes, which is in 
agreement with the Mannix and Meehan findings.  These studies were consistent with 
findings in higher phylogenetic species as well, specifically piglets.  Friess and 
colleagues showed that a 24-hour inter-injury interval produced more severe deficits and 
higher mortality rates than when the interval was extended to 7 days (Friess et al 2009).  
Finally, Kanayama and colleagues demonstrated a graded response in locomotor activity. 
Both shorter inter-injury intervals as well as greater number of total injuries were 
associated with worse outcome (Kanayama et al 1996). 
Weil and colleagues explored the effect of altering the inter-injury interval in 
relation to recovery from TBI. They used a clear clinical-minded approach and utilization 
of metabolic imaging (PET).  This group showed that injuries separated by only 3 days 
were associated with worse neuropathology and an inability to mount the typical 
hypermetabolic response with regards to glucose utilization following TBI.  This worse 
outcome was not seen following either a single injury or repeat injuries with an extended 
inter-injury interval of 20 days (Weil et al 2014).  Similarly, a brief inter-injury interval 
of 3 days was associated with elevated IL-1β and TNFα gene expression when compared 
with other experimental groups (Weil et al 2014). 
The longest interval between injuries used in preclinical studies, to the best 
knowledge of the authors, was 30 days.  The additional injury had no additive effect on 
anxiety (EPM), depression (FST), and cognitive function (MWM) when compared to 
animals receiving only one injury (Mychasiuk et al 2014).  These findings indicate that 
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either the window of vulnerability following the first injury was avoided or that the 
response to the first injury may protect the animal from subsequent injuries, a concept 
known as preconditioning (Mychasiuk et al 2014). The progression towards tauopathy 
was not well characterized in this work. 
In vitro studies have shown similar findings to the in vivo studies described above. 
Shorter inter-injury intervals between mechanical stretching resulted in an elevation in S-
100β protein release and increased cellular permeability identified with propidium iodide 
staining (Weber 2007).  Similarly, a ‘subthreshold’ level of stretch did not produce any 
overt cellular damage or death when repeated at 1-hour intervals but did cause neuronal 
loss and neuron-specific enolase (NSE) release when performed at incredibly short 
intervals (every 2 minutes) (Slemmer & Weber 2005, Weber 2007).  Remarkably, this 
rapid and repetitive ‘subthreshold’ stretch that produced changes in neurons, failed to 
produce an increase in S-100β protein release, indicating a differential response between 
neurons and glia to neurotrauma severity and interval (Slemmer & Weber 2005, Weber 
2007). 
In contrast to the above studies, one group showed that repeat injury, when 
administered in different anatomical locations within the brain, failed to result in 
heightened damage when an inter-injury interval was 3 days. It did however increase 
tissue vulnerability with a 7-day interval as evident by increased hemorrhage (Donovan et 
al 2012, Donovan et al 2014).  The authors of the study therefore argue that the period of 
susceptibility likely depends on not only the time interval between injuries, but also the 
anatomic location of injury (Donovan et al 2012, Donovan et al 2014).  Importantly, this 
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study utilized an open injury model (controlled cortical impact), a scenario that is only 
seen in a subset of clinical neurotraumas. 
In summary, these studies demonstrate a period of vulnerability following initial 
injury in which sustaining a second brain injury may result in an additive effect.  Additive 
injury is not clearly apparent when the brain is allowed a more extensive recovery period.  
Interestingly, this vulnerability may not solely be due to initial axonal pathology but may 
also be the result of cerebrovascular reactivity and the inability to utilize glucose 
effectively (Fujita et al 2012, Weil et al 2014).  This concept of a varied cellular response 
to TBI is consistent with findings from in vitro studies that demonstrate a varied response 
amongst glia and neurons (Slemmer & Weber 2005, Slemmer et al 2004, Weber 2007). 
Number of impacts 
The prevailing theory for ‘mild’ neurotrauma is that repetitive injuries are 
associated with more short- and long-term detrimental effects than a single injury alone 
(Bolton & Saatman 2014, Laurer et al 2001, Mouzon et al 2012).  This concept has been 
applied regardless of injury severity (concussive versus subconcussive) with emerging 
evidence indicating that even subthreshold impacts are cumulatively detrimental (Bailes 
et al 2013, Fujita et al 2012).  In this section we explore the effect of repeat injury 
through analysis of studies employing both repeat and single injury paradigms. 
One of these studies, conducted by Mouzon and colleagues, showed that when 
rodents are exposed to 5 total injuries with an interval of 48 hours, these animals exhibit 
both impaired learning and memory at extended time points (Mouzon et al 2014).  These 
findings are in contrast to single injured animals that display only learning deficits but no 
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retention impairment at the same time points (Mouzon et al 2014).  This study closely 
parallels the clinical findings documented by Guskiewicz and colleagues in which former 
athletes with a history of repetitive concussions experience memory-related issues at a 
rate 5 times higher than those without a history of concussion (Guskiewicz et al 2005, 
Mouzon et al 2014).   
Other work that investigated various iterations of impacts (0, 1, 3, 5, and 10) 
demonstrated that while a single injury does not produce deficits in MWM performance 
in comparison to sham-injured animals, repetitive injury does in fact produce deficits and 
these deficits may exhibit a dose-dependent relationship.  When mice were given 10 
concussive weight-drop injuries, those in which the weight was dropped from a height of 
42 inches performed worse than those injured from a height of 38 inches.  Therefore, this 
work demonstrates the potential for both injury number and injury severity in 
contributing to neurological dysfunction (Meehan et al 2012).  Luo and colleagues 
utilized a GFAP-driven luciferase mouse line and a repetitive closed head injury model to 
investigate cumulative decline.  The investigators showed that there appeared to be a 
linear increase in GFAP luminescence from 1 to 3 injuries but that this response appeared 
to reach a plateau by 5 injuries (Luo et al 2014a).  In addition to the increase in GFAP 
fluorescence with repetitive injuries, mice receiving three injuries demonstrated less 
freezing time than sham animals in both cued and contextual fear conditioning (Luo et al 
2014a).  This was in contrast to single injury animals that did not differ from sham-
injured animals in cued or contextual memory (Luo et al 2014a).  Consequently, this data 
demonstrates that an increase in injury number is associated with an increasing severity 
of injury markers (based on protein expression of GFAP) as well as functional deficits 
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(fear conditioning).  Others employing both single and repeat injury paradigms have 
shown that while single injury may not induce pathological findings, repeat injury, of the 
same severity, does.  This was particularly notable in work by Uryu and colleagues in 
which repetitive injury produced an increase in Aβ deposition in Tg2576 animals, 
whereas no increase was observed in single injury paradigms in these same animals 
(Uryu et al 2002).  Likewise, Kanayama and colleagues demonstrated that repeat injury 
paradigms induced tau hyperphosphorylation, a precursor to NFT formation, in 
conditions such as CTE and AD (Kanayama et al 1996).  
The observed findings in closed-head, repeat injury models, were also consistent 
with those found in open-head injury using a craniectomy and controlled cortical impact.  
In work by Donovan and colleagues, the investigators showed that repeat injury induces 
progressive and evolving changes that are not observed in single injury paradigms 
(Donovan et al 2014). The basis of many of the memory and cognitive changes following 
repeat TBI, may be explained by electrophysiological alterations in synaptic 
transmission.  In work by Aungst and colleagues, repetitive TBI was found to prevent the 
induction of long-term potentiation (LTP) 28-days post-injury due to alterations in the 
NMDA receptor.  This is in stark contrast to single injury paradigms that revealed the 
ability to induce LTP in both hemispheres, with the contralateral hemisphere exhibiting 
less LTP than the ipsilateral hemisphere.  The impairments in excitatory 
neurotransmission following repeat injury were accompanied by extensive 
neuroinflammation and neurodegeneration as well as behavioral/functional impairments 
(Aungst et al 2014b).  Specifically, repeat injury produced deficits more severe than 
single injury when measured at one-week intervals out to a month.  Importantly, even 
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single injury produced deficits at chronic time points post-injury when compared to sham 
animals, indicating long-term effects of TBI (Aungst et al 2014b). 
Povlishock and colleagues expanded the concept of subthreshold injury.  In these 
studies, the investigators showed that administering a single weight-drop injury from 1.0 
m resulted in neither axonal nor microvascular change.  With repeat injury of short inter-
injury intervals (hours), significant axonal and microvascular pathology was observed 
(Fujita et al 2012).  This work was the first to assess microvascular reactivity to 
acetylcholine (ACh) following repetitive subthreshold brain injury.  This work 
demonstrates the clear danger of subthreshold impacts when sustained in a repeated and 
rapid fashion.  It also illustrates the role of the microvasculature in neuronal injury, 
showing that the neurovascular unit is essential for neuronal homeostasis. 
Importantly, work regarding the number of impacts has been extended higher up 
the phylogenetic tree to rabbits and piglets (Olsson et al 1971, Raghupathi et al 2004).  In 
rabbits, repeated loading with loads of up to 1.5 atm failed to produce an additive 
concussive response over a single load.  A multi-loading paradigm at higher loads 
however caused respiratory arrest (Olsson et al 1971).  In piglets, multiple less severe 
injuries induced neuropathological findings similar to a severe load based on the density 
of injured axons as well as number and distribution of foci (Raghupathi et al 2004). 
In vitro studies have reported similar findings to the in vivo studies.  Weber and 
colleagues applied a mild stretch to hippocampal neuronal cultures that produced low-
grade injury when applied at a single time.  When this injury was repeated, the cells 
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exhibited cumulative damage with two injuries inducing an increase in neuron-specific 
enolase (NSE) (Slemmer & Weber 2005, Slemmer et al 2004, Weber 2007). 
Notably, the group led by Mychasiuk and colleagues provides evidence contrary 
to the widely held belief that an increased number of impacts are associated with 
detrimental findings on behavioral or histological measures.  With a 30-day inter-injury 
interval, rodents receiving multiple injuries performed similar to single-injury animals on 
measures of anxiety, depression, and cognitive ability.  Therefore, they propose that 
receiving head injury at an early age may prime the brain to be less susceptible to the 
effects of a later neurotrauma, a theory known as ‘pre-conditioning’ (Mychasiuk et al 
2014).  DeRoss, et al also showed that while one concussive impact resulted in 
diminished performance in 85% of animals, less deviation was seen with subsequent 
impacts. The number of impacts has an inverse relationship with animal performance in 
the water maze (DeRoss et al 2002).  Again, the mechanism behind these findings is not 
entirely clear as those animals sustaining multiple injuries also received additional 
exposure to the water maze, allowing for enhanced training/learning of the maze (DeRoss 
et al 2002).  Therefore, while repetitively injured animals did better than single-injured 
animals in the maze, this is likely a product of increased training rather than a protective 
response but this cannot be said with absolute certainty. 
Severity of impacts 
The effect of injury severity on likelihood of neurodegenerative disease 
development is not entirely clear, although some clinical reports indicate that more severe 
injury results in a greater predisposition for AD development (Plassman et al 2000, Uryu 
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et al 2002).  What is known from preclinical studies using an array of animal models is 
that there is a dose-dependent increase in neural injury markers and cognitive deficits 
with more severe injury (Budde et al 2013, DeFord et al 2002, Long et al 2009, Luo et al 
2014a, Manley et al 2006, Turner et al 2013).  Similarly, repetitive ‘mild’ injuries may 
produce a phenotype more consistent with a single more severe injury (DeFord et al 
2002).  
How ‘mild’ TBI contributes to the likelihood of developing CTE remains unclear.  
Emerging evidence from preclinical studies raises concern about lasting effects of 
subthreshold injuries when sustained in a rapid and repetitive fashion.  These repetitive 
injuries contribute to vascular reactivity and subsequent axonal degeneration in vivo 
(Fujita et al 2012).  Some studies suggest that severity of injury may dictate the rest 
period required to minimize cumulative cognitive deficits, although further studies are 
required to validate these findings (Meehan et al 2012). 
Similarly, preclinical studies, even those in which only a mild force is imparted to 
a thinned cranium, indicate that a substantive inflammatory response is produced quickly 
after injury (Roth et al 2014).  This response is associated with heightened vascular 
permeability, also seen clinically, as well as microglial response (Roth et al 2014).  It is 
these mechanisms, both primary and secondary, that may contribute to neurodegenerative 
disease post-neurotrauma. 
In vitro studies may be of further use in addressing the role of injury severity, 
particularly in subconcussive/subthreshold-type studies, as levels of injury and 
subsequent cellular responses can be monitored rapidly and performed over a greater 
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number of iterations at a lower cost in comparison to in vivo studies.  In fact, a number of 
injury paradigms and mechanisms have been investigated successfully in this manner 
including fluid pulse-induced shear stress, repetitive stretching, and other mechanical 
deformation procedures, both in vitro and ex vivo (LaPlaca & Thibault 1998, Morrison et 
al 2006, Mukhin et al 1998, Sieg et al 1999, Slemmer & Weber 2005, Slemmer et al 
2004).  The in vitro shearing studies found a significant amount of axonal beading and 
glial death (LaPlaca et al 2005). 
Age at time of impacts 
Age is the biggest risk factor for the development of neurodegenerative disease 
and has been associated with poor outcomes following TBI in a variety of clinical and 
preclinical reports (Anderson et al 2009, Hamm et al 1991, Hoane et al 2004, Maughan et 
al 2000, Mehan & Strauss 2012, Timaru-Kast et al 2012, Turner et al 2012c, Turner et al 
2014, Wali et al 2011).  Similarly, neurotrauma has been associated with an increased 
risk of neurodegenerative disease development with regards to AD (Magnoni & Brody 
2010, Plassman et al 2000, Sivanandam & Thakur 2012, Van Den Heuvel et al 2007), PD 
(Bower et al 2003), and CTE (Gavett et al 2011a, Goldstein et al 2012, McKee et al 2010, 
Montenigro et al 2014, Omalu 2014, Omalu et al 2011a, Omalu et al 2011b, Omalu et al 
2010a, Omalu et al 2006, Omalu et al 2005, Omalu et al 2010b, Omalu et al 2010c, Stern 
et al 2013).  One of the primary questions currently in the field is how the age at which 
the patient sustains the neurotrauma pertains to the development, or lack thereof, of CTE. 
Similar findings have been observed in preclinical studies.  Mychasiuk and 
colleagues showed that TBI during brain development leads to worse outcomes than TBI 
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affecting the mature brain (Mychasiuk et al 2015).  Preclinical work has also shown that 
young animals experience less edema than middle-aged animals following TBI (Kasturi 
& Stein 2009).  The increased edema is associated with an increase in lesion size in aged 
rodents experiencing TBI (Kumar et al 2013).  TBI in aged rodents is also more likely to 
increase sensorimotor and cognitive decline (Hoane et al 2004).  TBI in youth may 
ultimately be more detrimental for social development, whereas severe injury in the 
elderly results in rapid cognitive decline due to increased edema and therefore, lesion 
size.  In regards to human TBI, it is unclear if the elderly would have a more progressive 
form of the disease similar to rodent studies or if the disease would develop in the normal 
manner.  It is also important to consider that males <35 years old are the most likely to 
have repetitive TBIs, a group associated with heavy participation in sports and now the 
military (Theadom et al 2014).  Future preclinical studies should therefore continue to 
investigate TBI secondary mechanisms in both young and aged animals with particular 
attention paid to addressing repetitive injury paradigms and the development of CTE-like 
features, both behaviorally and biochemically. 
Mechanism of impact 
CTE has been diagnosed in athletes sustaining direct impacts as a result of 
participation in warfare, football, wrestling, and soccer (Gavett et al 2011a, Goldstein et 
al 2012, McKee et al 2010, Montenigro et al 2014, Omalu 2014, Omalu et al 2011a, 
Omalu et al 2011b, Omalu et al 2010a, Omalu et al 2006, Omalu et al 2005, Omalu et al 
2010b, Omalu et al 2010c, Stern et al 2013).  The mechanism of injury is different 
between blast and athletic concussions, but how these mechanisms relate to injury 
progression remains to be elucidated. For blast, primary to quaternary injury must be 
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considered (Kobeissy et al 2013). Other important questions include what is the influence 
of linear versus rotational impacts?  What is the effect of direct impacts such as a football 
tackle versus indirect impacts such as primary blast exposure?  Furthermore, how can 
comparisons most accurately be made across these various impacts?  Are accelerometers 
and recording systems (such as the HITS system) the best method for understanding and 
comparing these impacts?  What role does high-speed videography and subsequent 
kinematic analysis play?  Each of these questions remains to be answered and may 
provide further insight into understanding the role that impact type plays in CTE 
development. 
Biochemical mechanisms 
Interestingly, glymphatic clearance has recently been shown to play a role in 
injury progression. Iliff and colleagues showed increased tauopathy accumulation in 
aquaporin knock-out mice following traumatic brain injury due to disrupted glymphatic 
clearance (Iliff et al 2014). It has yet to be determined how the primary injury mechanism 
causes the disruption to glymphatic channels. Cernak proposed an interesting theory 
about low-frequency stress waves transmitting kinetic energy through tissue (Cernak 
2015). This mechanism may account for the dysfunction of the aquaporin channels. The 
energy transfer may also injure other cellular components such as axons or vessels. 
Chodobski and colleagues have shown that kinetic transfer of energy can account for 
blood brain barrier disruption (Chodobski et al 2011). Blood brain barrier disruption post-
injury can trigger increased neuroinflammation. Agoston and colleagues showed that 
blast traumatic brain injury, in particular, causes persistent neuroinflammation, which 
leads to behavioral deficits (Kovesdi et al 2012). The neuroinflammation can also 
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contribute to post-traumatic epilepsy and tauopathy (Salazar & Grafman 2015). 
Investigating how tauopathy spreads is a topic warranting further investigation (Koliatsos 
& Xu 2015). Furthermore, Kobeissy and colleagues highlight in their recent review that 
underlying neuronal damage can cause lasting neuropsychiatric deficits such as post-
concussion syndrome and post-traumatic stress disorder (Kobeissy et al 2013). 
Role of genetics 
Genetics and lifestyle choices may play a role in likelihood of sustaining a TBI 
and also the outcome following a TBI.  Little to no evidence currently exists regarding 
lifestyle choices associated with TBI and only recently has genetic contribution to CTE 
been addressed.  Specifically, it is well known in the human literature that the APOε4 
allele is associated with worse outcome following TBI (Ponsford et al 2011).  APOε4 and 
APOε3 have also been implicated in the development of both CTE and AD (Saulle & 
Greenwald 2012, Weber 2007).  The mechanism by which APOε4 worsens outcome 
following TBI is poorly defined (Mannix et al 2013), but targeted replacement of the 
allele in mice has allowed focused research into cholesterol metabolism and may lead to 
insights in the field of traumatic brain injury and subsequent neurodegeneration 
(Laskowitz & Dawson 2014).  Notably, a study by Maroon and colleagues recently 
demonstrated that there was no significant difference between ApoE4 carriers in a 
population of patients afflicted with CTE when compared to the general population, 
suggesting that perhaps ApoE may not represent a significant risk factor for CTE 




Other genetic influences have also been observed but are currently limited to 
preclinical evidence. Rare genetic alterations such as mutation of the CACNA1A calcium 
subunit gene have also been shown to lead to poor TBI outcomes in human patients (Kors 
et al 2001).  Recent pre-clinical studies have shed light on other potential genetic factors 
that may influence TBI outcomes.  Decreases in micro RNA 23a and 27a increase 
apoptosis following TBI in rodents (Sabirzhanov et al 2014).  Deficient caveolin 
expression can exacerbate neuroinflammation post-TBI (Niesman et al 2014).  The 
knock-in mouse APP696swe has accelerated deposition of Aβ following TBI 
(Yoshiyama et al 2005).  Emerging evidence also suggests dysfunctional mitochondrial 
genes following TBI such as Fas, Apaf1, and Chp.  Interestingly, these genes become 
more dysfunctional and mutated with time after mild TBI (Sharma et al 2012).  TBI can 
also induce DNA fragmentation leading to an upregulation of p53, a critical regulator of 
cell cycle (Lu et al 2000).  On the other hand, upregulation of insulin growth factor 
expression prior to TBI is associated with neuroprotection (Carlson et al 2014).  
Similarly, genetic regulation of aquaporin 4 channels can reduce edema formation 
following TBI in rodent models (Ke et al 2001).  Surprisingly, disruption or the PARP1 
gene offers protection against TBI hypoxia (Hagberg et al 2004).  Studying genetic risk 
factors for TBI is an area of growing importance and requires further investigation.  
Understanding factors that lead to increased or decreased TBI severity may also allow the 
development of novel pharmaceutics for the prevention of neurodegenerative disease.  
An emerging area is the role of epigenetic modulation following TBI. Epigenetic 
markers are now being used preliminarily to predict recovery following injury (Lipsky & 
Lin 2015). VandeVord and colleagues show enhanced methylation of DNA in the rat 
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hippocampus following blast traumatic brain injury (Bailey et al 2015a). These epigenetic 
changes are mediated by HDACs and DNMTs (Bailey et al 2015b). Interestingly, the 
methylation changes are cumulative with repetitive injury (Haghighi et al 2015). HDAC 
has been shown to contribute to GSK3β activation, which is a known tau kinase. When 
HDAC is inhibited white matter damage is reduced (Wang et al 2015). Epigenetic 
regulation has been tied to the development of post-traumatic stress disorder clinically 
(Almli et al 2015). Targeting epigenetic regulation may therefore be a viable target in 
preventing tauopathy and behavioral deficits following traumatic brain injury. 
Influence of gender 
The influence of gender on outcome after TBI remains controversial, particularly 
in light of the few cases of CTE diagnosed in women.  Some studies claim that females 
have better outcomes following neural injury (Bramlett & Dietrich 2001) while others 
report no change (Bruce-Keller et al 2007, Kadyan et al 2004), or worse outcome (Farace 
& Alves 2000a).  Estrogen treatment has shown improved outcomes in rodent models of 
neural injury (Jia et al 2009, Li et al 2011, Simpkins et al 1997, Suzuki et al 2007), 
including TBI (Day et al 2013, Gatson et al 2012).  Female rodents exhibit better 
outcomes after neural injury as evidenced by increased neurotrophin production (Gatson 
et al 2012), decreased neuroinflammation (Brown et al 2009), and better performance on 
motor tasks (Wagner et al 2004b).  Clinical evidence shows that female patients exhibit 
lower oxidative damage after TBI (Wagner et al 2004a), which could be the result of a 
higher estrogen circulation following injury.  Gender differences should be considered 
when conducting clinical trials for TBI therapy.  
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Interestingly, Dixon and colleagues found that TBI in female humans reduces 
estradiol in the CSF (Garringer et al 2013). The reduction of estradiol may have unique 
long-term effects because it is not yet known if this is transient or permanent. The limited 
amount of data about women with TBI has restricted the comparisons of injury between 
genders (Bell & Pepping 2001). The majority of traumatic brain injuries in women are 
subdural hematomas from falls. Elderly women with subdural hematomas tend to fair 
worse than the general TBI population as a whole (Farace & Alves 2000b). Menopause 
may therefore dampen the neuroprotective physiologic properties mediated by estrogen 
post-injury. TBI in elderly women is also linked with earlier onset Alzheimer’s disease 
(Nemetz et al 1999). Hormonal changes may also be a contributing factor to CTE, but 
this has yet to be verified. It is clear based on the limited pre-clinical and clinical data that 
further investigation into the gender differences surrounding TBI outcome is warranted. 
Effect of environment 
Another area of investigation required for elucidation of factors influencing the 
likelihood and/or severity of CTE development following neurotrauma includes the effect 
of environment.  Areas of particular interest include social support, diet, use of 
supplements, and use of drugs or anabolic steroids. 
Good social support has been shown to decrease the likelihood of developing a 
postconcussional disorder following acute head injury (McCauley et al 2001). Strong 
family support is linked to better outcomes (Khan et al 2003). Another important feature 
of environment is diet. While the effect of diet is well understood with regards to general 
health, there are limited studies relating diet and mental health, particularly in the context 
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of traumatic brain injury.  A preclinical study conducted by Mychasiuk and colleagues 
showed that high-fat diet in conjunction with TBI resulted in cumulative deficits on 
assessments of motor function, short-term working memory, and produced depressive-
like effects compared to animals with normal diet and TBI (Mychasiuk et al 2014).  
Similarly, administration of dietary supplements such as Vitamin E and DHA have been 
shown to improve outcomes from TBI in numerous studies (Bailes & Patel 2014, Conte 
et al 2004, Mills et al 2011a, Mills et al 2011b, Wu et al 2004).  The suggestion has been 
made previously, based on evidence that some cases of diagnosed CTE occurred in 
former athletes with a history of anabolic steroid use, that anabolic steroid use may 
predispose these athletes to CTE development.  While this question has not been 
completely resolved in terms of studying markers of CTE, preliminary studies found no 
difference in amyloid precursor protein (APP) expression post-TBI regardless of when 
anabolic steroids were used (Mills et al 2012). 
Preconditioning 
Any neural injury model has the potential to be complicated by the concept of 
preconditioning.  Preconditioning at the most basic levels refers to neuroprotection for a 
given injury induced by a prior stimulus/injury.  The concept of preconditioning has been 
well documented in a variety of neural injury models ranging from ischemic stroke to 
TBI (Weber 2007).  Initial stimuli that serve a protective effect in a subsequent injury 
include but are not limited to brief periods of ischemia, chronic exposure to moderate 
heat or heat acclimation, and subthreshold or mild injury (Weber 2007). The proposed 
mechanism is that neuronal antioxidant machinery is upregulated with subthreshold 
injury thereby increasing the cells ability to respond to free radical production during 
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subsequent injuries (Hu et al 2008) Whether preconditioning serves a protective 
phenomenon in the development of CTE is unclear, but the general clinical consensus is 
that any brain injury no matter how small may be detrimental long-term, minimizing any 
potential benefit of the preconditioning phenomenon (Bailes et al 2013, Talavage et al 
2014).  This is in contrast to preclinical literature demonstrating that sustaining repetitive 
mild injury prior to a single severe injury protects the animal from the most deleterious 
effects of the severe injury (Allen et al 2000).  In other words, animals receiving 
repetitive mild injury prior to a severe injury do better than animals receiving a single 
severe injury (Allen et al 2000).  Similar findings have been observed in vitro in which 
subthreshold stretch prevented more deleterious injury when a threshold stimulus was 
given (Slemmer & Weber 2005).  The concept of preconditioning versus additive injury 
is captured pictorially in figure 7.2. 
SUMMARY 
In conclusion, understanding CTE as a disease remains in its infancy and current 
studies remain largely speculative in nature without prospective clinical investigation.  
The required clinical studies to advance the field mandate extensive financial resources 
and time.  Preclinical studies represent the most promising mechanism for studying many 
of the basic biologic questions about CTE, as discussed above.  While these studies are 
continuing to evolve, numerous groups have reported exciting findings.  Better modeling 
has allowed more extensive biochemical and behavioral characteristics to be defined.  
Now that our laboratory and others have established CTE models, options for 
translational investigation of CTE pathophysiology abound.  In this work we discussed 
numerous avenues for addressing translational questions, namely the role of 1) inter-
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injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5) 
mechanism of impact, 6) genetics, 7) gender, and 8) effect of environment on the 
development of CTE.  We also highlighted some of the challenges of CTE modeling and 
specific requirements for successful models.  By improving our understanding about CTE 
mechanisms, we believe that significant strides can be made not only in understanding 
CTE but also potentially developing prevention and therapeutic-related approaches.  A 
companion manuscript describes our collective experience in modeling CTE, both 
neuropathologically and behaviorally. 
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Figure 7.1: Methodological challenges associated with repeat injury in comparison to 
single injury paradigms include balancing equal age at time of exposure versus age at 
sacrifice.  Two possibilities are shown depending on the variable the experimenter wants 









Figure 7.2: Schematic representation of factors influencing injury outcomes, particularly 
in repetitive injury paradigms.  Initial evidence indicates that longer inter-injury intervals, 
less severe initial injury, a younger age, and female gender may serve as protective 
effects in repeat paradigms.  In contrast, shorter intervals, increased severity, older age, 










Table 7.1: A collection of studies that propose to model CTE. The majority of the studies 
represent both neuropathologic and behavioral deficits. Tauopathy, behavioral changes, 









Table 7.2: A collection of studies utilizing blast-induced neurotrauma models are 
summarized here.  These studies employed both single and repeat-injury paradigms with 
experimental endpoints investigating both neurobehavioral changes and injury 
pathophysiology.  Notably, the referenced studies, consistent with most blast literature, 
have been conducted within the past 5 years, indicating that blast pathophysiology is 










Table 7.3: Selected studies using a conventional weight-drop model similar to the 
Marmarou or impact-acceleration injury models utilized both single and repeat-injury 












Table 7.4: Modification of the more traditional controlled cortical impact device has 
resulted in the ability to develop highly reproducible neurotrauma in preclinical models.  
Consequently, all of the selected studies demonstrate the implementation of repeat-injury 











Table 7.5: Selected studies of interest requiring craniotomy for administration of fluid-











Table 7.6: Less conventional models of neurotrauma due to species utilized, injury 
mechanism, and/or equipment adaptations.  Of particular interest is the study by Petraglia 
































































































Traumatic brain injury continues to be a daunting challenge with few available 
clinical treatment options. Repetitive concussions have been linked to chronic symptoms 
such as impulsivity, cognitive decline, and motor dysfunction. In order to advance 
forward towards the development of novel treatments that can prevent these debilitating 
symptoms it will be imperative to elucidate the mechanisms that link acute injury to 
chronic neurodegeneration. We have investigated in this dissertation several of these 
mechanisms that might contribute to disease progression. In particular, we examined 
blood brain barrier disruption and the role of protein kinase C activity, endoplasmic 
reticulum stress and tauopathy, and NADPH oxidative stress and neuronal plasma 
membrane damage. Once these mechanisms are more fully understood and shown to be 
similarly upregulated in humans, it will be possible to design targeted therapeutics that 
can both prevent degenerative changes and slow the progression of chronic traumatic 
encephalopathy.  
The pharmacologic compounds investigated in this dissertation target broad 
secondary injury cascades. Bryostatin was used historically as a chemotherapy agent with 
cytotoxic properties. Recent pre-clinical findings have shown its potential for modulating 
protein kinase C isozymes within the brain and preventing neuronal injury expansion. We 
showed it has neuroprotective benefits at the blood brain barrier. Docosahexaenoic acid 
has been shown to stabilize neuronal membranes, prevent axonal degeneration, and 
reduce endoplasmic reticulum stress. The multiple therapeutic targets and cost-effective 
nature of this supplement make it an ideal candidate for clinical trials. We were able to 
show that it successfully prevented cognitive decline when given after injury in our 
!
252 
rodent model. Furthermore, lipoic acid is known to readily cross the blood brain barrier 
and target oxidative stress. We showed that it was effective at reducing NADPH 
oxidative stress within the neuronal membrane. Further work is needed to determine if it 
also can prevent mitochondrial related oxidative stress.  
FUTURE DIRECTIONS 
Going forward, it will be necessary to utilize the expertise of multi-disciplinary 
teams. In this dissertation, we highlighted a project that was performed in conjunction 
with an astronautical engineer and physicist. The collaboration led to an enhanced 
understanding of the wave mechanisms and how the wave dynamics may be directly 
causing injury. Similarly, we partnered with Anthony Petraglia, MD to compare two 
proposed models of chronic traumatic encephalopathy. The collaborative nature of these 
projects will continue to propel the field further and allow a broader appreciation of 
different types of TBIs. 
We are currently working with a PhD in mechanical engineering for developing a 
strategic approach for handling concussion. In the first component, we are investigating 
strategies for early detection of concussion such as measurements of successive impacts 
and rotational acceleration. In the second component, we are working on the development 
of early diagnosis of concussion by blood-based biomarkers. In the third component, we 
are developing new preventative equipment such as neck sheaths and re-designed 
helmets. Finally, we will develop a brain health supplement regimen that can be used to 
prevent cognitive decline following injury.  
As mentioned in chapter 7, several unanswered questions are still looming in 
regards to understanding chronic traumatic encephalopathy development and progression. 
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While animal models can give us valuable data about secondary injury cascades, they fail 
to address the more complex questions regarding genetic predisposition, the association 
with comorbidities, and the number of impacts or intensity of impacts necessary to push 
the brain beyond a certain damage threshold. It will be necessary for further human 
epidemiologic studies to be performed in order to map the progression of the disease. 
These prospective studies can be used to gather better information about disease 
prevalence and incidence. The number of concussions is on the rise and the topic of 
degenerative brain changes is of great importance. This dissertation adds a small but 
informative piece to the puzzle for our overall understanding degenerative changes 
following neurotrauma. Future work will investigate how the acute secondary injury 
cascades work together to contribute to persistent neuroinflammation. Targeting 
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Rosen C.L. (2015) Elucidating the Underpinnings of Neurotrauma Related 
Neurodegeneration ACTS: AFMR Translational Science. 
16. Lucke-Wold, B.P., Logsdon A.F., Turner, R.C., Naser, Z., Bailes, J.E., Lee, J., 
Rosen C.L. (2015) Amelioration of NADPH-mediated Stress Reduces Cell Death 
following Blast Traumatic Brain Injury. Central Society of Clinical and 
Translational Research 
17. Lucke-Wold, B.P., Logsdon A.F., Turner, R.C., Naser, Z., Bailes, J.E., Lee, J., 
Rosen C.L. (2015). Lipoic Acid: the Anti-Oxidant for Neurotrauma. American 
Society of Clinical Investigation. 
18. Lucke-Wold, B.P., Logsdon A.F., Turner, R.C., Naser, Z., Bailes, J.E., Lee, J., 
Rosen C.L. (2015). Finding Treatments for Athletes and Soldiers Experiencing 
Brain Injury. American College of Physicians. 
19. Lucke-Wold, B.P., Xu, S., Logsdon, A.F., Rosen, C.L., He, P. (2015) Targeting 
Endothelial Cell Transcellular Diapedesis: Src Dependent Activation of ICAM-1. 
American Association of Pharmaceutical Sciences Research Day. West Virginia 
University. 
20. Lucke-Wold, B.P., Turner, R., Dashnaw, M., Lee, J., Rosen, C., Petraglia, A. 
(2015) Modeling Chronic Neurodegeneration Following Neurotrauma: A Multi-
Model Experience. National Neurotrauma Meeting. 
21. Lucke-Wold, B.P., Logsdon, A.F., Mohammad, A., Adkins, C., Ren, X., 
Lockman, P., Simpkins, J., Rosen, C. (2015) Stroke and Alzheimer’s Disease: 
Shared Vascular Mechanisms. WV Rural Health Meeting. 
22. Lucke-Wold, B.P. Logsdon, A., Turner, R.C., Lockman, P., Simpkins, J., Rosen, 
C. (2015) Novel Approach for Concussion Treatment: Protein Kinase C and the 
Blood Brain Barrier. American Association of Pharmaceutical Sciences Meeting. 
23. Lucke-Wold, B.P. Logsdon, A.F., Mohammad, A., Adkins, C., Ren, X., 
Lockman, P., Simpkins, J., Rosen, C. (2015) Understanding the Vascular Inter-
relationship Between Stroke and Alzheimer’s Disease. Future Tox 2015 
Washington, D.C. 
24. Ciporen, J., Lucke-Wold, B., Mendez, G., Cua, D.J., Chen, A., Banerjee, A., 
Akins, P.T., Balough, B. (2016) Single Staged Resections and 3D Reconstructions 
of the Nasion/Glabella/Medial Orbital Wall/Frontal Sinus and Bone: Long-Term 
Outcome and Review of the Literature. North American Skull Base Conference. 
25. Lucke-Wold, B.P., Ciporen, J., Cetas, J., Dogan, A., Cameron, W. (2016) Dual 
Endoscopic Endonasal Transphenoidal and Precaruncular Transorbital 
Approaches for Clipping of the Cavernous Carotid Artery-Enhanced Degrees of 




26. Lucke-Wold, B.P., Logsdon, A., Mohammad, A., Adkins, C., Ren, X., Simpkins, 
J., Lockman, P., Rosen, C. (2016) The Vascular Inter-relationship between Stroke 
and Alzheimer’s disease. International Stroke Conference. 
 
Oral Presentations: 
1. Lucke-Wold, B.P. (2011) Embarking on New Paths in the World of 
Metallacarborane Chemistry. Thesis Defense Baylor University. 
2. Lucke-Wold, B.P. (2012) Ethanol, Zebrafish, and Conditioned Place Preference. 
Meeting of Behavioral and Biomedical Researchers WVU. 
3. Lucke-Wold, B.P., Logsdon, A.F., Turner, R.C., Tan, Z., Huber, J.D., Rosen, 
C.L. (2013) PERK-mediated ER Stress: Linking Acute Blast-Induced 
Neurotrauma with Tau-dependent Neurodegeneration. American College of 
Physicians WV Meeting. 
4. Lucke-Wold, B.P. (2013) Blast Exposure Induces PTSD Related Traits in a Rat 
Model. Meeting of Behavioral and Biomedical Researchers WVU. 
5. Lucke-Wold, B.P., Tan, Z., Huber, J.D., Rosen, C.L. (2013) The Effect of 
Bryostatin on Blood Brain Barrier Disruption and Hemorrhagic Transformation. 
American Association of Pharmaceutical Sciences Regional Meeting. 
6. Lucke-Wold, B.P. (2014) The ER Stress Response: Linking acute traumatic brain 
injury to chronic tau-dependent neurodegeneration. Neurological Surgery Society 
of the Virginias Meeting. 
7. Lucke-Wold, B.P. (2014) Linking Acute Neurotrauma to Chronic Traumatic 
Encephalopathy: the Role of the ER Stress Response. Van Liere 
8. Lucke-Wold, B.P. (2014) The ER Stress Response: A Bridge Between Acute 
Neurotrauma and Chronic Neurodegeneration. Synapse Meeting. 
9. Lucke-Wold, B.P. (2014) Bryostatin Restores Blood Brain Barrier Integrity 
following Blast-Induced Traumatic Brain Injury. WVU Neuroscience Retreat. 
10. Lucke-Wold, B.P. (2014) Blast!induced Traumatic Brain Injury, Oxidative 
Stress, and Apoptosis: the Beneficial Effects of Alpha Lipoic Acid. American 
College of Physicians WV Scientific Meeting. 
11. Lucke-Wold, B.P. (2014) Amelioration of NADPH-Mediated Stress Reduces 
Cell Death following Blast Traumatic Brain Injury. American Association of 
Pharmaceutical Sciences Pittsburgh Meeting. 
12. Lucke-Wold, B.P. (2014) The Effects of Sporting Events on Trauma Transport 
Time at a Level 1 Trauma Center. Meeting of Behavioral and Biomedical 
Researchers WVU. 
13. Lucke-Wold, B.P. (2015) Ameliorating NADPH-stress reduces cell death 
following blast traumatic brain injury. Neurological Surgery Society of the 
Virginias Meeting. 
14. Lucke-Wold, B.P. (2015) The Case for Medical Marijuana in Epilepsy. West 
Virginia University Neuroscience Blitz. 
15. Lucke-Wold, B.P. (2015) Elucidating the Underpinnings of Neurotrauma-related 
Neurodegeneration. ACTS:AFMR Translational Science 
16. Lucke-Wold, B.P. (2015) Progressive Tauopathy: Understanding Neurotrauma-
Related Neurodegeneration. Alzheimer’s Association International Conference. 
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17. Lucke-Wold, B.P., Logsdon, A.F., Mohammad, A., Adkins, C., Ren, X., 
Lockman, P., Simpkins, J., Rosen, C. (2015) Stroke and Alzheimer’s Disease: 
Shared Vascular Mechanisms. WV ACP Scientific Meeting. 
18. Lucke-Wold, B.P. (2015) Tackling Neural Injury: the Importance of Team 
Science. WVU Neuroscience Research Forum. 
19. Lucke-Wold, B.P., Logsdon, A.F., Mohammad, A., Adkins, C. Lockman, P., 
Rosen, C.L. (2015) Targeting Trauma-induced Blood Brain Barrier Disruption: an 
Innovative Approach for Treating Concussion. Appalachian Regional Cell 
Conference. 
20. Lucke-Wold, B.P., Ciporen, J., Cetas, J., Dogan, A., Cameron, W. (2016) 
Endoscopic Endonasal Transclival Approach vs Dual Transorbital Port Technique 
for Clip Application to the Posterior Circulation: an Anatomic and Cadaveric 




1. Lucke-Wold, B.P. & Turner, R.C. (2014) Modeling Blast-induced Traumatic 
Brain Injury & Solving the Chronic Traumatic Encephalopathy Crisis. 
NorthShore Health System. 
2. Lucke-Wold, B.P. & Logsdon, A.F. (2015) Investigating Pathophysiologic 




1. Lucke-Wold, B.P. (2016) Novel Approach for Concussion Treatment: Protein 
Kinase C and the Blood Brain Barrier. AAPS Best Abstract Presentations. 
 
Funding 
• West Virginia University Research Funding and Development Grant Co-
investigator 2013: $17000 
• West Virginia University Distinguished Doctoral Fellowship 2014: $5000 and 
2015: $5000 
• American Medical Association Foundation Seed Grant 2015: $2500 
• American Foundation of Pharmaceutical Education Pre-doctoral Fellowship 2015: 
$10000 and 2016: $10000 
• Neurosurgery Research and Education Foundation Medical Student Summer 
Research Fellowship 2015: $2500 





• Neurological Surgery Society of the Virginias Meeting, Greenbrier, WV, 2014, 
2015 
• American Physician Scientist Association Institutional Representative Annual 
Meeting Chicago, IL, 2014, 2015 
• National Neurotrauma Society Meeting 2014, 2015 
• American College of Physicians National Meeting 2014, 2015 
• Experimental Biology Meeting 2015, 2016 
• American Association of Neurological Surgeons National Meeting 2015, 2016 
• American Federation for Medical Research Eastern 2015, and Central 2015  
• NINDS/AUPN/ANA/CNS Combining Clinical and Research Careers in 
Neuroscience Symposium 2015 
• Alzheimer’s Association International Conference 2015 
• American Association of Pharmaceutical Sciences 2015 
• FutureTOX 2015 
• North American Skull Base Society 2016 
 
Professional Service: 
• Poster Judging – Undergraduate scholars at the WVU Neuroscience Retreat 
• Nu Rho Psi National Council – Honor Society for Neuroscience 
• Neuroscience Breakthrough Blitz- Speaker Committee  
• Diabetes Health Coach – School of Public Health 
• Blind Reviewer – Compass Clinical Trial 
 
Certification 
• NIH Stroke Scale (1/17/16) 
• Modified Rankin Scale Test (1/17/16) 
 
Editorial: 
• Reviewer, Molecular Neurobiology 
• Reviewer, NeuroReport 
• Reviewer, PlosOne 
 
Teaching: 
• West Virginia University Graduate Neuroanatomy: Teaching Assistant and 
Discussion Leader (Spring 2015) 
• West Virginia University Graduate Journal Club: Ran Sessions on Neuroscience 
Articles (Fall 2015) 
• West Virginia University Introductory Psychology: Taught Lectures on Hormones 





• NIH Grant Writing Workshop (Fall 2015) 





• Honors Thesis: Metallacarborane research under the direction of Dr. Bruce Hodson 
and Dr. Gordon Stone at Baylor University.  My Thesis Project involved four newly 
synthesized metallacarborane compounds.  I used simple Schlenk line procedures, 
nuclear magnetic imaging, spectroscopy, and chromatography tubes to execute most 
of the experiments I conducted.  After a substantial yield of the synthesized 
compound had been collected, I ran the compound through a series of reactions.  I 
also conducted a thorough examination of structure through crystallography 
procedures.  The work was published by Lambert Academic Publishing. (Spring 
2008-2011) 
• Dissertation Work: Utilizing a blast traumatic brain injury model we investigated 
blood brain barrier disruption, axonal shearing, endoplasmic reticulum stress 
activation, NADPH activity, and iron mediated toxicity. Areas of interest include 
chronic traumatic encephalopathy, tauopathy, blast traumatic brain injury, and 
neurodegeneration. In addition to mechanistic investigation, we looked for 
therapeutic agents targeting the aforementioned pathways. We likewise investigated 
blood brain barrier disruption in ischemic stroke looking at the relationship between 
Alzheimer’s disease and ischemic infarct.  
• Past Laboratory Work:  
1. Neuroanatomy vascular perfusions with endoscopic skull based surgery using 
cadaveric models. Perfusion simulation model and microfil injections to map 
intracranial vasculature. Oregon Health & Science University. (Summer 2015) 
2. Neuroscience research rotation focused on Alzheimer’s disease and Post 
Traumatic Stress Disorder using rabbit eye blink conditioning under the 
direction of Dr. Schreurs at Blanchette Rockefeller Neurosciences Institute. 
(Summer 2011) 
3. Neuroscience research focused on Conditioned Place Preference for alcohol 
under the direction of Dr. Diaz-Granados at Baylor University. Review article 
published in Impulse: Premier Undergraduate Journal for Neuroscience 
Research (Fall 2010-Spring 2011)  
4. Immunology research focused on the mechanism of neddylation in specific 
regards to rheumatism and Alzheimer’s disease. I also looked at the role of the 
experimental drug MLN4924 on IL-2 production in a 2B411 cell line under 
the direction of Dr. Dragone at National Jewish Health in Denver, CO. 




5. Immunology research focused on malignant melanoma and the mechanism of 
toll ligand receptors under the direction of Dr. Karen Newell-Rogers and Dr. 
Josh Cabrera at University of Colorado, Colorado Springs. (Summer 2009) 
 
Memberships: 
• Alpha Lambda Delta Honor Society (Inducted Spring 2008) 
• National Society Collegiate Scholars (Inducted Spring 2008) 
• Delta Epsilon Iota Honor Society (Inducted Fall 2008) 
• Alpha Epsilon Delta Pre-medical Honor Society (Inducted Spring 2009) 
• Golden Key Honor Society (Inducted Fall 2009) 
• Nu Rho Psi- Neuroscience Honor Society (Inducted Spring 2010) 
• Alpha Chi Honor Society (Inducted Spring 2010) 
• Omicron Delta Kappa Circle of Leaders (Inducted Spring 2010)  
• American Medical Association (Fall 2011 to present) 
• American Medical Student Association (Fall 2011 to present) 
• American Physician Scientist Association (Spring 2014 to present) 
• American Association of Pharmaceutical Sciences (Spring 2014 to present) 
• American Academy of Neurology (Spring 2014 to present) 
• National Neurotrauma Society (Spring 2014 to present) 
• American Society for Pharmacology and Experimental Therapeutics (Fall 2014 to 
present) 
• American Heart Association (Spring 2015 to present) 
• American Association of Neurological Surgeons (Spring 2015 to present) 
• American College of Surgeons (Spring 2015 to present) 
• American Chemistry Society Division of Medicinal Chemistry (Spring 2015 to 
present) 
• Sigma Xi Research Society Full Member (Spring 2015 to present) 
• American Federation of Medical Research Member (Spring 2015 to present) 
• American Society of Cell Biology (Spring 2015 to present) 
• Society of Toxicology (Spring 2015 to present) 
• Microcirculatory Society (Fall 2015 to present) 
 
Achievements and Awards:   
College 
• Congressional Award Gold Medalist (Summer 2007) 
• LeadAmerica Advanced Medicine and Healthcare (Summer 2008) 
• William Carey Crane Scholar (Fall 2008) 
• Integrity Scholar of National Society of Collegiate Scholars (Spring 2008) 
• Summer Surgery Experience Fellow-University of Cincinnati (Summer 2009) 
• Intercollegiate Studies Institute-Honors Program Fellow (Summer 2009) 
• Founder’s Scholarship-Baylor University (Fall 2009) 
• Cullen Trust Symposium on Translational Research (Spring 2010) 
!
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• Who’s Who Among American College Students (Spring 2010) 
• President’s Volunteer Service Award (Spring 2010) 
• Scholar of Promise (Spring 2010) 
• Earhart Foundation Scholarship-The Philadelphia Society (Fall 2010) 
• Goodrich Foundation Scholarship-The Philadelphia Society (Spring 2011) 
• Most Outstanding Neuroscience Senior (Spring 2011) 
MD/PhD Program 
• John E. Pescott Award for Academic Excellence (Spring 2012) 
• 1st Place Oral Presentation American College of Physicians Scientific Meeting 
(Fall 2013) 
• 1st Place Oral Presentation American Association of Pharmaceutical Sciences 
Regional Meeting (Fall 2013) 
• 1st Place Oral Presentation Neurological Surgery Society of Virginias Meeting. 
The Crutchfield, Gage, and Thomson Award. (Spring 2014) 
• Behavioral and Biomedical Sciences Research Scholarship (Spring 2014) 
• American Physician Scientist Association Travel Award (Spring 2014) 
• 2nd Place Van Liere Oral Presentation (Spring 2014) 
• Synapse Travel Award (Spring 2014) 
• American Association of Clinical Investigation Travel Award (Spring 2014) 
• Neurotrauma Travel Award (Summer 2014) 
• WVU Innovator Award Finalist (Fall 2014) 
• 1st Place Oral Presentation American College of Physicians Scientific Meeting 
(Fall 2014) 
• 1st Place Oral Presentation American Association of Pharmaceutical Sciences 
Regional Meeting (Fall 2014) 
• 1st Place Poster Presentation Appalachian Regional Cell Conference (Fall 2014) 
• American Society of Pharmacology and Experimental Therapeutics Travel Award 
(Spring 2015) 
• American Society of Pharmacology and Experimental Therapeutics Best Abstract 
Competition (Spring 2015) 
• Central Society for Clinical and Translational Research Travel Award (Spring 
2015) 
• Behavioral and Biomedical Sciences Research Scholarship (Spring 2015) 
• American Federation of Medical Research Scholar (Spring 2015) 
• Burroughs-Wellcome Fund Trainee Travel Award Translational Science Meeting 
(Spring 2015) 
• 1st Place Poster Competition National American College of Physicians Meeting 
(Spring 2015) 
• Alzheimer’s Association International Conference Travel Fellowship (Summer 
2015) 
• Cranial Trauma Research Award American Association of Neurological 
Surgeons/Congress of Neurological Surgeons Section on Neurotrauma and 
Critical Care (Summer 2015) 
• American Association of Pharmaceutical Science Biotec Graduate Student 
Research Award (Fall 2015) 
• WV Rural Health Conference Travel Award (Fall 2015) 
!
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• Society of Toxicology Future Tox Silver Award (Fall 2015) 
• American College of Physicians Research Meeting 2nd Place (Fall 2015) 
• Washington Fellow’s Program American Society of Pharmacology and 
Experimental Therapeutics (2015/2016) 
• American Association of Neurological Surgeons Medical Student Summer 
Research Fellowship Award (Spring 2016) 
• American Society of Pharmacology and Experimental Therapeutics Travel Award 
and Best Abstract Award (Spring 2016) 
 
Business: 
• Co-founder of Wright Wold Scientific, LLC. Provisional patent filed.  
 
Leadership:   
      College 
• Kappa Kappa Psi National Honorary Band Fraternity:  Corresponding Secretary 
(2008-2009) and President (2009-2010). We organized and hosted the national 
convention while I was president.  
• Baylor Neuroscience Society:  Historian (2008-2009) and Vice President (2009-
2011). We introduced students to the field of neuroscience through a speaker 
series and volunteer work at the local Alzheimer’s care facility.  
• Nu Rho Psi: Vice President (2010-2011) and Regional Vice President (2011-
2014). Through this neuroscience honor society, we started an endowment to fund 
travel awards for students in order for students to present at national conferences. 
• Delta Epsilon Iota: Treasurer (2009-2010) and President (2010-2011). Our 
chapter won chapter of the year, and I was awarded most outstanding chapter 
president for our campus projects focused on career development and networking. 
• American Medical Student Association:  Treasurer (2008-2010) and Vice 
President (2010-2011). We hosted a speaker series, organized a medical service 
trip, and sent members to the national convention. 
• Alpha Epsilon Delta pre-med honor society: Treasurer (2009-2010). Through 
fundraising, we raised $3,000 for our organizational activities.  
• National Society of Collegiate Scholars: President (2009-2011) and National 
Leadership Council (2010-2011). We were named a gold star chapter for our 
focus on community service, professional development, and campus involvement. 
MD/PhD Program 
• Academic Council WVU School of Medicine (2011-2013). We were student 
advocates for our class and presented academic concerns to the professors and 
associate deans. 
• American Medical Student Association: Vice President (2012-2013). We hosted 




• Students for Global Health: Vice President (2012-2013). We hosted global health 
week featuring several well-known keynote speakers. The week long activities 
increased exposure about global health concerns campus wide.  
• Student Interest Group in Surgery:  Committee Leader (2012-2013). We hosted a 
speaker’s series regarding the different subspecialties of surgery and sponsored a 
suturing workshop.  
• Neuroscience Graduate Student Organization: Committee Chair (2014-2015). I 
worked closely with the academic steering committee to select high quality and 
engaging speakers for the neuroscience seminar series. Vice President (2015-
2016). As vice president, I helped grow the organization and expand its influence 
around campus. 
• American Association of Pharmaceutical Sciences: Treasurer (2014-2015). I 
orchestrated fundraising activities and managed a several thousand-dollar budget. 
President (2015-2016). We sponsored a regional meeting, participated in 
community service endeavors, and had multiple networking events. 
• American Physician Scientist Association: Partnerships Committee (2015-2016). 
I orchestrated new partnerships for MD/PhD students with the American 
Association of Neurological Surgeons and American College of Physicians.  
• American Foundation of Pharmaceutical Education: Development Committee 
(2016-2017). Interacted with Pharmaceutical company leaders and investors to 
provide sustainable funding for the AFPE pre-doctoral fellowships. 
 
Extracurricular: 
      College 
• Baylor University Golden Wave Marching Band (2007-2009) 
• Baylor University Concert Band (2008-2010) 
• Intramural Soccer and Basketball (2007-2010) 
• 1st place Great Brazos Relay long distance run (Fall 2009) 
• Age-division Champion Miracle Match 5K (Fall 2008) 
MD/PhD Program 
• September Stride 5K (2011)  
• Run For Cover 5K, Jim Dunn 5mile Run, Ruckus Pittsburgh, Weekly Yoga 
Classes, Racket ball, and Turkey Trot 5K  (2012) 
• WVU Indoor Triathlon, Run For Cover 5K, 2nd Place Color Run, Decker’s Creek 
Half Marathon, Ruckus, Age-division Champion Gene’s run (2013). 
• 2nd Place Cooper’s Rock Run, 3rd Place Wild Warrior Challenge, State 10k race, 
Decker’s Creek Half Marathon, Jim Dunn 5mile Run, Turkey Trot 5K (2014) 
• Technology Park Veteran’s 5k age group winner, Decker’s Creek Half Marathon, 
Bark in the Park 5k, Akron Blue Half Marathon, Marathon on the Mountain Half 
Marathon (2015) 
 
Other Life Experience: 
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• Worked at Angry Squirrel Tree Company (2005-2006) and Rocky Mountain 
Landscaping (2006-2007) 
• CPR and First Aid Certified through the American Heart Association (2010-2012) 
Renewed (2011-2013) 
• All-State Track Athlete (2007) 
• Canoed from Eli, Minnesota into Canada (2004), Backpacked in the Wemuniche 
Wilderness of Durango, CO (2005), Snowshoed in Cooper’s Rock State Park, 
WV (2014) 
• Worked at Nuremberg YMCA in Germany during the World Cup (2006) 
• Visited 48 of the 50 United States 
• Zip-Lined through the jungle in Costa Rica (2010), kayaked in bioluminescent 
bay in Puerto Rico (2014), and took a river cruise through Hungary, Slovakia, 
Austria, and Germany (2016) 
• Climbed Pikes Peak, Mt. Sherman, Mt. Lincoln, Mt. Democrat, and Mt. Bros in 
Colorado (2010) 
• Honeymooned in Iceland (2011): went deep-sea fishing, hiked along waterfalls 
and geysers, and visited the world-renowned Blue Lagoon. 
 
 
Service:   
      College 
• 100+ hours of volunteer work at the GI Lab of Memorial Hospital North in 
Colorado Springs, CO (2008-2010) 
• 60+ hours of volunteer work in Emergency Room at Hillcrest Hospital in Waco, 
TX (2009-2010) 
• 100+ hours mentoring under-privileged youth at Antioch Community Center 
(2007-2008) 
• 30+ hours of volunteer work at Wesley Woods Alzheimer Care Center (2008-
2010) 
• Two medical service trips to Belize and Mexico.  In Belize, we worked in Mayan 
villages providing medical care via a make-shift clinic, triage, and pharmacy 
under the direction of two United States physicians.  We also gathered population 
data for the Red Cross.  In Mexico, we worked with a local physician to provide 
medical care for villagers in the mountains of central Mexico.  (Spring 2009 and 
Spring 2010 respectively) 
• Civic engagement project at J.H. Hines elementary school in poverty stricken East 
Waco. I set up a tutoring program and parent involvement day, raised money 
through box tops for education, and recruited physicians to do annual check-ups 
for the students.  (2010-2011) 
MD/PhD 
• 30+ hours Mushroom Leader: Mushroom is the homeless outreach at WVU 
School of Medicine. We pass out food, water, and clothes and do basic medical 
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work under the supervision of licensed physicians. Street Rounds are every other 
Thursday evening. (2011-2013)  
• 20+ hours volunteer work at S.A.F.E. Clinic: Student run clinic for underinsured 
in Morgantown and surrounding area. (2011-2014) 
• Guest Presenter WVU Neuroscience Research Day: I interacted with 
undergraduate students, presented my research, and encouraged pursuit of further 
education. (Spring 2015) 
• Panel Participant WVU Neuroscience Career Development Session: I served on a 
panel for undergraduate neuroscience students to help encourage the pursuit of 
medical or graduate degrees training in neuroscience. (Spring 2015) 
• 100+ hours Diabetes Health Coach: taught sessions in the local community to 
foster diabetes prevention and enhance knowledge about diabetes. Was mentored 
and supervised by Dr. Ranjita Misra in the School of Public Health. (2015-2016) 
 
